C534880 | 1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane | "1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CCL2 mRNA]" | 25406165 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA]" | 11340305 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 11340305 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]" | 11340305 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester results in decreased expression of CCL2 mRNA" | 11340305 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased expression of CCL2 mRNA]" | 22915474 |
C070046 | 1,2-dioleoyloxy-3-(trimethylammonium)propane | "[Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL2 mRNA" | 22129739 |
C049325 | 1,2-dithiol-3-thione | "1,2-dithiol-3-thione results in increased expression of CCL2 mRNA" | 19162173 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA]" | 11961005 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]" | 17529908 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]" | 14576080 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Superoxides results in increased expression of CCL2 mRNA]" | 8856246 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea results in decreased expression of CCL2 mRNA" | 11128050 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [Coal Ash results in increased expression of CCL2 mRNA]" | 14569496 |
C038649 | 13-hydroperoxy-9,11-octadecadienoic acid | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 mRNA" | 22135674 |
C038649 | 13-hydroperoxy-9,11-octadecadienoic acid | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 protein" | 22135674 |
C038649 | 13-hydroperoxy-9,11-octadecadienoic acid | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 mRNA" | 22135674 |
C038649 | 13-hydroperoxy-9,11-octadecadienoic acid | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 protein" | 22135674 |
C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of CCL2 mRNA" | 22698814 |
C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of CCL2 mRNA]" | 22698814 |
C495626 | 14-deoxy-11,12-didehydroandrographolide | "14-deoxy-11,12-didehydroandrographolide analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]" | 27089844 |
C035342 | 1,4-naphthoquinone | "1,4-naphthoquinone results in increased expression of CCL2 mRNA" | 23333790 |
C046760 | 15-acetyldeoxynivalenol | 15-acetyldeoxynivalenol results in increased expression of CCL2 mRNA | 24793808 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]" | 15187150 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]" | 15187150 |
C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 15531761 |
C477819 | 15-deoxyprostaglandin J2 | Fluticasone promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 15531761 |
C477819 | 15-deoxyprostaglandin J2 | Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 15531761 |
C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 results in decreased expression of CCL2 mRNA | 12087064 |
C524733 | 17-ethynyl-5-androstene-3, 7, 17-triol | "17-ethynyl-5-androstene-3, 7, 17-triol results in decreased expression of CCL2" | 22384159 |
C062894 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid | "17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 21724996 |
C031572 | 1-carboxyheptylimidazole | 1-carboxyheptylimidazole inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16784723 |
C031572 | 1-carboxyheptylimidazole | 1-carboxyheptylimidazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16784723 |
C051246 | 1-methylanthracene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA | 28329830 |
C051246 | 1-methylanthracene | SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA] | 28329830 |
C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CCL2 mRNA | 19933214 |
C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CCL2 mRNA" | 23146750 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CCL2 mRNA" | 28712647 |
C501339 | 2-(2,6-diisopropylphenyl)-5-hydroxy-1H-isoindole-1,3-dione | "2-(2,6-diisopropylphenyl)-5-hydroxy-1H-isoindole-1,3-dione results in decreased expression of CCL2" | 21788198 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 19132243 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 19132243 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | 12016129 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein]] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein]] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein]] | 10919993 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 mRNA]] | 22700867 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]] | 22700867 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
C046728 | 2,2'-azobis(2-amidinopropane) | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C046728 | 2,2'-azobis(2-amidinopropane) | "sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]]" | 21130106 |
C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | "2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 15698426 |
C003585 | 22-hydroxycholesterol | [22-hydroxycholesterol co-treated with alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]] | 21268089 |
C003585 | 22-hydroxycholesterol | 22-hydroxycholesterol results in increased expression of CCL2 mRNA | 19426978 |
C558395 | 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone | "2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 27523796 |
C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CCL2 mRNA" | 20959002 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C010422 | 2,4,6-trichlorophenyl 4-nitrophenyl ether | "2,4,6-trichlorophenyl 4-nitrophenyl ether results in increased expression of CCL2 mRNA" | 15110079 |
C010422 | 2,4,6-trichlorophenyl 4-nitrophenyl ether | "2,4,6-trichlorophenyl 4-nitrophenyl ether results in increased expression of CCL2 protein" | 15110079 |
C010914 | 2,4-diaminotoluene | "2,4-diaminotoluene results in increased expression of CCL2 mRNA" | 20713471 |
C044563 | 24-hydroxycholesterol | "[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA" | 24802026 |
C044563 | 24-hydroxycholesterol | 24-hydroxycholesterol results in increased expression of CCL2 mRNA | 24802026 |
C044563 | 24-hydroxycholesterol | "Quercetin analog inhibits the reaction [[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA]" | 24802026 |
C044563 | 24-hydroxycholesterol | Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of CCL2 mRNA] | 24802026 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]] | 19446813 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16794257 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 25171655 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19293636|2222551 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CCL2 mRNA | 23380242 |
C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C076996 | 27-hydroxycholesterol | "[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA" | 24802026 |
C076996 | 27-hydroxycholesterol | 27-hydroxycholesterol results in increased expression of CCL2 mRNA | 24802026 |
C076996 | 27-hydroxycholesterol | "Quercetin analog inhibits the reaction [[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA]" | 24802026 |
C076996 | 27-hydroxycholesterol | Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of CCL2 mRNA] | 24802026 |
C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "[flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CCL2 mRNA" | 23681119 |
C012796 | 2-butenal | 2-butenal results in decreased expression of CCL2 mRNA | 20471460 |
C457499 | 2-chloro-5-nitrobenzanilide | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 mRNA" | 22135674 |
C457499 | 2-chloro-5-nitrobenzanilide | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with 2-chloro-5-nitrobenzanilide] results in increased expression of CCL2 protein" | 22135674 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of CCL2 mRNA | 22446026 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of CCL2 protein | 21070800 |
C031278 | 2-chloroethyl ethyl sulfide | TNFRSF1A gene mutant form inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CCL2 mRNA] | 21070800 |
C518860 | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 22746536 |
C568680 | (2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 22746536 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "[3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to and results in increased activity of CNR2 protein] which results in increased expression of CCL2 mRNA" | 10821843 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA" | 10218491 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein" | 10218491 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]" | 10218491 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]" | 10218491 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]]" | 10218491 |
C054649 | 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol | "SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]]" | 10218491 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA" | 21925196 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA" | 19265715|2113010 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl results in increased secretion of CCL2 protein" | 19265715 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "Acetylcysteine inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "pyrazolanthrone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "SB 203580 inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "sulforafan inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
C028451 | 3,4,3',4'-tetrachlorobiphenyl | "Tretinoin promotes the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA" | 22262711|2835176 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22262711 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 protein" | 28973532 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA]" | 28973532 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA" | 19265715|2437806 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein" | 19265715|2816311 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased secretion of CCL2 protein" | 27663891 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]" | 19265715 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "Sunphenon inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 24378064 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CCL2 mRNA" | 23196670 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA" | 19692669|2095900 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA" | 19265715|2252160 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein" | 22521609 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22521609 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]" | 22521609 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "NFE2L2 protein affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22521609 |
C035419 | 3,4-dihydroxybenzohydroxamic acid | "3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 25843059 |
C035419 | 3,4-dihydroxybenzohydroxamic acid | "3,4-dihydroxybenzohydroxamic acid results in decreased expression of CCL2 mRNA" | 25843059 |
C028288 | 3',4'-dihydroxyflavone | "3',4'-dihydroxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]" | 24134915 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein promotes the reaction [BRD4 protein binds to CCL2 enhancer]] | 25263595 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to CCL2 enhancer]] | 25263595 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 17666914 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 19945525 |
C523668 | 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine | "3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine inhibits the reaction [Cisplatin results in increased expression of CCL2 protein]" | 25308879 |
C043247 | 3-acetyldeoxynivalenol | 3-acetyldeoxynivalenol results in increased expression of CCL2 mRNA | 24793808 |
C513113 | 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid | 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid inhibits the reaction [Fingolimod Hydrochloride results in increased expression of CCL2 protein] | 23043544 |
C106572 | 3-iodo-2-propynylbutylcarbamate | 3-iodo-2-propynylbutylcarbamate results in decreased expression of CCL2 | 21788198 |
C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | 21441140 |
C441128 | 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate | "3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate affects the reaction [Dietary Fats affects the expression of CCL2 mRNA]" | 28899902 |
C031285 | 3-xylene | 3-xylene results in increased expression of CCL2 protein | 17993253 |
C031285 | 3-xylene | 3-xylene results in increased expression of CCL2 protein | 15902427 |
C471109 | 4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline | "4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [TNF results in increased expression of CCL2 protein]" | 19020780 |
C471109 | 4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline | "4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [Palmitates results in increased secretion of CCL2 protein]" | 18303122 |
C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | 15721863 |
C572961 | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid | 4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid results in decreased expression of CCL2 protein | 25377915 |
C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 25724490 |
C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein] | 21832210 |
C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | stannous mesoporphyrin inhibits the reaction [4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein]] | 21832210 |
C524106 | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 23611540 |
C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of CCL2 mRNA" | 18648102 |
C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | 18645721 |
C583074 | 4,4'-hexafluorisopropylidene diphenol | "4,4'-hexafluorisopropylidene diphenol results in decreased expression of CCL2 mRNA" | 25912373 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide affects the expression of CCL2 mRNA | 17766677 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | ALOX5 protein affects the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide affects the expression of CCL2 mRNA] | 17766677 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCL2 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCL2 mRNA" | 27188386 |
C081510 | 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone | 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein | 15762874 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of CCL2 mRNA | 19191707 |
C108036 | 4'-hydroxydiclofenac | 4'-hydroxydiclofenac results in increased expression of CCL2 mRNA | 24104198 |
C097470 | 4'-methoxychalcone | 4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 28528971 |
C025566 | 4-methylhistamine | 4-methylhistamine results in decreased expression of CCL2 protein | 17507084 |
C549066 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | "4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA]" | 26546572 |
C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CCL2 protein | 15762874 |
C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid results in decreased expression of CCL2 mRNA | 28698385 |
C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased secretion of CCL2 protein | 22245253 |
C094782 | 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone | "5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA]" | 20438634 |
C103111 | 5,7,3',4'-tetramethylluteolin | "5,7,3',4'-tetramethylluteolin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]" | 24134915 |
C103112 | 5,7,4'-trimethylapigenin | "5,7,4'-trimethylapigenin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]" | 24134915 |
C524883 | 5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one | "5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]" | 24752613 |
C060298 | 5,7-dimethoxyflavone | "5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]" | 24134915 |
C056369 | 5-(N-methyl-N-isobutyl)amiloride | "5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C499823 | 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid | "5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of CCL2 protein]" | 20383154 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCL2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCL2 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 24465016 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide results in decreased expression of CCL2 mRNA]" | 24465016 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Quercetin results in decreased expression of CCL2 mRNA]" | 24465016 |
C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased expression of CCL2 protein | 24895526 |
C003001 | 7-ketocholesterol | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL2 protein] | 24895526 |
C505734 | 7-oxozeanol | 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
C505734 | 7-oxozeanol | 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein] | 23958496 |
C505734 | 7-oxozeanol | 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C505734 | 7-oxozeanol | 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein] | 23958496 |
C031433 | 8-(4-sulfophenyl)theophylline | 8-(4-sulfophenyl)theophylline inhibits the reaction [9-(2-hydroxy-3-nonyl)adenine results in increased secretion of CCL2 protein] | 17696452 |
C031433 | 8-(4-sulfophenyl)theophylline | 8-(4-sulfophenyl)theophylline results in decreased secretion of CCL2 protein | 17696452 |
C010192 | 9-(2-hydroxy-3-nonyl)adenine | 8-(4-sulfophenyl)theophylline inhibits the reaction [9-(2-hydroxy-3-nonyl)adenine results in increased secretion of CCL2 protein] | 17696452 |
C010192 | 9-(2-hydroxy-3-nonyl)adenine | 9-(2-hydroxy-3-nonyl)adenine results in increased secretion of CCL2 protein | 17696452 |
C574274 | 9-hydroxycanthin-6-one | 9-hydroxycanthin-6-one results in decreased expression of CCL2 mRNA | 29225138 |
C112040 | A2-E (N-retinylidene-N-retinylethanolamine) | CCL2 protein affects the abundance of A2-E (N-retinylidene-N-retinylethanolamine) | 20361964 |
C112040 | A2-E (N-retinylidene-N-retinylethanolamine) | Quercetin inhibits the reaction [CCL2 protein affects the abundance of A2-E (N-retinylidene-N-retinylethanolamine)] | 20361964 |
C048324 | abamectin | abamectin results in decreased expression of CCL2 | 21788198 |
C496492 | abrine | abrine results in increased expression of CCL2 mRNA | 22595364 |
D000040 | Abscisic Acid | CCL2 protein results in increased secretion of Abscisic Acid | 24211328 |
D000040 | Abscisic Acid | fluridone inhibits the reaction [CCL2 protein results in increased secretion of Abscisic Acid] | 24211328 |
D020909 | Acarbose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA] | 17133782 |
D020909 | Acarbose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 protein] | 17133782 |
D000079 | Acetaldehyde | Acetaldehyde results in increased expression of CCL2 mRNA | 17050345 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of CCL2 mRNA | 21420995|2906747 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CCL2 mRNA | 17562736 |
D000082 | Acetaminophen | [Acetaminophen co-treated with Ozone] results in increased expression of CCL2 mRNA | 20123758 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 mRNA | 12153990|1455074 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 protein | 11981759|1455738 |
D000082 | Acetaminophen | Acetaminophen results in increased secretion of CCL2 protein | 26079055 |
D000082 | Acetaminophen | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 19799668 |
D000082 | Acetaminophen | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein] | 19799668 |
D000082 | Acetaminophen | CAV1 affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 20100502 |
D000082 | Acetaminophen | Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 26079055 |
D000082 | Acetaminophen | Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of CCL2 protein] | 26079055 |
D000082 | Acetaminophen | IFNG protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 12153990 |
D000082 | Acetaminophen | KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 15578514 |
D000082 | Acetaminophen | MST1R protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 22575169 |
D000082 | Acetaminophen | [Ozone co-treated with Acetaminophen] results in increased expression of CCL2 protein | 20123758 |
D000082 | Acetaminophen | Ozone inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 20123758 |
D000082 | Acetaminophen | saikosaponin inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 25265579 |
D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 14550746|1455738 |
D000082 | Acetaminophen | TNFRSF1A protein promotes the reaction [Acetaminophen results in increased expression of CCL2 protein] | 14557383 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CCL2 protein | 16687475 |
C016635 | acetoacetic acid | acetoacetic acid results in increased secretion of CCL2 protein | 17665966 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | 16845898 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 22414048 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22414048 |
C056165 | acetovanillone | acetovanillone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C056165 | acetovanillone | acetovanillone results in decreased expression of CCL2 mRNA | 23380242 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 26683377 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17529908 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D000111 | Acetylcysteine | Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 11124598 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 10541287 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]] | 22700867 |
D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
D000171 | Acrolein | Acrolein results in increased expression of CCL2 mRNA | 17982132 |
D000171 | Acrolein | Acrolein results in increased expression of CCL2 mRNA | 17950725 |
D000171 | Acrolein | CD8A protein promotes the reaction [Acrolein results in increased expression of CCL2 mRNA] | 17950725 |
C036658 | acrylic acid | acrylic acid analog inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 mRNA] | 27018375 |
D000181 | Acrylonitrile | Acrylonitrile results in decreased expression of CCL2 mRNA | 16173056 |
D000181 | Acrylonitrile | Acetylcysteine inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
D000181 | Acrylonitrile | Acrylonitrile results in increased expression of CCL2 mRNA | 26332274 |
D000181 | Acrylonitrile | alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
D000181 | Acrylonitrile | Plant Extracts inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
C058956 | acteoside | "acteoside inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C058956 | acteoside | acteoside results in decreased expression of CCL2 mRNA | 21756928|2196761 |
C058956 | acteoside | acteoside results in decreased secretion of CCL2 protein | 21967610 |
C058956 | acteoside | acteoside inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C499366 | Active Hexose Correlated Compound | Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA] | 17449585 |
C499366 | Active Hexose Correlated Compound | Active Hexose Correlated Compound results in increased secretion of CCL2 protein | 23194525 |
C499366 | Active Hexose Correlated Compound | MYD88 protein affects the reaction [Active Hexose Correlated Compound results in increased secretion of CCL2 protein] | 23194525 |
C499366 | Active Hexose Correlated Compound | TLR4 protein affects the reaction [Active Hexose Correlated Compound results in increased secretion of CCL2 protein] | 23194525 |
C016957 | adenosine-3',5'-cyclic phosphorothioate | "adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [LEP protein results in increased expression of CCL2]" | 11342529 |
D000276 | Adjuvants, Immunologic | "Adjuvants, Immunologic results in increased expression of CCL2" | 19439372 |
C472668 | AEOL 10150 | AEOL 10150 results in decreased expression of CCL2 mRNA | 12374626 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CCL2 mRNA | 27153756 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CCL2 mRNA | 19770486 |
C027955 | aflatoxin G1 | aflatoxin G1 results in increased expression of CCL2 mRNA | 25445582 |
C412373 | AG 1879 | AG 1879 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
C031143 | AICA ribonucleotide | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 24465016 |
C031143 | AICA ribonucleotide | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide results in decreased expression of CCL2 mRNA]" | 24465016 |
C031143 | AICA ribonucleotide | AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 24465016 |
C031143 | AICA ribonucleotide | AICA ribonucleotide results in decreased expression of CCL2 mRNA | 24465016 |
C031143 | AICA ribonucleotide | AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D000393 | Air Pollutants | Air Pollutants analog results in increased expression of CCL2 mRNA | 21757418 |
D000393 | Air Pollutants | Air Pollutants results in increased expression of CCL2 mRNA | 21757418 |
D000393 | Air Pollutants | Air Pollutants affects the expression of CCL2 mRNA | 26618301 |
C000188 | alachlor | alachlor results in decreased expression of CCL2 | 21788198 |
D015766 | Albendazole | Albendazole results in increased expression of CCL2 protein | 20116850 |
C021137 | alclometasone dipropionate | alclometasone dipropionate results in decreased expression of CCL2 protein | 20116850 |
D000447 | Aldehydes | Aldehydes results in increased expression of CCL2 mRNA | 25014914 |
C001570 | alexidine | alexidine results in decreased expression of CCL2 protein | 20116850 |
C526957 | alisol B 23-acetate | alisol B 23-acetate inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
C103303 | alitretinoin | [22-hydroxycholesterol co-treated with alitretinoin] inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]] | 21268089 |
D000493 | Allopurinol | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | 19158351 |
D000493 | Allopurinol | Allopurinol inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D000493 | Allopurinol | Allopurinol results in increased expression of CCL2 mRNA | 26641773 |
D000493 | Allopurinol | pyrazolanthrone inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
D000493 | Allopurinol | SB 203580 inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
D000493 | Allopurinol | U 0126 inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
D000493 | Allopurinol | Allopurinol inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
D000496 | Alloxan | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]] | 18949387 |
C006463 | allyl alcohol | allyl alcohol results in increased expression of CCL2 mRNA | 21907259 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of CCL2 mRNA | 20409345 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of CCL2 protein | 26025059 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [TNF protein results in increased expression of CCL2 protein]" | 17666914 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA]" | 23958496 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein]" | 23958496 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 21426947 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 22225513 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]" | 23958496 |
C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]" | 23958496 |
D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 16317058 |
D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16317058 |
D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16317058 |
D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16317058 |
D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 16317058 |
C011512 | alpha-naphthoflavone | "alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22262711 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | 22262711 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in decreased expression of CCL2 mRNA | 22262711 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased expression of CCL2 mRNA | 22262711 |
C011512 | alpha-naphthoflavone | "alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | 19735175 |
D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 24333275 |
D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 10690939 |
D000534 | Alum Compounds | Alum Compounds results in increased secretion of CCL2 protein | 18390722 |
D000534 | Alum Compounds | Alum Compounds results in increased expression of CCL2 | 19439372 |
D000536 | Aluminum Hydroxide | Aluminum Hydroxide results in increased secretion of CCL2 protein | 18390722 |
D000537 | Aluminum Oxide | Aluminum Oxide results in increased secretion of CCL2 protein | 17618502 |
D000584 | Amiloride | "Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
D000584 | Amiloride | Amiloride inhibits the reaction [ALB protein results in increased expression of CCL2 protein] | 11340305 |
D000584 | Amiloride | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 11340305 |
D000584 | Amiloride | Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | 11340305 |
D000584 | Amiloride | Amiloride results in decreased expression of CCL2 mRNA | 11340305 |
D000584 | Amiloride | Amiloride results in decreased expression of CCL2 protein | 11340305 |
D000584 | Amiloride | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA] | 11340305 |
D000584 | Amiloride | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein] | 11340305 |
D006710 | Homocysteine | acetovanillone inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | 16845898 |
D006710 | Homocysteine | Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | 16845898 |
D006710 | Homocysteine | Homocysteine results in increased expression of CCL2 mRNA | 11356643|1684589 |
D006710 | Homocysteine | Homocysteine results in increased expression of CCL2 protein | 11356643 |
D006710 | Homocysteine | [Homocysteine results in increased expression of CCL2 protein] which results in increased phosphorylation of NFKBIA protein | 11356643 |
D006710 | Homocysteine | [Homocysteine results in increased expression of CCL2 protein] which results in increased reduction of NFKBIA mRNA | 11356643 |
D000638 | Amiodarone | Amiodarone inhibits the reaction [CRP protein results in increased expression of CCL2 protein] | 19225199 |
D000638 | Amiodarone | Amiodarone results in increased expression of CCL2 mRNA | 23397585 |
D000638 | Amiodarone | [Amiodarone co-treated with Dexamethasone] results in increased expression of CCL2 mRNA | 25900201 |
D000640 | Amitrole | Amitrole results in decreased expression of CCL2 mRNA | 23397585 |
D017311 | Amlodipine | Amlodipine results in decreased expression of CCL2 mRNA | 16392774 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CCL2 mRNA | 16483693 |
C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of CCL2 mRNA" | 22863853 |
C095108 | amprenavir | amprenavir results in increased expression of CCL2 protein | 17668557 |
C030419 | andrographolide | [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA | 19737545 |
D000841 | Anisomycin | Anisomycin results in decreased expression of CCL2 protein | 20116850 |
D039741 | Antigens, Dermatophagoides | "Antigens, Dermatophagoides results in increased expression of CCL2 mRNA" | 26091108 |
D039741 | Antigens, Dermatophagoides | "Nanotubes, Carbon promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL2 mRNA]" | 26091108 |
D000967 | Antimony Sodium Gluconate | Antimony Sodium Gluconate results in decreased expression of CCL2 mRNA | 20102417 |
D000968 | Antimycin A | Antimycin A results in decreased expression of CCL2 protein | 20116850 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CCL2 mRNA | 24449571 |
D047310 | Apigenin | Apigenin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 24134915 |
C519728 | archazolid B | archazolid B results in decreased expression of CCL2 mRNA | 25218289 |
C071942 | arctigenin | "arctigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 21426947 |
C031942 | argatroban | argatroban inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 22841818 |
C031942 | argatroban | argatroban inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 22841818 |
D034341 | Aristolochic Acids | Aristolochic Acids results in decreased susceptibility to CCL2 protein | 21453692 |
D001151 | Arsenic | Arsenic results in increased expression of CCL2 mRNA | 12928151 |
D001151 | Arsenic | CCL2 polymorphism results in increased susceptibility to Arsenic | 18022660 |
C058317 | arsenic disulfide | arsenic disulfide results in increased expression of CCL2 mRNA | 16918137 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA | 19828696 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 protein | 19828696 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 mRNA | 15761015|1823173 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 protein | 19828696 |
C006632 | arsenic trioxide | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CCL2 mRNA | 15894607 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 mRNA | 22488045 |
C006632 | arsenic trioxide | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | 22488045 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 mRNA | 22422340 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL2 protein | 22422340 |
C006632 | arsenic trioxide | [Sodium Fluoride co-treated with arsenic trioxide] results in increased expression of CCL2 protein | 22422340 |
C006632 | arsenic trioxide | Sodium Fluoride inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | 22422340 |
C015001 | arsenite | arsenite results in decreased expression of CCL2 mRNA | 16085347 |
C015001 | arsenite | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of CCL2 mRNA] | 16085347 |
D001194 | Asbestos | Asbestos results in increased expression of CCL2 mRNA | 22398240 |
D001194 | Asbestos | Asbestos results in increased expression of CCL2 protein | 18795166 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in decreased secretion of CCL2 protein" | 19041333 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CCL2 mRNA" | 23634900|2416032 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CCL2 mRNA" | 23917077|2683933 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CCL2 protein" | 23917077 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CCL2 mRNA" | 10923243 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CCL2 protein" | 10923243|1660178 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased secretion of CCL2 protein" | 10923243 |
D017638 | Asbestos, Crocidolite | "IL1B protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CCL2 mRNA]" | 10923243 |
D017638 | Asbestos, Crocidolite | "IL1B protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of CCL2 protein]" | 10923243 |
D017638 | Asbestos, Crocidolite | "TNF protein promotes the reaction [Asbestos, Crocidolite results in increased expression of CCL2 mRNA]" | 10923243 |
D017638 | Asbestos, Crocidolite | "TNF protein promotes the reaction [Asbestos, Crocidolite results in increased secretion of CCL2 protein]" | 10923243 |
D001205 | Ascorbic Acid | Ascorbic Acid affects the expression of CCL2 mRNA | 19932582 |
D001205 | Ascorbic Acid | Ascorbic Acid deficiency affects the expression of CCL2 mRNA | 19932582 |
D001205 | Ascorbic Acid | Ascorbic Acid results in decreased expression of CCL2 mRNA | 21796779 |
D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694 |
D001241 | Aspirin | Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D001241 | Aspirin | Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24211328 |
D001241 | Aspirin | Aspirin inhibits the reaction [TNF results in increased expression of CCL2 mRNA] | 15136050 |
D001241 | Aspirin | Aspirin inhibits the reaction [TNF results in increased secretion of CCL2 protein] | 15136050 |
D001241 | Aspirin | Aspirin inhibits the reaction [AGT protein modified form results in increased expression of CCL2 mRNA] | 22306536 |
C001579 | astragalin | astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22210036 |
C528574 | astressin-2B | "astressin-2B inhibits the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA]" | 16920976 |
D000069446 | Atazanavir Sulfate | Atazanavir Sulfate results in increased expression of CCL2 protein | 17668557 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [TNF results in increased expression of CCL2 mRNA] | 12117737 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in decreased expression of and results in decreased secretion of CCL2 protein | 12117737 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in decreased expression of CCL2 mRNA | 12117737 |
D000069059 | Atorvastatin Calcium | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737 |
D000069059 | Atorvastatin Calcium | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium results in decreased expression of CCL2 mRNA] | 12117737 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium inhibits the reaction [sodium arsenite results in increased expression of CCL2 protein] | 25058445 |
C072763 | azamethiphos | azamethiphos results in decreased expression of CCL2 | 21788198 |
C000609563 | AZD8848 | AZD8848 results in increased secretion of CCL2 protein | 29122671 |
D017963 | Azithromycin | Azithromycin results in decreased expression of CCL2 protein | 20231397 |
C547126 | AZM551248 | AZM551248 results in increased expression of CCL2 mRNA | 22323515 |
C000596027 | baricitinib | baricitinib inhibits the reaction [OSM protein results in increased expression of CCL2 mRNA] | 23968543 |
C028559 | bathocuproine sulfonate | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 11006087 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | 16705055 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D001507 | Beclomethasone | Beclomethasone results in decreased expression of CCL2 protein | 20116850 |
C044946 | benazepril | benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
C044946 | benazepril | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | 16284884 |
C030935 | benz(a)anthracene | [benz(a)anthracene co-treated with TNF protein] results in increased expression of CCL2 mRNA | 23396138 |
D001554 | Benzene | Benzene results in increased expression of CCL2 mRNA | 21843810 |
D001554 | Benzene | Benzene results in increased expression of CCL2 protein | 15902427 |
D001558 | Benzethonium | Benzethonium results in decreased expression of CCL2 protein | 20116850 |
D019324 | beta-Naphthoflavone | [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CCL2 mRNA | 19737545 |
D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of CCL2 mRNA | 22687991 |
D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA | 21295105 |
D019324 | beta-Naphthoflavone | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | 21295105 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CCL2 mRNA | 20064835 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CCL2 mRNA | 22316170|2835176 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to CCL2 promoter] | 19654925 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CCL2 mRNA | 19770486 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CCL2 mRNA | 20713471 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CCL2 | 19265715 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CCL2 mRNA" | 20382639 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 11230753 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 11698246 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 11698246 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 11230753 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 19945525 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 10541287 |
D001599 | Berberine | Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 16391493 |
D001599 | Berberine | Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 16391493 |
D001599 | Berberine | Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16391493 |
D001599 | Berberine | Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 16391493 |
D004958 | Estradiol | ESR1 protein affects the reaction [Estradiol results in decreased activity of CCL2 protein] | 17006379 |
D004958 | Estradiol | Estradiol affects the expression of CCL2 mRNA | 14699072 |
D004958 | Estradiol | Estradiol inhibits the reaction [IL1A protein promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to CCL2 promoter]] | 10614622 |
D004958 | Estradiol | Estradiol inhibits the reaction [IL1A protein results in increased expression of CCL2 mRNA] | 10614622 |
D004958 | Estradiol | Estradiol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 10614622 |
D004958 | Estradiol | Estradiol results in decreased activity of CCL2 protein | 17006379 |
D004958 | Estradiol | Estradiol results in decreased expression of CCL2 mRNA | 23397585 |
D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in decreased activity of CCL2 protein] | 17006379 |
D004958 | Estradiol | Estradiol affects the expression of CCL2 mRNA | 15598610 |
D004958 | Estradiol | Estradiol results in decreased secretion of CCL2 protein | 12538720 |
D004958 | Estradiol | Estradiol results in increased expression of CCL2 mRNA | 19484750 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of CCL2 mRNA | 21277368 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of CCL2 protein | 21277368 |
D004958 | Estradiol | Estradiol inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
D047071 | beta-Glucans | beta-Glucans results in increased expression of CCL2 protein | 17572156 |
C483161 | beta-hydroxy simvastatin acid | beta-hydroxy simvastatin acid results in decreased expression of CCL2 mRNA | 18192240 |
D001622 | Betaine | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D001623 | Betamethasone | Betamethasone results in decreased expression of CCL2 protein | 20116850 |
C013185 | beta-penta-O-galloyl-glucose | beta-penta-O-galloyl-glucose inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16253226 |
D001629 | Bezafibrate | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | 18513333 |
D001629 | Bezafibrate | Bezafibrate results in decreased expression of CCL2 mRNA | 16574099 |
C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 16317058 |
C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16317058 |
C018465 | bioallethrin | bioallethrin results in decreased expression of CCL2 | 21788198 |
C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of CCL2 mRNA | 25912373 |
C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CCL2 mRNA | 28628672 |
C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased expression of CCL2 protein | 28903498 |
C002791 | bismuth tripotassium dicitrate | bismuth tripotassium dicitrate results in increased expression of CCL2 mRNA | 15912405 |
D017298 | Bisoprolol | Bisoprolol results in decreased expression of CCL2 protein | 19840533 |
C006780 | bisphenol A | bisphenol A affects the expression of CCL2 mRNA | 19490990 |
C006780 | bisphenol A | bisphenol A inhibits the reaction [IL1A protein promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to CCL2 promoter]] | 10614622 |
C006780 | bisphenol A | bisphenol A inhibits the reaction [IL1A protein results in increased expression of CCL2 mRNA] | 10614622 |
C006780 | bisphenol A | bisphenol A inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 10614622 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CCL2 mRNA | 25912373|2768578 |
C006780 | bisphenol A | bisphenol A results in increased expression of CCL2 mRNA | 25333893 |
C006780 | bisphenol A | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
C006780 | bisphenol A | [bisphenol A co-treated with OVAL protein] results in increased expression of CCL2 mRNA | 27087817 |
C006780 | bisphenol A | bisphenol A results in increased expression of CCL2 mRNA | 27145005|2850008 |
C006780 | bisphenol A | bisphenol A results in increased expression of CCL2 protein | 25862758|2850008 |
C006780 | bisphenol A | bisphenol A affects the expression of CCL2 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of CCL2 gene | 28505145 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CCL2 | 21788198 |
D001761 | Bleomycin | Bleomycin results in increased expression of CCL2 mRNA | 15541506|1631446 |
D001761 | Bleomycin | Bleomycin results in increased expression of CCL2 protein | 15541506|1914782 |
D001761 | Bleomycin | Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 26520185 |
D001761 | Bleomycin | CCL11 protein promotes the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 16314464 |
D001761 | Bleomycin | CEBPB protein affects the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 17177178 |
D001761 | Bleomycin | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 26526764 |
D001761 | Bleomycin | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 19147827 |
D001761 | Bleomycin | SPL-334 inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 26209236 |
D001761 | Bleomycin | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 15541506 |
D001761 | Bleomycin | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 15541506 |
D000069286 | Bortezomib | Bortezomib results in decreased expression of CCL2 mRNA | 20471514 |
C006794 | brevianamide A | brevianamide A results in decreased expression of CCL2 mRNA | 19818335 |
D000551 | Ambroxol | Ambroxol affects the reaction [Paraquat results in increased expression of CCL2 mRNA] | 21921364 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 11230753 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] | 11230753 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | 16997883 |
D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCL2 protein | 20940016 |
C025191 | bromodichloromethane | bromodichloromethane promotes the reaction [Dietary Fats results in increased expression of CCL2 protein] | 23438451 |
C026535 | bucillamine | bucillamine inhibits the reaction [chlorobenzene results in increased secretion of CCL2 protein] | 19800902 |
D019819 | Budesonide | Budesonide results in decreased expression of CCL2 protein | 20116850 |
D019819 | Budesonide | "Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 15734790 |
D019819 | Budesonide | "Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 15734790 |
C487162 | butafenacil | butafenacil results in decreased expression of CCL2 | 21788198 |
D019328 | Buthionine Sulfoximine | [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of CCL2 mRNA | 22407903 |
D019328 | Buthionine Sulfoximine | [Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA | 26177832 |
D019328 | Buthionine Sulfoximine | gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA] | 26177832 |
C006852 | butralin | butralin results in decreased expression of CCL2 | 21788198 |
D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | 16822543 |
D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased expression of CCL2 protein | 16443645 |
D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased secretion of CCL2 protein | 16443645 |
D020122 | tert-Butylhydroperoxide | [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
D020122 | tert-Butylhydroperoxide | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter] | 20847119 |
D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA | 20847119 |
D020122 | tert-Butylhydroperoxide | [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
D020122 | tert-Butylhydroperoxide | troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]] | 20847119 |
D020122 | tert-Butylhydroperoxide | troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA] | 20847119 |
C018475 | butyraldehyde | butyraldehyde results in increased expression of CCL2 mRNA | 26079696 |
D020148 | Butyric Acid | Butyric Acid results in increased expression of CCL2 mRNA | 17928716 |
D002104 | Cadmium | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | 21481475 |
D002104 | Cadmium | Cadmium results in increased expression of CCL2 protein | 25343288 |
D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 26809137 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CCL2 mRNA | 23397585 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CCL2 mRNA | 23921151 |
D019256 | Cadmium Chloride | [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which affects the expression of CCL2 mRNA | 23921151 |
D019256 | Cadmium Chloride | [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of CCL2 mRNA | 23921151 |
D019256 | Cadmium Chloride | [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which affects the expression of CCL2 mRNA | 23921151 |
D019256 | Cadmium Chloride | [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of CCL2 mRNA | 23921151 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of CCL2 promoter | 22457795 |
C058667 | cadmium selenide | [cadmium selenide co-treated with zinc sulfide] results in decreased expression of CCL2 mRNA | 22342292 |
C040048 | caffeic acid | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | 16806235 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [arsenite results in decreased expression of CCL2 mRNA] | 16085347 |
D000001 | Calcimycin | Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 18799549 |
D000001 | Calcimycin | Calcimycin results in increased expression of CCL2 mRNA | 8764118 |
D002118 | Calcium | CCL2 protein results in increased abundance of Calcium | 16771778 |
D002118 | Calcium | CCL2 protein results in increased uptake of Calcium | 10984371 |
D002118 | Calcium | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | 16771778 |
D002118 | Calcium | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | 10843593 |
D002118 | Calcium | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | 16212921 |
D002122 | Calcium Chloride | Calcium Chloride results in increased expression of CCL2 mRNA | 21530968 |
D002122 | Calcium Chloride | Calcium Chloride results in increased expression of CCL2 protein | 22728078 |
D002122 | Calcium Chloride | Calcium Chloride results in increased phosphorylation of CCL2 protein | 21530968 |
D002122 | Calcium Chloride | Quercetin inhibits the reaction [Calcium Chloride results in increased expression of CCL2 protein] | 22728078 |
D002122 | Calcium Chloride | resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CCL2 mRNA] | 21530968 |
D002122 | Calcium Chloride | resveratrol inhibits the reaction [Calcium Chloride results in increased phosphorylation of CCL2 protein] | 21530968 |
C031293 | calcium silicate | calcium silicate results in increased expression of CCL2 protein | 16601788 |
C117342 | calfactant | "[Nanotubes, Carbon co-treated with calfactant] results in increased expression of CCL2 mRNA" | 23026733 |
C117342 | calfactant | "[Nanotubes, Carbon co-treated with calfactant] results in increased expression of CCL2 protein" | 23026733 |
C058819 | calphostin C | calphostin C inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | 11961005 |
D002166 | Camptothecin | Camptothecin results in decreased expression of CCL2 protein | 20116850 |
C081643 | candesartan | candesartan inhibits the reaction [AGT protein results in increased secretion of CCL2 protein] | 17922026 |
D002185 | Cannabidiol | "Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 19910459 |
D002185 | Cannabidiol | Cannabidiol results in decreased expression of CCL2 mRNA | 21542829 |
C073718 | cannabidiol hydroxyquinone | cannabidiol hydroxyquinone results in decreased expression of CCL2 mRNA | 16571653 |
C070646 | CAP18 lipopolysaccharide-binding protein | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]] | 18949387 |
C070646 | CAP18 lipopolysaccharide-binding protein | CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 mRNA | 18949387 |
C070646 | CAP18 lipopolysaccharide-binding protein | CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein | 18949387 |
C070646 | CAP18 lipopolysaccharide-binding protein | Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 mRNA] | 18949387 |
C070646 | CAP18 lipopolysaccharide-binding protein | Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein] | 18949387 |
C070646 | CAP18 lipopolysaccharide-binding protein | CAP18 lipopolysaccharide-binding protein inhibits the reaction [[Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21731756 |
D002211 | Capsaicin | Capsaicin results in decreased expression of CCL2 mRNA | 17719033|1979806 |
D002211 | Capsaicin | Capsaicin results in decreased expression of CCL2 protein | 19798065 |
D002211 | Capsaicin | Capsaicin results in decreased secretion of CCL2 protein | 17719033|1979806 |
D002211 | Capsaicin | capsazepine inhibits the reaction [Capsaicin results in decreased secretion of CCL2 protein] | 19798065 |
D002211 | Capsaicin | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | 17719033 |
D002211 | Capsaicin | Capsaicin results in increased expression of CCL2 mRNA | 20349343 |
D002211 | Capsaicin | Capsaicin results in increased expression of CCL2 protein | 22150557 |
D002211 | Capsaicin | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
D002211 | Capsaicin | Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
D002211 | Capsaicin | Sumatriptan affects the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
C071423 | capsazepine | capsazepine inhibits the reaction [Capsaicin results in decreased secretion of CCL2 protein] | 19798065 |
C005563 | captax | captax results in decreased expression of CCL2 mRNA | 20713136 |
D002229 | Carbenoxolone | Carbenoxolone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 27523796 |
D002251 | Carbon Tetrachloride | ABCB11 inhibits the reaction [NR1H4 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA]] | 28505368 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CCL2 mRNA | 12500195|1712587 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CCL2 protein | 22206755|2543296 |
D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of LTB mRNA] | 17125873 |
D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] | 17125873 |
D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] | 17125873 |
D002251 | Carbon Tetrachloride | CCL2 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA] | 17125873 |
D002251 | Carbon Tetrachloride | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein]] | 25432964 |
D002251 | Carbon Tetrachloride | FOXF1 protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 12500195 |
D002251 | Carbon Tetrachloride | ginsan inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 19913046 |
D002251 | Carbon Tetrachloride | GW0742 inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 18622026 |
D002251 | Carbon Tetrachloride | HAS3 protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 27042213 |
D002251 | Carbon Tetrachloride | HAS3 protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 27042213 |
D002251 | Carbon Tetrachloride | NR1H4 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 28505368 |
D002251 | Carbon Tetrachloride | obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 27865854 |
D002251 | Carbon Tetrachloride | PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 18622026 |
D002251 | Carbon Tetrachloride | PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 25432964 |
D002251 | Carbon Tetrachloride | SC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 25432964 |
D002251 | Carbon Tetrachloride | TBXA2R protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 22206755 |
D002251 | Carbon Tetrachloride | TBXA2R protein affects the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 22206755 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CCL2 mRNA | 22683883 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CCL2 protein | 25478064 |
D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 22683883 |
D002251 | Carbon Tetrachloride | Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 25478064 |
C010063 | carbonyl sulfide | carbonyl sulfide results in increased expression of CCL2 mRNA | 19395590 |
D002330 | Carmustine | Carmustine affects the activity of CCL2 protein | 17522861 |
D002330 | Carmustine | Carmustine results in decreased expression of CCL2 protein | 17522861 |
D002330 | Carmustine | Carmustine results in increased expression of CCL2 mRNA | 15980968 |
D002330 | Carmustine | CCL2 mRNA affects the susceptibility to Carmustine | 16365179 |
D002336 | Carnosine | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 19799668 |
D002336 | Carnosine | Carnosine inhibits the reaction [Acetaminophen results in increased expression of CCL2 protein] | 19799668 |
D002336 | Carnosine | Carnosine inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | 29191451 |
D002351 | Carrageenan | "5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of CCL2 protein]" | 20383154 |
D002351 | Carrageenan | Carrageenan results in increased expression of CCL2 protein | 12444156|2038315 |
D002392 | Catechin | Catechin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | 17103373 |
D002392 | Catechin | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | 16806235 |
C034221 | catechol | catechol results in increased expression of CCL2 protein | 17572062 |
D000068579 | Celecoxib | Celecoxib inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
D000068579 | Celecoxib | Celecoxib results in decreased expression of CCL2 mRNA | 12902868 |
D000068579 | Celecoxib | Celecoxib inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 20039930 |
D000068579 | Celecoxib | Celecoxib inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 20039930 |
C005963 | cephaelin | cephaelin results in decreased expression of CCL2 protein | 20116850 |
C086276 | cerivastatin | cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA] | 12117737 |
C086276 | cerivastatin | cerivastatin results in decreased expression of and results in decreased secretion of CCL2 protein | 12117737 |
C086276 | cerivastatin | cerivastatin results in decreased expression of CCL2 mRNA | 12117737 |
C086276 | cerivastatin | Mevalonic Acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737 |
D002108 | Ceruletide | Ceruletide results in increased expression of CCL2 mRNA | 17463185|2148488 |
D002108 | Ceruletide | PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA] | 17463185 |
D002108 | Ceruletide | rosiglitazone inhibits the reaction [Ceruletide results in increased expression of CCL2 mRNA] | 17463185 |
D047188 | Chalcones | Chalcones inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 22410118 |
D047188 | Chalcones | Chalcones inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22410118 |
D002635 | Chenodeoxycholic Acid | Chenodeoxycholic Acid results in increased expression of CCL2 mRNA | 21224055 |
D002635 | Chenodeoxycholic Acid | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CCL2 mRNA] | 21224055 |
D002713 | Chlorine | Chlorine results in increased expression of CCL2 mRNA | 24582687 |
D002713 | Chlorine | Chlorine results in increased expression of CCL2 protein | 23146759 |
D002713 | Chlorine | Chlorine results in increased expression of CCL2 mRNA | 22533443 |
C031294 | chlorobenzene | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | 18645721 |
C031294 | chlorobenzene | bucillamine inhibits the reaction [chlorobenzene results in increased secretion of CCL2 protein] | 19800902 |
C031294 | chlorobenzene | CCL2 protein promotes the reaction [chlorobenzene results in increased expression of IL13 protein] | 18514500 |
C031294 | chlorobenzene | chlorobenzene results in increased expression of CCL2 protein | 17993253|1851450 |
C031294 | chlorobenzene | chlorobenzene results in increased secretion of CCL2 protein | 19800902 |
C031294 | chlorobenzene | SB 203580 inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | 18645721 |
C031294 | chlorobenzene | Tiopronin inhibits the reaction [chlorobenzene results in increased secretion of CCL2 protein] | 19800902 |
D020111 | Chlorodiphenyl (54% Chlorine) | [Chlorodiphenyl (54% Chlorine) co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCL2 | 24582691 |
D002725 | Chloroform | Chloroform results in increased expression of CCL2 mRNA | 21907259 |
D002726 | Chlorogenic Acid | Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 26079055 |
D002726 | Chlorogenic Acid | Chlorogenic Acid inhibits the reaction [Acetaminophen results in increased secretion of CCL2 protein] | 26079055 |
D002738 | Chloroquine | Acetylcysteine inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
D002738 | Chloroquine | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
D002738 | Chloroquine | Chloroquine results in increased expression of CCL2 mRNA | 15139008 |
D002738 | Chloroquine | diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
D002738 | Chloroquine | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
C011724 | cholest-5-en-3 beta,7 alpha-diol | "[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA" | 24802026 |
C011724 | cholest-5-en-3 beta,7 alpha-diol | "cholest-5-en-3 beta,7 alpha-diol results in increased expression of CCL2 mRNA" | 24802026 |
C011724 | cholest-5-en-3 beta,7 alpha-diol | "Quercetin analog inhibits the reaction [[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA]" | 24802026 |
C011724 | cholest-5-en-3 beta,7 alpha-diol | "Quercetin analog inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased expression of CCL2 mRNA]" | 24802026 |
D002784 | Cholesterol | Cholesterol results in increased expression of CCL2 protein | 16148612 |
D002784 | Cholesterol | olmesartan inhibits the reaction [Cholesterol results in increased expression of CCL2 protein] | 16148612 |
D002784 | Cholesterol | "[Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL2 mRNA" | 22129739 |
D002784 | Cholesterol | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 mRNA] | 19028402 |
D002784 | Cholesterol | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 protein] | 19028402 |
D002784 | Cholesterol | Cholesterol results in increased expression of CCL2 mRNA | 19028402 |
D002784 | Cholesterol | Cholesterol results in increased expression of CCL2 protein | 19028402 |
D002784 | Cholesterol | [Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA | 25833014 |
D002784 | Cholesterol | [Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein | 25833014 |
D002784 | Cholesterol | [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CCL2 mRNA | 26606054 |
D002784 | Cholesterol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA] | 25833014 |
D002784 | Cholesterol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein] | 25833014 |
D002791 | Cholesterol, Dietary | "[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 mRNA" | 18287887 |
D002791 | Cholesterol, Dietary | "[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 protein" | 18287887 |
D002791 | Cholesterol, Dietary | "Felodipine inhibits the reaction [[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 mRNA]" | 18287887 |
D002791 | Cholesterol, Dietary | "Felodipine inhibits the reaction [[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 protein]" | 18287887 |
D002791 | Cholesterol, Dietary | "[Cholesterol, Dietary co-treated with naringenin] affects the expression of CCL2 mRNA" | 11396955 |
D002791 | Cholesterol, Dietary | "[Cholesterol, Dietary co-treated with naringin] affects the expression of CCL2 mRNA" | 11396955 |
D002794 | Choline | Choline affects the expression of CCL2 mRNA | 17616785 |
D002794 | Choline | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 protein" | 28973532 |
D002794 | Choline | "3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA]" | 28973532 |
D002794 | Choline | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | 18513333 |
D002794 | Choline | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein] | 20697377 |
D002794 | Choline | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA] | 20697377 |
D002794 | Choline | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CTGF mRNA] | 20697377 |
D002794 | Choline | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA | 18513333 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | 20938992 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA | 23038002|2897353 |
D002794 | Choline | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA] | 23038002 |
D002794 | Choline | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D002809 | Chondroitin Sulfates | Chondroitin Sulfates binds to CCL2 protein | 16385517 |
C022990 | chromic chloride | chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
C022990 | chromic chloride | chromic chloride results in increased expression of CCL2 protein | 23629852 |
C022990 | chromic chloride | [cobaltous chloride co-treated with chromic chloride] results in increased expression of CCL2 mRNA | 25966675 |
C023600 | chromic oxide | chromic oxide analog results in increased secretion of CCL2 protein | 24885771 |
D002858 | Chromium Alloys | Chromium Alloys results in increased expression of CCL2 mRNA | 25966675 |
C102874 | chromium nicotinic acid complex | chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
D002911 | Chrysenes | Chrysenes results in decreased expression of CCL2 protein | 20116850 |
D002922 | Ciguatoxins | Ciguatoxins affects the expression of CCL2 mRNA | 18353800 |
C045645 | cilostazol | cilostazol inhibits the reaction [TNF protein results in increased expression of CCL2] | 19967051 |
C045645 | cilostazol | cilostazol promotes the reaction [Probucol inhibits the reaction [TNF protein results in increased expression of CCL2]] | 19967051 |
C045645 | cilostazol | Probucol promotes the reaction [cilostazol inhibits the reaction [TNF protein results in increased expression of CCL2]] | 19967051 |
D002927 | Cimetidine | "Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
D019343 | Citric Acid | [Silver analog co-treated with Citric Acid] results in increased secretion of CCL2 protein | 27021274 |
C086108 | clobenpropit | clobenpropit results in decreased expression of CCL2 protein | 17507084 |
D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694|1913224 |
D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694|1913224 |
D002994 | Clofibrate | Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D003000 | Clonidine | "Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C000593591 | coagulin-L | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
C000593591 | coagulin-L | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D060729 | Coal Ash | "1,3-dimethylthiourea inhibits the reaction [Coal Ash results in increased expression of CCL2 mRNA]" | 14569496 |
D060729 | Coal Ash | Coal Ash results in increased expression of CCL2 mRNA | 14569496 |
D003035 | Cobalt | Cobalt results in decreased expression of CCL2 protein | 22173130 |
D003035 | Cobalt | Cobalt results in increased expression of CCL2 mRNA | 19132727 |
D003035 | Cobalt | Cobalt results in increased secretion of CCL2 protein | 19132727 |
D003035 | Cobalt | [tungsten carbide co-treated with Cobalt] results in decreased expression of CCL2 mRNA | 18078969 |
D003035 | Cobalt | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 23503329 |
D003035 | Cobalt | [Zinc co-treated with Nickel co-treated with Cobalt] affects the reaction [Dietary Fats affects the expression of CCL2 mRNA] | 23503329 |
D003035 | Cobalt | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 23503329 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [Vehicle Emissions analog results in increased expression of CCL2 mRNA] | 25620054 |
C007095 | cobaltiprotoporphyrin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 25171655 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin affects the expression of CCL2 protein | 23435964 |
C007095 | cobaltiprotoporphyrin | "cobaltiprotoporphyrin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CCL2 protein]" | 22461696 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25171655 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [Dietary Fats results in increased secretion of CCL2 protein] | 22193921 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in decreased expression of CCL2 protein | 20357190 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in decreased secretion of CCL2 protein | 20667508|2534324 |
C007095 | cobaltiprotoporphyrin | stannous mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Dietary Fats results in increased secretion of CCL2 protein]] | 22193921 |
C007095 | cobaltiprotoporphyrin | stannous mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased secretion of CCL2 protein] | 20667508 |
C007095 | cobaltiprotoporphyrin | zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of CCL2 protein] | 20357190 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 20580034 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of CCL2 mRNA | 14652683|1937684 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of and results in increased secretion of CCL2 protein | 23629852 |
C018021 | cobaltous chloride | cobaltous chloride results in increased secretion of CCL2 protein | 21110705 |
C018021 | cobaltous chloride | CCL2 results in increased susceptibility to cobaltous chloride | 23043544 |
C018021 | cobaltous chloride | [cobaltous chloride co-treated with chromic chloride] results in increased expression of CCL2 mRNA | 25966675 |
C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CCL2 mRNA | 23684559|2596667 |
C018021 | cobaltous chloride | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | 18635243|1927835 |
C060728 | cobalt oxide | cobalt oxide analog results in increased secretion of CCL2 protein | 25526690 |
D003042 | Cocaine | Cocaine results in increased secretion of CCL2 protein | 10065903 |
D003042 | Cocaine | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | AG 1879 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | Cocaine promotes the reaction [RELA protein binds to CCL2 promoter] | 20354174 |
D003042 | Cocaine | Cocaine results in increased expression of CCL2 mRNA | 20354174 |
D003042 | Cocaine | Cocaine results in increased expression of CCL2 protein | 20354174 |
D003042 | Cocaine | methyl-beta-cyclodextrin inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | "N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]" | 20354174 |
D003042 | Cocaine | pyrazolanthrone inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | RELA mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | SC 514 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | SIGMAR1 mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | U 0126 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D003042 | Cocaine | Cocaine results in increased expression of CCL2 protein | 20354174 |
C052387 | cocoa butter | [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CCL2 mRNA | 26606054 |
D003061 | Codeine | Codeine results in increased secretion of CCL2 protein | 17441793 |
D003078 | Colchicine | Colchicine results in increased expression of CCL2 mRNA | 20624997|3119359 |
D003300 | Copper | [Disulfiram binds to Copper] which results in increased expression of CCL2 mRNA | 24690739 |
D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in increased expression of CCL2 protein | 20931265 |
D003300 | Copper | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | 20302851 |
D003300 | Copper | [Copper deficiency co-treated with Fructose] results in increased expression of CCL2 protein | 21781943 |
D003300 | Copper | deferiprone inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D003300 | Copper | Deferoxamine inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D003300 | Copper | [Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein | 25813056 |
D003300 | Copper | gadolinium chloride inhibits the reaction [[Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D003300 | Copper | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | 20302851 |
D003300 | Copper | [Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein | 25813056 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of CCL2 mRNA | 24225134 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of CCL2 protein | 24225134 |
D019327 | Copper Sulfate | tetrathiomolybdate inhibits the reaction [Copper Sulfate results in increased expression of CCL2 mRNA] | 24225134 |
D019327 | Copper Sulfate | tetrathiomolybdate inhibits the reaction [Copper Sulfate results in increased expression of CCL2 protein] | 24225134 |
C000666 | coralyne | coralyne results in decreased expression of CCL2 protein | 20116850 |
D003345 | Corticosterone | Corticosterone results in decreased expression of CCL2 mRNA | 15755911 |
D003348 | Cortisone | Cortisone results in increased expression of CCL2 mRNA | 24135201 |
C089698 | CP 105696 | CP 105696 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19880577 |
C010561 | crocetin | crocetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21925167 |
D003436 | Croton Oil | Croton Oil results in increased expression of CCL2 mRNA | 19647056 |
C030973 | cupric oxide | cupric oxide affects the expression of CCL2 mRNA | 28705761 |
C030973 | cupric oxide | cupric oxide results in increased secretion of CCL2 protein | 28705761 |
D003471 | Cuprizone | Cuprizone results in increased expression of CCL2 mRNA | 27523638 |
D003471 | Cuprizone | Cuprizone results in increased expression of CCL2 protein | 27523638 |
D003474 | Curcumin | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 23452621 |
D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 17666914|1915291 |
D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 17666914 |
D003474 | Curcumin | Curcumin results in increased expression of CCL2 mRNA | 17198877 |
D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
D003474 | Curcumin | Curcumin results in decreased expression of CCL2 mRNA | 18403477 |
D003474 | Curcumin | Curcumin results in decreased expression of CCL2 protein | 18403477 |
D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 22683883 |
D003474 | Curcumin | Curcumin results in decreased expression of CCL2 mRNA | 10925121|1105305 |
D003474 | Curcumin | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19243473 |
D003474 | Curcumin | Curcumin results in decreased expression of CCL2 | 18462866 |
C038459 | curdlan | curdlan affects the expression of CCL2 mRNA | 19904525 |
C465366 | cyazofamid | cyazofamid results in decreased expression of CCL2 | 21788198 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22121136 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 22121136 |
D003513 | Cycloheximide | Cycloheximide results in increased expression of CCL2 mRNA | 21146893 |
D003513 | Cycloheximide | TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL2 mRNA] | 21146893 |
D003513 | Cycloheximide | Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL2 mRNA]] | 21146893 |
D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of CCL2 mRNA | 21068404 |
D003520 | Cyclophosphamide | Cyclophosphamide results in decreased expression of CCL2 protein | 18848347 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of CCL2 mRNA | 22147139|2798913 |
D016572 | Cyclosporine | 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
D016572 | Cyclosporine | 7-oxozeanol inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein] | 23958496 |
D016572 | Cyclosporine | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA]" | 23958496 |
D016572 | Cyclosporine | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein]" | 23958496 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CCL2 mRNA | 23958496|2758566 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CCL2 protein | 23958496 |
D016572 | Cyclosporine | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496|2758566 |
D016572 | Cyclosporine | Glycyrrhizic Acid inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 27585667 |
D016572 | Cyclosporine | parthenolide inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
D016572 | Cyclosporine | pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
D016572 | Cyclosporine | pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein] | 23958496 |
D016572 | Cyclosporine | salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
D016572 | Cyclosporine | sulforafan inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
D016572 | Cyclosporine | TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 27585667 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of CCL2 mRNA | 25051504 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of CCL2 protein | 25051504 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of CCL2 mRNA | 27585667 |
D016572 | Cyclosporine | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 27585667 |
C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of CCL2 mRNA] | 25203536 |
C037304 | cyhalothrin | cyhalothrin results in increased expression of CCL2 protein | 27348886 |
D015084 | 2,4-Dichlorophenoxyacetic Acid | "2,4-Dichlorophenoxyacetic Acid results in increased expression of CCL2 protein" | 19467290 |
D003609 | Dactinomycin | Dactinomycin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | 16705055 |
D003609 | Dactinomycin | Dactinomycin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 15531761 |
D003620 | Dantrolene | Dantrolene results in decreased expression of CCL2 mRNA | 25051504 |
D000069439 | Dasatinib | Dasatinib results in decreased expression of CCL2 protein | 17962511 |
D003630 | Daunorubicin | Daunorubicin results in decreased expression of CCL2 protein | 20116850 |
C012864 | dazomet | dazomet results in decreased expression of CCL2 | 21788198 |
C568335 | DCB-SLE1 | DCB-SLE1 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein] | 21677146 |
D016047 | Zalcitabine | Zalcitabine results in increased expression of CCL2 protein | 17761732 |
C044919 | deferiprone | deferiprone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 14576080 |
C044919 | deferiprone | deferiprone inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D003676 | Deferoxamine | Deferoxamine inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
C107676 | deguelin | deguelin promotes the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22745725 |
D003703 | Demecolcine | Demecolcine results in increased expression of CCL2 mRNA | 23649840 |
D003840 | Deoxycholic Acid | Deoxycholic Acid results in increased expression of CCL2 mRNA | 21224055|2391179 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 mRNA | 22846391 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 mRNA | 15371230|1568116 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 protein | 17090620 |
C007262 | deoxynivalenol | "Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL2 mRNA]" | 15681167 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with nivalenol] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | [deoxynivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | deoxynivalenol results in decreased expression of CCL2 mRNA | 23688591 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CCL2 mRNA | 23688591 |
D003868 | Dequalinium | Dequalinium results in decreased expression of CCL2 protein | 20116850 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein] | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | Dermatophagoides pteronyssinus antigen p 1 results in decreased expression of CCL2 mRNA | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | Glutathione inhibits the reaction [[Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | Glutathione inhibits the reaction [[Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | [Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased expression of CCL2 mRNA | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | [Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein]] | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | [Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased expression of CCL2 mRNA | 10919993 |
C451162 | Dermatophagoides pteronyssinus antigen p 1 | [Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein | 10919993 |
D064791 | Desoxycorticosterone Acetate | Desoxycorticosterone Acetate results in increased expression of CCL2 protein | 23089228 |
D064791 | Desoxycorticosterone Acetate | heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CCL2 protein] | 23089228 |
D003907 | Dexamethasone | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]" | 15187150 |
D003907 | Dexamethasone | [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein | 15187150 |
D003907 | Dexamethasone | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | 16997883 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Mitomycin results in increased expression of CCL2 mRNA] | 20002897 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Mitomycin results in increased secretion of CCL2 protein] | 20002897 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 19255438 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of CCL2 mRNA | 19853017 |
D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CCL2 mRNA | 28628672 |
D003907 | Dexamethasone | "15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [[Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein]" | 15187150 |
D003907 | Dexamethasone | [Amiodarone co-treated with Dexamethasone] results in increased expression of CCL2 mRNA | 25900201 |
D003907 | Dexamethasone | [Dexamethasone binds to NR3C1 protein] which results in decreased expression of CCL2 protein | 15187150 |
D003907 | Dexamethasone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 16054899 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of CCL2 mRNA | 21041162 |
D003907 | Dexamethasone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D003907 | Dexamethasone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D003907 | Dexamethasone | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 23503329 |
D003907 | Dexamethasone | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 23503329 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 25851902 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 25851902 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of CCL2 mRNA | 18234956 |
D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of CCL2 mRNA | 19645018|2007934 |
D016264 | Dextran Sulfate | Dextran Sulfate results in increased secretion of CCL2 protein | 21858153 |
D016264 | Dextran Sulfate | [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of CCL2 protein | 24146755 |
D016264 | Dextran Sulfate | Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein] | 21858153 |
C527766 | diapocynin | diapocynin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22414048 |
C000912 | diazoxon | diazoxon results in decreased expression of CCL2 | 21788198 |
C020735 | dibutyldichlorotin | dibutyldichlorotin results in increased expression of CCL2 mRNA | 10722888 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of CCL2 mRNA | 21266533 |
D003995 | Dibutyryl Cyclic GMP | Dibutyryl Cyclic GMP results in increased expression of CCL2 protein | 20940016 |
D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of CCL2 mRNA | 28962523 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of CCL2 mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in increased expression of CCL2 mRNA | 27594783 |
D002945 | Cisplatin | "3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine inhibits the reaction [Cisplatin results in increased expression of CCL2 protein]" | 25308879 |
D002945 | Cisplatin | "4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA]" | 26546572 |
D002945 | Cisplatin | Carnosine inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | 29191451 |
D002945 | Cisplatin | [Cisplatin co-treated with TNF protein] results in increased expression of CCL2 mRNA | 23103562 |
D002945 | Cisplatin | Cisplatin results in increased expression of CCL2 mRNA | 15701814|1581453 |
D002945 | Cisplatin | Cisplatin results in increased expression of CCL2 protein | 20844023|2530887 |
D002945 | Cisplatin | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | 15814532 |
D002945 | Cisplatin | TIMD2 promotes the reaction [Cisplatin results in increased expression of CCL2 mRNA] | 20702592 |
D002945 | Cisplatin | Cisplatin affects the expression of CCL2 mRNA | 25051504 |
D002945 | Cisplatin | Cisplatin results in decreased expression of CCL2 mRNA | 22023808 |
D002945 | Cisplatin | Cisplatin results in increased expression of CCL2 protein | 23603837 |
D002945 | Cisplatin | Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of CCL2 protein] | 23603837 |
D004008 | Diclofenac | Diclofenac analog results in increased expression of CCL2 mRNA | 24104198 |
D004008 | Diclofenac | Diclofenac analog results in increased secretion of CCL2 protein | 24104198 |
D004008 | Diclofenac | SB 203580 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA] | 24104198 |
D004008 | Diclofenac | U 0126 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA] | 24104198 |
D004008 | Diclofenac | Diclofenac results in increased expression of CCL2 mRNA | 22285467|2767191 |
D004008 | Diclofenac | Diclofenac affects the expression of CCL2 mRNA | 25051504 |
D004008 | Diclofenac | "Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 23939143 |
D004008 | Diclofenac | Diclofenac results in increased expression of CCL2 protein | 25051504 |
C027118 | didecyldimethylammonium | didecyldimethylammonium results in increased expression of CCL2 protein | 19762220 |
D018119 | Stavudine | Stavudine results in increased expression of CCL2 protein | 17668557 |
C023635 | dienogest | dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | 22014880 |
D004041 | Dietary Fats | "3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate affects the reaction [Dietary Fats affects the expression of CCL2 mRNA]" | 28899902 |
D004041 | Dietary Fats | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 25724490 |
D004041 | Dietary Fats | argatroban inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 22841818 |
D004041 | Dietary Fats | argatroban inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 22841818 |
D004041 | Dietary Fats | bromodichloromethane promotes the reaction [Dietary Fats results in increased expression of CCL2 protein] | 23438451 |
D004041 | Dietary Fats | Dietary Fats affects the expression of CCL2 mRNA | 23503329|2889990 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA | 28611668 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein | 28611668 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Fructose] results in increased expression of CCL2 protein | 26824242 |
D004041 | Dietary Fats | [Dietary Fats co-treated with Streptozocin] results in increased expression of CCL2 protein | 27769711 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CCL2 mRNA | 19513120|2284181 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CCL2 protein | 22841818|2343845 |
D004041 | Dietary Fats | Diosgenin inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 26408789 |
D004041 | Dietary Fats | [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL2 mRNA | 23665937 |
D004041 | Dietary Fats | esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of CCL2 protein] | 27769711 |
D004041 | Dietary Fats | [hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of CCL2 mRNA | 24398136 |
D004041 | Dietary Fats | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
D004041 | Dietary Fats | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
D004041 | Dietary Fats | Quercetin inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 24465016|2561471 |
D004041 | Dietary Fats | Quercetin inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 24465016|2561471 |
D004041 | Dietary Fats | RALBP1 affects the reaction [Dietary Fats results in increased expression of CCL2 protein] | 23821548 |
D004041 | Dietary Fats | RALBP1 protein affects the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 23821548 |
D004041 | Dietary Fats | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
D004041 | Dietary Fats | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
D004041 | Dietary Fats | sarpogrelate inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CCL2 protein] | 26824242 |
D004041 | Dietary Fats | Tamoxifen inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 23038002 |
D004041 | Dietary Fats | [Zinc co-treated with Nickel co-treated with Cobalt] affects the reaction [Dietary Fats affects the expression of CCL2 mRNA] | 23503329 |
D004041 | Dietary Fats | Celecoxib inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 20039930 |
D004041 | Dietary Fats | Celecoxib inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 20039930 |
D004041 | Dietary Fats | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D004041 | Dietary Fats | cobaltiprotoporphyrin inhibits the reaction [Dietary Fats results in increased secretion of CCL2 protein] | 22193921 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CCL2 | 20039930 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CCL2 protein | 25025298 |
D004041 | Dietary Fats | Dietary Fats results in increased secretion of CCL2 protein | 22193921 |
D004041 | Dietary Fats | nimesulide inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 20039930 |
D004041 | Dietary Fats | nimesulide inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 20039930 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 25025298 |
D004041 | Dietary Fats | stannous mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Dietary Fats results in increased secretion of CCL2 protein]] | 22193921 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CCL2 mRNA | 21852083 |
D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 21852083 |
D004042 | Dietary Fats, Unsaturated | "Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of CCL2 mRNA]" | 23626681 |
D019422 | Dietary Sucrose | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D019422 | Dietary Sucrose | Dietary Sucrose results in increased expression of CCL2 mRNA | 26033743 |
D000073417 | Dietary Sugars | [Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA | 28611668 |
D000073417 | Dietary Sugars | [Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein | 28611668 |
D000073417 | Dietary Sugars | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
D000073417 | Dietary Sugars | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
D000073417 | Dietary Sugars | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
D000073417 | Dietary Sugars | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
D004052 | Diethylnitrosamine | [Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | 20302851 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA | 21295105 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CCL2 mRNA | 25051504 |
D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CCL2 protein | 25051504 |
D004052 | Diethylnitrosamine | [Iron co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | 20302851 |
D004052 | Diethylnitrosamine | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | 20302851 |
D004052 | Diethylnitrosamine | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | 21295105 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CCL2 protein | 15794588 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of CCL2 mRNA | 21658437 |
C031394 | difenzoquat | difenzoquat results in decreased expression of CCL2 | 21788198 |
D004073 | Digitoxigenin | Digitoxigenin results in decreased expression of CCL2 protein | 20116850 |
D004074 | Digitoxin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]] | 19446813 |
D004074 | Digitoxin | Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | 19446813 |
D004076 | Digoxigenin | Digoxigenin results in decreased expression of CCL2 protein | 20116850 |
D004077 | Digoxin | Digoxin results in decreased expression of CCL2 protein | 20116850 |
D002117 | Calcitriol | Calcitriol results in decreased expression of CCL2 mRNA | 26485663 |
D002117 | Calcitriol | Calcitriol results in decreased expression of CCL2 protein | 18379402 |
D002117 | Calcitriol | Calcitriol inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 26520185 |
D015650 | 24,25-Dihydroxyvitamin D 3 | "24,25-Dihydroxyvitamin D 3 results in decreased expression of CCL2 protein" | 18379402 |
C012621 | dimemorfan | dimemorfan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18500357 |
C012621 | dimemorfan | dimemorfan results in decreased expression of CCL2 protein | 18173806 |
D004117 | Dimethoate | Dimethoate results in increased expression of CCL2 mRNA | 23397585 |
C076154 | dimethomorph | dimethomorph results in decreased expression of CCL2 | 21788198 |
C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased expression of CCL2 mRNA | 16507463 |
D000069462 | Dimethyl Fumarate | Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 26683377 |
D000069462 | Dimethyl Fumarate | Dimethyl Fumarate inhibits the reaction [IKBKB protein results in increased expression of CCL2 mRNA] | 26683377 |
D000069462 | Dimethyl Fumarate | Dimethyl Fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to CCL2 promoter]] | 26683377 |
D000069462 | Dimethyl Fumarate | Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 26683377 |
D000069462 | Dimethyl Fumarate | Dimethyl Fumarate results in decreased expression of CCL2 mRNA | 26683377 |
D000069462 | Dimethyl Fumarate | "Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 27277809 |
D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of CCL2 protein | 17719030 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 21878375 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17529908 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17529908 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 14576080 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in increased secretion of CCL2 protein | 26860701 |
D004121 | Dimethyl Sulfoxide | Tetrachlorodibenzodioxin promotes the reaction [Dimethyl Sulfoxide results in increased secretion of CCL2 protein] | 26860701 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide results in decreased expression of CCL2 mRNA | 10925121 |
C049346 | diniconazole | diniconazole results in decreased expression of CCL2 | 21788198 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased expression of CCL2 mRNA | 17374397|2071313 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in decreased secretion of CCL2 protein | 20488241 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of CCL2 mRNA | 15585374 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased secretion of CCL2 protein | 20488241 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of CCL2 mRNA | 19647056|2313349 |
D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased secretion of CCL2 protein | 22245253 |
D004137 | Dinitrochlorobenzene | Plant Extracts inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL2 mRNA] | 23133493 |
D004137 | Dinitrochlorobenzene | Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL2 mRNA] | 23133493 |
D004139 | Dinitrofluorobenzene | [CCL2 protein results in increased expression of CCR2 protein] which affects the susceptibility to Dinitrofluorobenzene | 21362464 |
D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of CCL2 mRNA | 15719370 |
D004144 | Diosgenin | Diosgenin inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 26408789 |
D004144 | Diosgenin | Diosgenin results in decreased expression of CCL2 mRNA | 26408789 |
C493087 | diphenylarsinic acid | diphenylarsinic acid results in increased secretion of CCL2 protein | 26645585|2808783 |
C493087 | diphenylarsinic acid | pyrazolanthrone inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C493087 | diphenylarsinic acid | SB 203580 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C493087 | diphenylarsinic acid | SCH772984 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C493087 | diphenylarsinic acid | U 0126 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] | 17668557 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of CCL2 protein] | 17668557 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of CCL2 protein] | 17668557 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein] | 17668557 |
C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 14576080 |
C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
C031291 | diphenyliodonium | diphenyliodonium inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16794257 |
D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 16765938 |
D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 20940016 |
D004176 | Dipyridamole | tin protoporphyrin IX inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]] | 20940016 |
D004221 | Disulfiram | [Disulfiram binds to Copper] which results in increased expression of CCL2 mRNA | 24690739 |
D004280 | Dobutamine | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 12818967 |
D004280 | Dobutamine | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 12818967 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 15698426 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15698426 |
D004281 | Docosahexaenoic Acids | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
D004281 | Docosahexaenoic Acids | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
D004281 | Docosahexaenoic Acids | "sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]]" | 21130106 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of and results in increased secretion of CCL2 protein | 12908082 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CCL2 mRNA | 15033991 |
D004317 | Doxorubicin | Acetylcysteine affects the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 11124598 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CCL2 mRNA | 11124598|1991584 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CCL2 protein | 18806609 |
D004317 | Doxorubicin | Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 27181935 |
D004317 | Doxorubicin | Razoxane inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 19915844 |
C570583 | duanbanhuain A | duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 22036992 |
C570584 | duanbanhuain B | duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 22036992 |
D017886 | Durapatite | Durapatite analog results in increased expression of CCL2 | 22939914 |
D004391 | Dust | Dust affects the expression of CCL2 protein | 17805423 |
D004391 | Dust | Dust results in increased expression of CCL2 mRNA | 17805423|2088375 |
D004391 | Dust | Dust results in increased secretion of CCL2 protein | 20883751 |
D004391 | Dust | Dust results in increased expression of CCL2 mRNA | 22118940 |
D004391 | Dust | Dust results in increased expression of CCL2 protein | 22118940|2688288 |
D004391 | Dust | Dust results in increased secretion of CCL2 protein | 22118940 |
D004391 | Dust | MYD88 gene mutant form inhibits the reaction [Dust results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | MYD88 gene mutant form inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | [Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein | 26882889 |
D004391 | Dust | Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | TLR2 gene mutant form inhibits the reaction [Dust results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | TLR2 gene mutant form promotes the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | TLR4 gene mutant form inhibits the reaction [Dust results in increased expression of CCL2 protein] | 26882889 |
D004391 | Dust | TLR4 gene mutant form promotes the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
C098320 | efavirenz | efavirenz results in increased secretion of CCL2 protein | 21619898 |
D015777 | Eicosanoids | Eicosanoids analog inhibits the reaction [Cisplatin results in increased expression of CCL2 protein] | 23603837 |
D015118 | Eicosapentaenoic Acid | "2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 15698426 |
D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 15698426 |
D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15698426 |
D015118 | Eicosapentaenoic Acid | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22169119 |
D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased expression of CCL2 mRNA | 21193197 |
D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased expression of CCL2 protein | 21193197 |
D015118 | Eicosapentaenoic Acid | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
D015118 | Eicosapentaenoic Acid | "[2,2'-azobis(2-amidinopropane) results in increased oxidation of Eicosapentaenoic Acid] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
C035276 | eicosapentaenoic acid ethyl ester | [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL2 mRNA | 23665937 |
D004610 | Ellagic Acid | Ellagic Acid results in decreased secretion of CCL2 protein | 20816778 |
C108024 | emamectin benzoate | emamectin benzoate results in decreased expression of CCL2 | 21788198 |
D004640 | Emetine | Emetine results in decreased expression of CCL2 protein | 20116850 |
C007590 | emulphogene BC 720 | emulphogene BC 720 results in increased expression of CCL2 mRNA | 25398874 |
D004656 | Enalapril | Enalapril inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
D004656 | Enalapril | Enalapril results in decreased expression of CCL2 protein | 20720404|2503705 |
D004656 | Enalapril | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | 20720404 |
D004656 | Enalapril | Enalapril results in decreased expression of CCL2 mRNA | 10925121|1962701 |
D004656 | Enalapril | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | 17513326 |
D015773 | Enalaprilat | Enalaprilat inhibits the reaction [AGT protein modified form results in increased expression of CCL2] | 24342267 |
C044101 | endotoxin, Escherichia coli | "cobaltiprotoporphyrin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CCL2 protein]" | 22461696 |
C044101 | endotoxin, Escherichia coli | "endotoxin, Escherichia coli results in increased expression of CCL2 protein" | 22461696 |
D004731 | Endotoxins | Endotoxins promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | 12217210 |
D004731 | Endotoxins | Endotoxins results in increased expression of CCL2 mRNA | 12217210 |
C017435 | enilconazole | enilconazole results in decreased expression of CCL2 | 21788198 |
C031818 | enterotoxin B, staphylococcal | "enterotoxin B, staphylococcal results in increased expression of and results in increased secretion of CCL2 protein" | 25556216 |
C118739 | entinostat | entinostat results in increased expression of CCL2 mRNA | 27188386 |
C038939 | enzacamene | enzacamene results in increased expression of CCL2 mRNA | 23397585 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased secretion of CCL2 protein | 20816778 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCL2 mRNA | 22079256 |
C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of CCL2 protein] | 22101032 |
C045651 | epigallocatechin gallate | "epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 22521609 |
C045651 | epigallocatechin gallate | "epigallocatechin gallate inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]" | 22521609 |
C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 20580034 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of CCL2 mRNA | 22521609 |
C045651 | epigallocatechin gallate | HMOX1 protein promotes the reaction [epigallocatechin gallate inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 20580034 |
C046855 | epostane | [Dinoprost co-treated with epostane] results in increased expression of CCL2 mRNA | 21505051 |
C015860 | ergosta-4,6,8(14),22-tetraen-3-one | "ergosta-4,6,8(14),22-tetraen-3-one inhibits the reaction [AGT protein results in increased expression of CCL2 protein]" | 28578904 |
C015860 | ergosta-4,6,8(14),22-tetraen-3-one | "ergosta-4,6,8(14),22-tetraen-3-one inhibits the reaction [AGT protein results in increased expression of CCL2 protein]" | 28578904 |
D004875 | Ergosterol | [Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA | 25833014 |
D004875 | Ergosterol | [Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein | 25833014 |
D004875 | Ergosterol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA] | 25833014 |
D004875 | Ergosterol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein] | 25833014 |
C007619 | eriodictyol | eriodictyol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D000069347 | Erlotinib Hydrochloride | [Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in decreased expression of CCL2 mRNA | 27738319 |
D000069347 | Erlotinib Hydrochloride | [Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in increased expression of CCL2 mRNA | 27738319 |
D004917 | Erythromycin | Erythromycin results in increased expression of CCL2 mRNA | 27503388 |
D004917 | Erythromycin | [Penicillin G co-treated with Erythromycin] results in increased expression of CCL2 mRNA | 27503388 |
C007628 | esculetin | esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of CCL2 protein] | 27769711 |
D004967 | Estrogens | benazepril inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
D004967 | Estrogens | Estradiol inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
D004967 | Estrogens | Estrogens deficiency results in increased expression of CCL2 protein | 19553526 |
D004967 | Estrogens | Losartan inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
D004966 | Estrogens, Conjugated (USP) | "Estrogens, Conjugated (USP) results in decreased expression of CCL2 protein" | 16842799 |
D004977 | Ethambutol | Ethambutol affects the expression of CCL2 mRNA | 25051504 |
D000431 | Ethanol | Ethanol results in increased expression of and results in increased secretion of CCL2 protein | 26014148 |
D000431 | Ethanol | Ethanol results in increased expression of CCL2 mRNA | 26014148 |
D000431 | Ethanol | Ethanol results in increased expression of CCL2 mRNA | 22173916 |
D000431 | Ethanol | Ethanol results in increased expression of CCL2 protein | 26769846 |
D000431 | Ethanol | [Fructose co-treated with Ethanol] results in increased expression of CCL2 mRNA | 26858005 |
D000431 | Ethanol | RIPK3 protein affects the reaction [Ethanol results in increased expression of CCL2 protein] | 26769846 |
D000431 | Ethanol | rosiglitazone inhibits the reaction [Ethanol results in increased expression of CCL2 mRNA] | 22173916 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the secretion of CCL2 protein | 15885639 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased secretion of CCL2 protein | 12538720 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CCL2 mRNA | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CCL2 mRNA | 17351261 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of CCL2 mRNA | 25051504 |
D005000 | Ethionamide | Ethionamide results in increased expression of CCL2 mRNA | 25051504 |
D005000 | Ethionamide | Ethionamide results in increased expression of CCL2 protein | 25051504 |
C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496|2758566 |
C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 23958496 |
C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 27585667 |
C507035 | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate results in decreased secretion of CCL2 protein | 25343247 |
D019830 | Adenosine-5'-(N-ethylcarboxamide) | Adenosine-5'-(N-ethylcarboxamide) results in increased secretion of CCL2 protein | 17696452 |
D019855 | Ethylene Glycol | Ethylene Glycol results in increased expression of CCL2 mRNA | 21907259 |
D019855 | Ethylene Glycol | acrylic acid analog inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 mRNA] | 27018375 |
D019855 | Ethylene Glycol | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | 16284884 |
D019855 | Ethylene Glycol | Ethylene Glycol results in increased expression of CCL2 mRNA | 27018375 |
D019855 | Ethylene Glycol | Ethylene Glycol results in increased expression of CCL2 protein | 16284884 |
D019855 | Ethylene Glycol | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | 16284884 |
C039614 | ethylisopropylamiloride | "ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C508136 | etoxazole | etoxazole results in decreased expression of CCL2 | 21788198 |
D005054 | Eugenol | Eugenol results in decreased expression of CCL2 mRNA | 17374397|1793652 |
D005054 | Eugenol | Eugenol results in increased expression of CCL2 mRNA | 15585374 |
D005054 | Eugenol | Eugenol results in increased secretion of CCL2 protein | 22245253 |
C045325 | eupatilin | "eupatilin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]" | 21565208 |
D015025 | Zearalenone | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | [deoxynivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | [nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | [Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
D015025 | Zearalenone | Zearalenone results in increased expression of CCL2 mRNA | 23688591 |
D005227 | Fatty Acids | [LEP protein results in increased oxidation of Fatty Acids] which results in increased expression of CCL2 | 11342529 |
D005228 | Fatty Acids, Essential | "Fatty Acids, Essential deficiency results in increased expression of CCL2 protein" | 23333450 |
D000069465 | Febuxostat | Febuxostat results in increased expression of CCL2 mRNA | 26641773 |
C500582 | Feitai | Feitai results in decreased expression of CCL2 mRNA | 16445573 |
D015736 | Felodipine | "Felodipine inhibits the reaction [[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 mRNA]" | 18287887 |
D015736 | Felodipine | "Felodipine inhibits the reaction [[APOE gene mutant form affects the susceptibility to Cholesterol, Dietary] which results in increased expression of CCL2 protein]" | 18287887 |
D005273 | Fenbendazole | Fenbendazole results in increased expression of CCL2 protein | 20116850 |
D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694|1913224 |
D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694|1913224 |
D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16306350 |
D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 15968640 |
D011345 | Fenofibrate | Fenofibrate results in decreased expression of CCL2 mRNA | 18356826 |
D011345 | Fenofibrate | Fenofibrate results in decreased expression of CCL2 protein | 18356826 |
C052034 | fenoxycarb | fenoxycarb results in decreased expression of CCL2 | 21788198 |
C415144 | fenpyroximate | fenpyroximate results in decreased expression of CCL2 | 21788198 |
C017690 | fenvalerate | fenvalerate results in decreased expression of CCL2 mRNA | 23397585 |
C000499 | ferric oxide | ferric oxide results in increased secretion of CCL2 protein | 24885771 |
C008169 | ferric oxide, saccharated | "ferric oxide, saccharated results in increased expression of CCL2 protein" | 17699372 |
C077139 | fidarestat | fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22253906 |
C077139 | fidarestat | fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22253906 |
D000068876 | Fingolimod Hydrochloride | 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid inhibits the reaction [Fingolimod Hydrochloride results in increased expression of CCL2 protein] | 23043544 |
D000068876 | Fingolimod Hydrochloride | CCL2 results in increased susceptibility to Fingolimod Hydrochloride | 23043544 |
D000068876 | Fingolimod Hydrochloride | Fingolimod Hydrochloride results in increased expression of CCL2 protein | 23043544 |
D005395 | Fish Oils | Fish Oils inhibits the reaction [Fructose results in increased expression of CCL2 protein] | 15752949 |
C109799 | FK 706 | FK 706 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 12676771 |
C109799 | FK 706 | FK 706 inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | 12676771 |
C109799 | FK 706 | FK 706 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 12676771 |
C109799 | FK 706 | FK 706 inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 12676771 |
C043562 | flavone | flavone results in decreased expression of CCL2 mRNA | 23782265 |
C043562 | flavone | flavone inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of CCL2]] | 23782265 |
D005419 | Flavonoids | Flavonoids results in decreased expression of CCL2 mRNA | 19627010 |
C012976 | flumequine | "[flumequine co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of CCL2 mRNA" | 23681119 |
C007738 | fluoranthene | [1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA | 28329830 |
C007738 | fluoranthene | SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA] | 28329830 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene affects the expression of CCL2 mRNA | 25051504 |
D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene affects the expression of CCL2 protein | 25051504 |
D005438 | Fludrocortisone | Fludrocortisone results in decreased expression of CCL2 protein | 20116850 |
C550006 | fluoxastrobin | fluoxastrobin results in decreased expression of CCL2 | 21788198 |
D005473 | Fluoxetine | Fluoxetine results in decreased secretion of CCL2 protein | 21083617 |
C013351 | fluridone | fluridone inhibits the reaction [CCL2 protein results in increased secretion of Abscisic Acid] | 24211328 |
C013351 | fluridone | fluridone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24211328 |
C013351 | fluridone | fluridone inhibits the reaction [Zymosan results in increased expression of CCL2 protein] | 24211328 |
D005485 | Flutamide | Flutamide results in decreased expression of CCL2 protein | 25051504 |
D000068298 | Fluticasone | Fluticasone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 15531761 |
D000068298 | Fluticasone | Fluticasone promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 15531761 |
C065180 | fluvastatin | fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA] | 16452496 |
D005492 | Folic Acid | [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of CCL2 mRNA | 22975265 |
D005492 | Folic Acid | Folic Acid deficiency results in increased expression of and results in increased secretion of CCL2 protein | 19152916 |
D005492 | Folic Acid | Folic Acid deficiency results in increased expression of CCL2 mRNA | 19152916 |
D005492 | Folic Acid | Folic Acid deficiency results in increased expression of CCL2 protein | 24657277 |
D005492 | Folic Acid | Folic Acid inhibits the reaction [Homocysteine results in increased expression of CCL2 mRNA] | 16845898 |
D005492 | Folic Acid | Folic Acid results in decreased expression of CCL2 protein | 16491109 |
D005492 | Folic Acid | SB 203580 inhibits the reaction [Folic Acid deficiency results in increased expression of and results in increased secretion of CCL2 protein] | 19152916 |
D005492 | Folic Acid | SB 203580 inhibits the reaction [Folic Acid deficiency results in increased expression of CCL2 mRNA] | 19152916 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | 20938992 |
D005492 | Folic Acid | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of CCL2 mRNA | 21907259|2364984 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of CCL2 protein | 15003329 |
C071317 | Foropafant | Foropafant inhibits the reaction [Platelet Activating Factor results in increased secretion of CCL2 protein] | 15149885 |
D005620 | Freund's Adjuvant | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | 16822543 |
D005620 | Freund's Adjuvant | Freund's Adjuvant results in increased expression of CCL2 mRNA | 20846436|2569866 |
D005620 | Freund's Adjuvant | Freund's Adjuvant results in increased expression of CCL2 protein | 25698669|2761348 |
D005620 | Freund's Adjuvant | Freund's Adjuvant results in increased secretion of CCL2 protein | 27613480 |
D005620 | Freund's Adjuvant | Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
D005620 | Freund's Adjuvant | Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 25698669 |
D005620 | Freund's Adjuvant | Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
D005620 | Freund's Adjuvant | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 27613480 |
D005620 | Freund's Adjuvant | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 27613480 |
D005620 | Freund's Adjuvant | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased secretion of CCL2 protein] | 27613480 |
D005620 | Freund's Adjuvant | [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
D005620 | Freund's Adjuvant | morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
D005620 | Freund's Adjuvant | morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 25698669 |
D005620 | Freund's Adjuvant | morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
D005620 | Freund's Adjuvant | trikatu inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 27613480 |
D005620 | Freund's Adjuvant | trikatu inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 27613480 |
D005620 | Freund's Adjuvant | trikatu inhibits the reaction [Freund's Adjuvant results in increased secretion of CCL2 protein] | 27613480 |
D005632 | Fructose | acetovanillone inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | Acetylcysteine inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | Allopurinol inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | [Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein | 19158351 |
D005632 | Fructose | Fructose results in increased secretion of CCL2 protein | 19158351 |
D005632 | Fructose | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | KHK protein promotes the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Fructose results in increased secretion of CCL2 protein]" | 19158351 |
D005632 | Fructose | Superoxides affects the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005632 | Fructose | [Dietary Fats co-treated with Fructose] results in increased expression of CCL2 protein | 26824242 |
D005632 | Fructose | [FGF21 gene mutant form results in increased susceptibility to Fructose] which results in increased expression of CCL2 mRNA | 28123933 |
D005632 | Fructose | [Fructose co-treated with Ethanol] results in increased expression of CCL2 mRNA | 26858005 |
D005632 | Fructose | sarpogrelate inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CCL2 protein] | 26824242 |
D005632 | Fructose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA] | 17133782 |
D005632 | Fructose | Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 protein] | 17133782 |
D005632 | Fructose | [Copper deficiency co-treated with Fructose] results in increased expression of CCL2 protein | 21781943 |
D005632 | Fructose | deferiprone inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D005632 | Fructose | Deferoxamine inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D005632 | Fructose | Fish Oils inhibits the reaction [Fructose results in increased expression of CCL2 protein] | 15752949 |
D005632 | Fructose | [Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein | 25813056 |
D005632 | Fructose | Fructose results in increased expression of CCL2 mRNA | 17133782 |
D005632 | Fructose | Fructose results in increased expression of CCL2 protein | 15752949|1713378 |
D005632 | Fructose | gadolinium chloride inhibits the reaction [[Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D005632 | Fructose | [Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein | 25813056 |
C096856 | FTI 277 | FTI 277 results in decreased expression of CCL2 mRNA | 18192240 |
C069837 | fullerene C60 | fullerene C60 results in increased expression of CCL2 mRNA | 20471445 |
D037741 | Fullerenes | Fullerenes analog results in decreased expression of CCL2 mRNA | 22342292 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in decreased activity of CCL2 protein] | 17006379 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [nonylphenol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in decreased activity of CCL2 protein] | 17006379 |
C056933 | fumonisin B1 | [deoxynivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | [deoxynivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | fumonisin B1 results in decreased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | [nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C056933 | fumonisin B1 | [Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
D062610 | Fungal Polysaccharides | Fungal Polysaccharides results in increased secretion of CCL2 protein | 28235615 |
D062610 | Fungal Polysaccharides | Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 27181935 |
C039281 | furan | furan results in increased expression of CCL2 mRNA | 27387713 |
C002469 | fusarenon-X | fusarenon-X results in increased expression of CCL2 mRNA | 24793808 |
C064925 | gadodiamide | gadodiamide results in increased expression of CCL2 mRNA | 20959327 |
C064925 | gadodiamide | gadodiamide results in increased secretion of CCL2 protein | 20959327 |
C064925 | gadodiamide | gadodiamide results in increased expression of CCL2 mRNA | 20938346 |
C064925 | gadodiamide | gadodiamide results in increased expression of CCL2 protein | 20938346 |
C038958 | gadolinium chloride | gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA] | 26177832 |
C038958 | gadolinium chloride | gadolinium chloride inhibits the reaction [[Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D005688 | Galactosamine | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCL2 mRNA" | 28887131 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 21146893 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | 21146893 |
D005688 | Galactosamine | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCL2 mRNA]" | 28887131 |
D005688 | Galactosamine | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21146893 |
D005688 | Galactosamine | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 21146893 |
D005707 | Gallic Acid | Gallic Acid analog inhibits the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
C043055 | gallium arsenide | gallium arsenide results in increased secretion of CCL2 protein | 14560044 |
C054597 | garcinol | garcinol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 22748497 |
C054597 | garcinol | garcinol promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 22748497 |
C054597 | garcinol | garcinol promotes the reaction [resveratrol results in decreased expression of CCL2 mRNA] | 22748497 |
C579046 | GDC-0152 | GDC-0152 results in increased expression of CCL2 protein | 22956632 |
C579046 | GDC-0152 | GDC-0152 results in increased expression of CCL2 protein | 22956632 |
C056507 | gemcitabine | gemcitabine results in decreased expression of CCL2 protein | 20531411 |
D015248 | Gemfibrozil | Gemfibrozil results in decreased expression of CCL2 mRNA | 25051504 |
D015248 | Gemfibrozil | Gemfibrozil results in decreased expression of CCL2 protein | 25051504 |
D019833 | Genistein | Genistein inhibits the reaction [LEP protein results in increased expression of CCL2] | 11342529 |
D019833 | Genistein | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 23452621 |
D019833 | Genistein | Genistein results in decreased secretion of CCL2 protein | 20816778 |
D019833 | Genistein | Genistein results in decreased expression of CCL2 mRNA | 21048042 |
D019833 | Genistein | Genistein results in decreased expression of CCL2 mRNA | 12846738 |
D005839 | Gentamicins | Gentamicins inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17699551 |
D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17699551 |
D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17442725 |
D005839 | Gentamicins | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17442725 |
D005839 | Gentamicins | Gentamicins results in increased expression of CCL2 mRNA | 17442725 |
D005839 | Gentamicins | Gentamicins affects the expression of CCL2 mRNA | 25051504 |
D005839 | Gentamicins | Gentamicins results in decreased expression of CCL2 protein | 25051504 |
D005839 | Gentamicins | Gentamicins results in increased expression of CCL2 mRNA | 22061828 |
D005839 | Gentamicins | Gentamicins results in increased expression of CCL2 protein | 16401625 |
D005839 | Gentamicins | KLK1 protein inhibits the reaction [Gentamicins results in increased expression of CCL2 protein] | 16401625 |
C102521 | GGTI 298 | GGTI 298 results in decreased expression of CCL2 mRNA | 18192240 |
C111520 | ginsan | ginsan inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 19913046 |
D005944 | Glucosamine | Alloxan inhibits the reaction [Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein]] | 18949387 |
D005944 | Glucosamine | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL2 protein] | 18080321 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 mRNA] | 18949387 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [CAP18 lipopolysaccharide-binding protein results in increased expression of CCL2 protein] | 18949387 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 mRNA] | 19020780 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [TNF results in increased expression of CCL2 protein] | 19020780 |
D005944 | Glucosamine | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL2 mRNA] | 17109745 |
D005944 | Glucosamine | Glucosamine results in increased expression of CCL2 mRNA | 17109745 |
D005944 | Glucosamine | IL1B promotes the reaction [Glucosamine results in increased expression of CCL2 mRNA] | 17109745 |
D005947 | Glucose | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 19132243 |
D005947 | Glucose | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 19132243 |
D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694 |
D005947 | Glucose | Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | CCL2 mRNA affects the reaction [Glucose results in increased expression of CTGF protein] | 21367880 |
D005947 | Glucose | chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
D005947 | Glucose | chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694|1913224 |
D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694|1913224 |
D005947 | Glucose | Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D005947 | Glucose | diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694|1913224 |
D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 16600694|1913224 |
D005947 | Glucose | Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D005947 | Glucose | Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA] | 19225232 |
D005947 | Glucose | Glucose results in increased expression of CCL2 mRNA | 16143069|1660069 |
D005947 | Glucose | Glucose results in increased expression of CCL2 protein | 16600694|1765588 |
D005947 | Glucose | Glucose results in increased secretion of CCL2 protein | 16600694|1766596 |
D005947 | Glucose | HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 21367880 |
D005947 | Glucose | isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 21367880 |
D005947 | Glucose | manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 23329836 |
D005947 | Glucose | picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
D005947 | Glucose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 17655880 |
D005947 | Glucose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 17655880 |
D005947 | Glucose | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D005947 | Glucose | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 24436987|2451350 |
D005947 | Glucose | [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 24436987|2451350 |
D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 24436987 |
D005947 | Glucose | resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 24436987 |
D005947 | Glucose | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16143069|1765588 |
D005947 | Glucose | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 19132243 |
D005947 | Glucose | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16143069 |
D005947 | Glucose | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D005947 | Glucose | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D005947 | Glucose | [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | 19225232 |
D005947 | Glucose | Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | 19225232 |
D005947 | Glucose | Glucose results in increased expression of CCL2 mRNA | 17178593 |
D005947 | Glucose | Glucose results in increased expression of CCL2 protein | 17607302 |
D005947 | Glucose | Glucose results in increased secretion of CCL2 protein | 23329836 |
D005947 | Glucose | manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 23329836 |
D005947 | Glucose | Glucose promotes the reaction [Particulate Matter results in increased expression of CCL2 mRNA] | 19505525 |
D005947 | Glucose | duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 22036992 |
D005947 | Glucose | duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 22036992 |
D005947 | Glucose | Glucose results in increased secretion of CCL2 protein | 22036992 |
C007858 | glucuronyl glucosamine glycan sulfate | glucuronyl glucosamine glycan sulfate results in decreased secretion of CCL2 protein | 21455109 |
D005978 | Glutathione | Glutathione inhibits the reaction [[Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
D005978 | Glutathione | Glutathione inhibits the reaction [[Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
C094503 | glyceryl 2-arachidonate | glyceryl 2-arachidonate results in increased expression of CCL2 protein | 15115777 |
D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 27585667 |
D006046 | Gold | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein | 22155353 |
D006046 | Gold | Gold results in increased secretion of CCL2 protein | 22155353 |
D006072 | Gossypol | Gossypol results in decreased expression of CCL2 mRNA | 19825521 |
D006072 | Gossypol | zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] | 19825521 |
D006108 | Graphite | Graphite results in increased expression of CCL2 protein | 27440207 |
C479979 | GW0742 | GW0742 inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 18622026 |
C412815 | GW 4064 | GW 4064 results in decreased expression of CCL2 mRNA | 23371517 |
C412815 | GW 4064 | GW 4064 results in increased expression of CCL2 mRNA | 26655953 |
C425931 | GW 501516 | BCL6 mutant form inhibits the reaction [GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 23737761 |
C425931 | GW 501516 | GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 23737761 |
C425931 | GW 501516 | GW 501516 inhibits the reaction [Palmitates results in increased expression of CCL2 mRNA] | 21966476 |
C425931 | GW 501516 | GW 501516 inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 21966476 |
C425931 | GW 501516 | GW 501516 results in decreased expression of CCL2 mRNA | 16574099 |
C453899 | GW 7647 | GW 7647 inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | 21268089 |
D006221 | Halothane | Halothane results in decreased expression of CCL2 mRNA | 15564938 |
D006246 | Harmaline | "Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
D006388 | Hemagglutinins | Hemagglutinins results in increased secretion of CCL2 protein | 22839698 |
D006418 | Heme | Heme metabolite results in increased expression of CCL2 mRNA | 19191707 |
C048849 | heme arginate | heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CCL2 protein] | 23089228 |
D006493 | Heparin | Heparin results in decreased expression of CCL2 protein | 11053056 |
C013015 | hesperetin | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D007975 | Leukotriene B4 | CCL2 protein results in increased abundance of Leukotriene B4 | 12388339 |
D007975 | Leukotriene B4 | Leukotriene B4 results in increased expression of CCL2 protein | 19880577 |
D007975 | Leukotriene B4 | zileuton inhibits the reaction [CCL2 protein results in increased abundance of Leukotriene B4] | 12388339 |
D006571 | Heterocyclic Compounds | Heterocyclic Compounds results in decreased expression of CCL2 mRNA | 26683377 |
C089796 | hexabromocyclododecane | [hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of CCL2 mRNA | 24398136 |
C001335 | hexachlorobutadiene | hexachlorobutadiene results in increased expression of CCL2 mRNA | 21905055 |
C080043 | hexyl cinnamic aldehyde | hexyl cinnamic aldehyde results in increased secretion of CCL2 protein | 22245253 |
D006632 | Histamine | Lipopolysaccharides promotes the reaction [Histamine results in increased expression of CCL2 protein] | 11336536 |
D006632 | Histamine | TNF protein promotes the reaction [Histamine results in increased expression of CCL2 protein] | 11336536 |
C005499 | honokiol | honokiol affects the expression of CCL2 mRNA | 21265825 |
D017313 | Fenretinide | Fenretinide results in increased expression of CCL2 mRNA | 28973697 |
D012701 | Serotonin | CCL2 protein results in increased activity of Serotonin | 11455205 |
D012701 | Serotonin | sarpogrelate inhibits the reaction [CCL2 protein results in increased activity of Serotonin] | 11455205 |
C506615 | HTS 466284 | HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 21367880 |
D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of CCL2 mRNA | 16129981 |
D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of CCL2 protein | 16129981 |
D006851 | Hydrochloric Acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 mRNA] | 16129981 |
D006851 | Hydrochloric Acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 protein] | 16129981 |
D006852 | Hydrochlorothiazide | Hydrochlorothiazide results in decreased expression of CCL2 mRNA | 19627010 |
D006854 | Hydrocortisone | Hydrocortisone results in decreased expression of CCL2 protein | 20116850 |
D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 25851902 |
D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 25851902 |
D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCL2 protein | 18951874 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [ALB protein results in increased expression of CCL2 mRNA] | 11961005 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of CCL2 mRNA | 26339600 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CCL2 mRNA | 12419474|1614306 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CCL2 protein | 17529908 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 9292787 |
D006861 | Hydrogen Peroxide | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 16143069 |
D006861 | Hydrogen Peroxide | Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 16143069 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased secretion of CCL2 protein | 18303122 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased secretion of CCL2 protein | 26766292 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased secretion of CCL2 protein] | 26766292 |
D006861 | Hydrogen Peroxide | resveratrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of CCL2 protein] | 26766292 |
C031927 | hydroquinone | hydroquinone results in decreased secretion of CCL2 protein | 22302391 |
C031927 | hydroquinone | hydroquinone results in increased expression of CCL2 protein | 17572062 |
C031927 | hydroquinone | hydroquinone results in increased secretion of CCL2 protein | 20946948 |
C031927 | hydroquinone | "hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]" | 22465845 |
C031927 | hydroquinone | "hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of CCL2 protein]" | 22465845 |
C031927 | hydroquinone | hydroquinone results in decreased expression of CCL2 mRNA | 22465845 |
C031927 | hydroquinone | hydroquinone results in decreased secretion of CCL2 protein | 22465845 |
D006886 | Hydroxychloroquine | Hydroxychloroquine results in increased expression of CCL2 mRNA | 15139008 |
D019796 | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | "[15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid binds to and results in increased activity of TBXA2R protein] which results in increased expression of CCL2 mRNA" | 22206755 |
C013038 | hydroxyhydroquinone | hydroxyhydroquinone affects the expression of CCL2 protein | 17572062 |
D003900 | Desoxycorticosterone | "[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 mRNA" | 21135038 |
D003900 | Desoxycorticosterone | "[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein" | 21135038 |
D003900 | Desoxycorticosterone | "Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein]" | 21135038 |
D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 11230753 |
D007052 | Ibuprofen | Ibuprofen results in increased expression of CCL2 mRNA | 17070997 |
D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 18799549 |
D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | 18799549 |
D007052 | Ibuprofen | Ibuprofen results in decreased expression of CCL2 mRNA | 15552841 |
C492448 | ICG 001 | ICG 001 inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
C492448 | ICG 001 | ICG 001 inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
C490483 | icilin | icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 protein] | 23596210 |
D000068877 | Imatinib Mesylate | Imatinib Mesylate inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased secretion of CCL2 protein] | 21935477 |
D007200 | Indican | Indican results in increased expression of CCL2 mRNA | 22056374 |
D007200 | Indican | Indican results in increased expression of CCL2 protein | 22056374 |
D019469 | Indinavir | diphenyleneiodonium inhibits the reaction [Indinavir results in increased expression of CCL2 protein] | 17668557 |
D019469 | Indinavir | Indinavir results in increased expression of CCL2 protein | 17668557 |
D007213 | Indomethacin | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]] | 21913898 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 11230753 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CCL2 mRNA | 28628672 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 18799549 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] | 18799549 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 18799549 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 18799549 |
D007213 | Indomethacin | cobaltiprotoporphyrin inhibits the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
D007213 | Indomethacin | Gallic Acid analog inhibits the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
D007213 | Indomethacin | Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 25698669 |
D007213 | Indomethacin | Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
D007213 | Indomethacin | Indomethacin results in increased expression of CCL2 mRNA | 23892052|2505150 |
D007213 | Indomethacin | Indomethacin results in increased expression of CCL2 protein | 25051504 |
D007213 | Indomethacin | [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
D007213 | Indomethacin | morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
D007213 | Indomethacin | zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
C401104 | indoxacarb | indoxacarb results in decreased expression of CCL2 | 21788198 |
C541917 | INT 131 | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
C541917 | INT 131 | INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
D019807 | Iodoacetic Acid | Iodoacetic Acid results in decreased expression of CCL2 mRNA | 23397585 |
D015759 | Ionomycin | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein | 17685462 |
D015759 | Ionomycin | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein] | 17685462 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | 17572062 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 mRNA | 25613284 |
C081309 | irbesartan | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 mRNA] | 19028402 |
C081309 | irbesartan | Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 protein] | 19028402 |
D007501 | Iron | Iron deficiency results in increased expression of CCL2 mRNA | 20368581 |
D007501 | Iron | [Iron co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA | 20302851 |
D007501 | Iron | Iron promotes the reaction [[Copper co-treated with Diethylnitrosamine] results in increased expression of CCL2 mRNA] | 20302851 |
D019266 | Iron, Dietary | "Iron, Dietary affects the expression of CCL2 mRNA" | 18032466 |
D019266 | Iron, Dietary | "Iron, Dietary affects the reaction [Thioacetamide affects the expression of CCL2 mRNA]" | 18032466 |
C551631 | isoangustone A | isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 21367880 |
D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA | 16997883 |
D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CCL2 mRNA | 28628672 |
D015056 | 1-Methyl-3-isobutylxanthine | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D015056 | 1-Methyl-3-isobutylxanthine | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 23503329 |
D015056 | 1-Methyl-3-isobutylxanthine | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 23503329 |
C036643 | isoeugenol | isoeugenol results in decreased secretion of CCL2 protein | 20488241 |
D007530 | Isoflurane | Isoflurane results in decreased expression of CCL2 mRNA | 15564938 |
D007545 | Isoproterenol | Isoproterenol results in increased expression of CCL2 mRNA | 21823215 |
C016527 | isoquercitrin | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CCL2 mRNA] | 21295105 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of CCL2 mRNA | 27392435 |
C098607 | JP8 aviation fuel | JP8 aviation fuel affects the expression of CCL2 mRNA | 17085751 |
C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of CCL2 mRNA | 15251112 |
C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of CCL2 protein | 15251112|1733775 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [TNF protein promotes the reaction [BRD4 protein binds to CCL2 enhancer]] | 25263595 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 23686307|2526359 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CCL2 mRNA | 22904298|2443544 |
C561695 | (+)-JQ1 compound | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 24799421 |
C561695 | (+)-JQ1 compound | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 23420887 |
C561695 | (+)-JQ1 compound | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 23420887 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25890327|2658214 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CCL2 mRNA | 27436852 |
C006552 | kaempferol | kaempferol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
C006552 | kaempferol | kaempferol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16434028 |
C006552 | kaempferol | kaempferol inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 16434028 |
D007608 | Kainic Acid | Kainic Acid results in increased expression of CCL2 mRNA | 19700661 |
D007654 | Ketoconazole | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16784723 |
D007654 | Ketoconazole | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
D007654 | Ketoconazole | Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16784723 |
D007654 | Ketoconazole | Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16784723 |
D007654 | Ketoconazole | PTGER2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
D007654 | Ketoconazole | PTGER3 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
C055370 | lactofen | lactofen results in decreased expression of CCL2 | 21788198 |
C018548 | lanatoside C | lanatoside C results in decreased expression of CCL2 protein | 20116850 |
D007840 | Latex | Latex promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18938192 |
D007840 | Latex | Latex results in increased expression of CCL2 protein | 18938192 |
D007854 | Lead | Lead results in increased expression of CCL2 mRNA | 17715263 |
C008261 | lead acetate | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C008261 | lead acetate | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C008261 | lead acetate | Celecoxib inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C008261 | lead acetate | lead acetate results in decreased expression of CCL2 mRNA | 21829687 |
C008261 | lead acetate | lead acetate results in increased secretion of CCL2 protein | 24530660 |
C008261 | lead acetate | Minocycline inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C008261 | lead acetate | U 0126 inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C038753 | leptomycin B | leptomycin B results in increased secretion of CCL2 protein | 21967610 |
C038753 | leptomycin B | polydatin inhibits the reaction [leptomycin B results in increased secretion of CCL2 protein] | 21967610 |
C038753 | leptomycin B | acteoside inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C038753 | leptomycin B | leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein] | 21967610 |
C038753 | leptomycin B | Quercetin inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C038753 | leptomycin B | resveratrol inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C038753 | leptomycin B | Rutin inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
D008012 | Lidocaine | Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 14570645 |
D008012 | Lidocaine | Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 14570645 |
D008055 | Lipids | [Methotrexate analog binds to Lipids] which results in decreased expression of CCL2 mRNA | 24065615 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA" | 23090859 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "nickel chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]" | 23090859 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "TGFB1 protein inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]" | 21693323 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "eupatilin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]" | 21565208 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]" | 22465845 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of CCL2 protein]" | 22465845 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein" | 22465845 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA" | 21565208|2169332 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in increased secretion of CCL2 protein" | 22465845 |
C482199 | lipopolysaccharide, E coli O55-B5 | "5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "acteoside inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12107048 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA" | 17880982 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA" | 21756928|2186541 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein" | 12107048|2186541 |
C482199 | lipopolysaccharide, E coli O55-B5 | "polydatin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Quercetin inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA]" | 17880982 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Quercetin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C482199 | lipopolysaccharide, E coli O55-B5 | "resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C482199 | lipopolysaccharide, E coli O55-B5 | "ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 23604539 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Cannabidiol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 19910459 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCL2 mRNA" | 28887131 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA" | 19910459|2172487 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein" | 12832678|1752659 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased secretion of and results in increased expression of CCL2 protein" | 21724870 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein" | 22965302|2721663 |
C482199 | lipopolysaccharide, E coli O55-B5 | "naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 22965302 |
C482199 | lipopolysaccharide, E coli O55-B5 | "naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]" | 22965302 |
C482199 | lipopolysaccharide, E coli O55-B5 | "neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 23604539 |
C482199 | lipopolysaccharide, E coli O55-B5 | "neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]]" | 23604539 |
C482199 | lipopolysaccharide, E coli O55-B5 | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCL2 mRNA]" | 28887131 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Particulate Matter analog promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12832678 |
C482199 | lipopolysaccharide, E coli O55-B5 | "tetrathiomolybdate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21724870 |
C482199 | lipopolysaccharide, E coli O55-B5 | "tetrathiomolybdate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of and results in increased expression of CCL2 protein]" | 21724870 |
C482199 | lipopolysaccharide, E coli O55-B5 | "titanium dioxide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]" | 27216632 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Vehicle Emissions analog promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12832678 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Diclofenac promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 23939143 |
C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA" | 23939143 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 22020770 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein" | 22020770 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 22020770 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 21426947 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "arctigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 21426947 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD2 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 mRNA]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD2 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 protein]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD2 protein affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 mRNA]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD3 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 mRNA]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD3 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 protein]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD4 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 mRNA]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "BRD4 mutant form affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 protein]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 24799421 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "(+)-JQ1 compound inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 mRNA" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CCL2 protein" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of CCL2 protein" | 23420887 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA" | 24799421|2516466 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein" | 21865055|2202077 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein" | 21426947|2342088 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "Particulate Matter analog promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 23896513 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 15734790 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 15734790 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA" | 12954792|1573479 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein" | 15734790 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 12954792 |
C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 15734790 |
D008070 | Lipopolysaccharides | "1,3-dimethylthiourea inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]" | 17529908 |
D008070 | Lipopolysaccharides | "2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 15698426 |
D008070 | Lipopolysaccharides | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17529908 |
D008070 | Lipopolysaccharides | ANXA1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21777521 |
D008070 | Lipopolysaccharides | Aspirin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24211328 |
D008070 | Lipopolysaccharides | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 16317058 |
D008070 | Lipopolysaccharides | [Cadmium Chloride co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 26809137 |
D008070 | Lipopolysaccharides | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D008070 | Lipopolysaccharides | dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | 22014880 |
D008070 | Lipopolysaccharides | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16317058 |
D008070 | Lipopolysaccharides | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17529908 |
D008070 | Lipopolysaccharides | Dimethyl Sulfoxide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17529908 |
D008070 | Lipopolysaccharides | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]] | 21913898 |
D008070 | Lipopolysaccharides | Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D008070 | Lipopolysaccharides | Dinoprostone promotes the reaction [roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D008070 | Lipopolysaccharides | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 12818967 |
D008070 | Lipopolysaccharides | Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 12818967 |
D008070 | Lipopolysaccharides | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 15698426 |
D008070 | Lipopolysaccharides | Docosahexaenoic Acids inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15698426 |
D008070 | Lipopolysaccharides | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 15698426 |
D008070 | Lipopolysaccharides | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15698426 |
D008070 | Lipopolysaccharides | fluridone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24211328 |
D008070 | Lipopolysaccharides | Gentamicins inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17699551 |
D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17699551 |
D008070 | Lipopolysaccharides | hesperetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D008070 | Lipopolysaccharides | Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D008070 | Lipopolysaccharides | Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 14570645 |
D008070 | Lipopolysaccharides | Lidocaine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 14570645 |
D008070 | Lipopolysaccharides | Lipopolysaccharides affects the secretion of CCL2 protein | 15196211 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein | 22014880 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of CCL2 mRNA | 21878375 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL2 protein | 21878375 |
D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Histamine results in increased expression of CCL2 protein] | 11336536 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased secretion of CCL2 protein | 28065790 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | 12818967|1457064 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | 11336536|1281896 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CCL2 protein | 17618502|1839072 |
D008070 | Lipopolysaccharides | Naloxone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17084265 |
D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 23724058 |
D008070 | Lipopolysaccharides | Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D008070 | Lipopolysaccharides | Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | 22014880 |
D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21371465 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21371465|2458490 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24584901|2470711 |
D008070 | Lipopolysaccharides | Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21913898 |
D008070 | Lipopolysaccharides | roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21913898 |
D008070 | Lipopolysaccharides | Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D008070 | Lipopolysaccharides | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15824212|1644322 |
D008070 | Lipopolysaccharides | telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22124178 |
D008070 | Lipopolysaccharides | telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22124178 |
D008070 | Lipopolysaccharides | "17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 21724996 |
D008070 | Lipopolysaccharides | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
D008070 | Lipopolysaccharides | "2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 27523796 |
D008070 | Lipopolysaccharides | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
D008070 | Lipopolysaccharides | "2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]] | 25171655 |
D008070 | Lipopolysaccharides | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19293636|2222551 |
D008070 | Lipopolysaccharides | "3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 25843059 |
D008070 | Lipopolysaccharides | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
D008070 | Lipopolysaccharides | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]" | 24465016 |
D008070 | Lipopolysaccharides | AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 22273745 |
D008070 | Lipopolysaccharides | AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 24465016 |
D008070 | Lipopolysaccharides | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 22225513 |
D008070 | Lipopolysaccharides | astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22210036 |
D008070 | Lipopolysaccharides | CAP18 lipopolysaccharide-binding protein inhibits the reaction [[Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21731756 |
D008070 | Lipopolysaccharides | Carbenoxolone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 27523796 |
D008070 | Lipopolysaccharides | coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D008070 | Lipopolysaccharides | cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25171655 |
D008070 | Lipopolysaccharides | CP 105696 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19880577 |
D008070 | Lipopolysaccharides | crocetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21925167 |
D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
D008070 | Lipopolysaccharides | DCB-SLE1 inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein] | 21677146 |
D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 27568862 |
D008070 | Lipopolysaccharides | dimemorfan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18500357 |
D008070 | Lipopolysaccharides | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 16765938 |
D008070 | Lipopolysaccharides | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 23958496 |
D008070 | Lipopolysaccharides | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16306350 |
D008070 | Lipopolysaccharides | Fenofibrate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 15968640 |
D008070 | Lipopolysaccharides | fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22253906 |
D008070 | Lipopolysaccharides | fidarestat inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22253906 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 21146893 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | 21146893 |
D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17442725 |
D008070 | Lipopolysaccharides | Gentamicins promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17442725 |
D008070 | Lipopolysaccharides | IFNB1 protein affects the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18323514 |
D008070 | Lipopolysaccharides | IL10 protein inhibits the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]] | 22273745 |
D008070 | Lipopolysaccharides | IL10 protein inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 22273745 |
D008070 | Lipopolysaccharides | IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 15804595 |
D008070 | Lipopolysaccharides | (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25890327|2658214 |
D008070 | Lipopolysaccharides | Latex promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18938192 |
D008070 | Lipopolysaccharides | LCN2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18292240 |
D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [RELA protein binds to CCL2 promoter] | 21138578 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein | 21677146|2691878 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 | 12963494 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | 10027076|1022374 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | 17076685|1744272 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CCL2 protein | 15593098|1630318 |
D008070 | Lipopolysaccharides | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
D008070 | Lipopolysaccharides | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22225513 |
D008070 | Lipopolysaccharides | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein]" | 26918785 |
D008070 | Lipopolysaccharides | Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24561310 |
D008070 | Lipopolysaccharides | Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22093924 |
D008070 | Lipopolysaccharides | Nicotine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22093924 |
D008070 | Lipopolysaccharides | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25472953 |
D008070 | Lipopolysaccharides | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 23170834 |
D008070 | Lipopolysaccharides | NR1H4 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22135065 |
D008070 | Lipopolysaccharides | PARP1 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17438151 |
D008070 | Lipopolysaccharides | Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17076685 |
D008070 | Lipopolysaccharides | Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17076685 |
D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20423518 |
D008070 | Lipopolysaccharides | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16306350 |
D008070 | Lipopolysaccharides | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18323514 |
D008070 | Lipopolysaccharides | PPARA affects the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 21262334 |
D008070 | Lipopolysaccharides | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18323514 |
D008070 | Lipopolysaccharides | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22169119 |
D008070 | Lipopolysaccharides | procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22169119 |
D008070 | Lipopolysaccharides | pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
D008070 | Lipopolysaccharides | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
D008070 | Lipopolysaccharides | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18500357 |
D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22210036 |
D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22869926 |
D008070 | Lipopolysaccharides | resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21724996 |
D008070 | Lipopolysaccharides | resolvin D2 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21724996 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19293636|2071290 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19279313|1929363 |
D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22118570 |
D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
D008070 | Lipopolysaccharides | [Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 21731756 |
D008070 | Lipopolysaccharides | [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | 22273745 |
D008070 | Lipopolysaccharides | t-butyloxycarbonyl-methionyl-leucyl-phenylalanine inhibits the reaction [resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21724996 |
D008070 | Lipopolysaccharides | terameprocol inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CCL2 promoter]] | 21138578 |
D008070 | Lipopolysaccharides | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19133137|2113857 |
D008070 | Lipopolysaccharides | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19133137|2113857 |
D008070 | Lipopolysaccharides | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20682337|2544633 |
D008070 | Lipopolysaccharides | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 25446332 |
D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18706406 |
D008070 | Lipopolysaccharides | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21146893 |
D008070 | Lipopolysaccharides | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 21146893 |
D008070 | Lipopolysaccharides | Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17076685 |
D008070 | Lipopolysaccharides | Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17076685 |
D008070 | Lipopolysaccharides | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
D008070 | Lipopolysaccharides | ZFP36 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22093924 |
D008070 | Lipopolysaccharides | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 11340305 |
D008070 | Lipopolysaccharides | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
D008070 | Lipopolysaccharides | ADM protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21803157 |
D008070 | Lipopolysaccharides | alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 24333275 |
D008070 | Lipopolysaccharides | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 11340305 |
D008070 | Lipopolysaccharides | CALCA protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21803157 |
D008070 | Lipopolysaccharides | deferiprone inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D008070 | Lipopolysaccharides | Deferoxamine inhibits the reaction [[Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein] | 25813056 |
D008070 | Lipopolysaccharides | Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 20940016 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Fructose co-treated with Copper deficiency] results in increased expression of CCL2 protein | 25813056 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 | 22939914 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | 11340305|2180315 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 protein | 11340305|1572186 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased secretion of CCL2 protein | 21504754|2614138 |
D008070 | Lipopolysaccharides | Sodium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 11340305 |
D008070 | Lipopolysaccharides | tin protoporphyrin IX inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]] | 20940016 |
D008070 | Lipopolysaccharides | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25446332 |
D008070 | Lipopolysaccharides | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 25446332 |
D008070 | Lipopolysaccharides | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19243473 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CCL2 mRNA | 19243473 |
D008070 | Lipopolysaccharides | [TNF protein co-treated with IL1B protein co-treated with IFNG protein co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 20816778 |
D008070 | Lipopolysaccharides | [TNF protein co-treated with IL1B protein co-treated with IFNG protein co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | 20816778 |
C009900 | lipoteichoic acid | lipoteichoic acid results in increased secretion of CCL2 protein | 23981542 |
C009900 | lipoteichoic acid | resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CCL2 protein] | 23981542 |
C059516 | loganin | loganin affects the expression of CCL2 protein | 21864639 |
D061466 | Lopinavir | diphenyleneiodonium inhibits the reaction [Lopinavir results in increased expression of CCL2 protein] | 17668557 |
D061466 | Lopinavir | Lopinavir results in increased expression of CCL2 protein | 17668557 |
C558899 | lopinavir-ritonavir drug combination | lopinavir-ritonavir drug combination results in increased secretion of CCL2 protein | 20884875 |
C558899 | lopinavir-ritonavir drug combination | Pravastatin inhibits the reaction [lopinavir-ritonavir drug combination results in increased secretion of CCL2 protein] | 20884875 |
D019808 | Losartan | Losartan inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
D019808 | Losartan | Losartan inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
D019808 | Losartan | Losartan inhibits the reaction [Estrogens deficiency results in increased expression of CCL2 protein] | 19553526 |
D019808 | Losartan | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL2 protein] | 16284884 |
D019808 | Losartan | Losartan results in decreased expression of CCL2 mRNA | 10925121 |
D019808 | Losartan | Losartan results in decreased expression of CCL2 protein | 17922026 |
D019808 | Losartan | Losartan inhibits the reaction [AGT protein modified form results in increased expression of CCL2 mRNA] | 22306536 |
C485003 | LR-90 | LR-90 inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | 17327432 |
C485003 | LR-90 | LR-90 inhibits the reaction [S100B protein results in increased expression of CCL2 protein] | 17327432 |
D017997 | Leukotriene C4 | Leukotriene C4 results in increased expression of CCL2 mRNA | 12388339 |
D047311 | Luteolin | Luteolin inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 24134915 |
C106335 | macrophage stimulatory lipopeptide 2 | [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of CCL2 mRNA | 18832182 |
C106335 | macrophage stimulatory lipopeptide 2 | macrophage stimulatory lipopeptide 2 results in increased expression of CCL2 mRNA | 18096868|1883218 |
C106335 | macrophage stimulatory lipopeptide 2 | macrophage stimulatory lipopeptide 2 results in increased secretion of CCL2 protein | 18096868 |
C106335 | macrophage stimulatory lipopeptide 2 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CCL2 protein] | 18096868 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA | 26378955 |
D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA | 21641980 |
D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA | 26378955 |
D008344 | Maneb | Maneb results in decreased expression of CCL2 | 21788198 |
D008345 | Manganese | Manganese results in increased expression of CCL2 mRNA | 19782702 |
C025340 | manganese chloride | manganese chloride inhibits the reaction [CCL2 protein results in increased expression of ICAM1 protein] | 23329836 |
C025340 | manganese chloride | manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 23329836 |
C025340 | manganese chloride | manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 23329836 |
C025340 | manganese chloride | manganese chloride results in decreased secretion of CCL2 protein | 23329836 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C013592 | mangiferin | mangiferin results in decreased expression of CCL2 mRNA | 15135318 |
C054218 | manidipine | manidipine results in decreased expression of CCL2 mRNA | 16392774 |
D008463 | Mebendazole | Mebendazole results in increased expression of CCL2 protein | 20116850 |
D008464 | Mecamylamine | Mecamylamine inhibits the reaction [Nicotine results in decreased expression of CCL2 mRNA] | 15135227 |
D008466 | Mechlorethamine | Mechlorethamine results in increased expression of CCL2 mRNA | 26273949 |
C100122 | meclocycline | meclocycline results in decreased expression of CCL2 protein | 20116850 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in decreased expression of CCL2 mRNA | 18606702 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in decreased expression of CCL2 protein | 18606702 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in decreased secretion of CCL2 protein | 18606702 |
C011907 | melamine | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased expression of CCL2 mRNA]" | 22915474 |
C011907 | melamine | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C011907 | melamine | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C011907 | melamine | melamine results in increased expression of CCL2 mRNA | 22915474 |
C011907 | melamine | SB 203580 inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C011907 | melamine | SN50 peptide inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
D008550 | Melatonin | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
D008550 | Melatonin | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22225513 |
C000600816 | mercaptosteroid 4 | mercaptosteroid 4 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 25851902 |
C000600816 | mercaptosteroid 4 | mercaptosteroid 4 inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 25851902 |
C000600817 | mercaptosteroid 6 | mercaptosteroid 6 inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 25851902 |
C000600817 | mercaptosteroid 6 | mercaptosteroid 6 inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 25851902 |
D008627 | Mercuric Chloride | CCL2 protein results in increased susceptibility to Mercuric Chloride | 12834626 |
D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of CCL2 mRNA | 12834626 |
D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of CCL2 protein | 12834626 |
D008687 | Metformin | Metformin results in decreased expression of CCL2 mRNA | 20956498 |
D008687 | Metformin | Metformin inhibits the reaction [IL13 protein results in increased expression of CCL2 mRNA] | 26497364 |
D008687 | Metformin | Metformin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D008691 | Methadone | Methadone results in increased secretion of CCL2 protein | 20178837 |
D008701 | Methapyrilene | Methapyrilene affects the expression of CCL2 protein | 25051504 |
D008701 | Methapyrilene | Methapyrilene results in increased expression of CCL2 mRNA | 25051504 |
D008701 | Methapyrilene | Methapyrilene results in increased expression of CCL2 protein | 25051504 |
D008713 | Methimazole | Methimazole results in increased expression of CCL2 mRNA | 23397585 |
D008713 | Methimazole | [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of CCL2 mRNA | 22407903 |
D008713 | Methimazole | [Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA | 26177832 |
D008713 | Methimazole | gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CCL2 mRNA] | 26177832 |
D008715 | Methionine | "[3,4,5,3',4'-pentachlorobiphenyl co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 protein" | 28973532 |
D008715 | Methionine | "3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA]" | 28973532 |
D008715 | Methionine | Bezafibrate inhibits the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA] | 18513333 |
D008715 | Methionine | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ACTA2 protein] | 20697377 |
D008715 | Methionine | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A1 mRNA] | 20697377 |
D008715 | Methionine | CCL2 protein inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CTGF mRNA] | 20697377 |
D008715 | Methionine | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of CCL2 mRNA | 18513333 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCL2 mRNA | 20938992 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA | 23038002|2897353 |
D008715 | Methionine | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA] | 23038002 |
D008717 | Methionine Sulfoximine | Methionine Sulfoximine results in decreased expression of CCL2 protein | 20116850 |
D003915 | Dextromethorphan | Dextromethorphan results in decreased expression of CCL2 protein | 19189960 |
D008727 | Methotrexate | Methotrexate results in decreased expression of CCL2 mRNA | 17400583 |
D008727 | Methotrexate | Methotrexate results in increased secretion of CCL2 protein | 27605418 |
D008727 | Methotrexate | [Methotrexate analog binds to Lipids] which results in decreased expression of CCL2 mRNA | 24065615 |
D008727 | Methotrexate | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 27613480 |
D008727 | Methotrexate | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 27613480 |
D008727 | Methotrexate | Methotrexate inhibits the reaction [Freund's Adjuvant results in increased secretion of CCL2 protein] | 27613480 |
C013598 | methoxyacetic acid | methoxyacetic acid results in increased expression of CCL2 mRNA | 28238932 |
D008731 | Methoxychlor | Methoxychlor results in decreased expression of CCL2 mRNA | 23397585 |
D008731 | Methoxychlor | Methoxychlor results in decreased expression of CCL2 | 21788198 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL2 protein]" | 26918785 |
C005106 | methylbenzethonium chloride | methylbenzethonium chloride results in decreased expression of CCL2 protein | 20116850 |
C108732 | methyl-beta-cyclodextrin | methyl-beta-cyclodextrin inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CCL2 mRNA | 23397585 |
D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CCL2 mRNA | 20713471 |
C008435 | methyldithiocarbamate | methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CCL2 protein] | 24056979 |
C028912 | methylene bis(thiocyanate) | methylene bis(thiocyanate) results in decreased expression of CCL2 | 21788198 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CCL2 mRNA | 24213012 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of CCL2 mRNA | 23397585 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of CCL2 | 23208443 |
D008767 | Methylmercury Compounds | RELA mutant form inhibits the reaction [Methylmercury Compounds results in increased expression of CCL2] | 23208443 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of ABCB1A mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of BAX mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of COX1 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of CYTB mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of MT2 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of SDHB mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of SOD1 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in decreased expression of SOD2 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of ABCB1A mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of BAX mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of COX1 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of CYTB mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of SOD1 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of SOD1 protein] | 21976372 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of SOD2 mRNA] | 22837723 |
D008767 | Methylmercury Compounds | CCL2 protein affects the reaction [Methylmercury Compounds results in increased expression of SOD2 protein] | 21976372 |
D008767 | Methylmercury Compounds | CCL2 protein affects the susceptibility to Methylmercury Compounds | 21976372|2283772 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of CCL2 protein | 21976372 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased expression of CCL2 mRNA | 21628967|2320844 |
D020366 | Methylmethacrylate | Methylmethacrylate results in increased expression of CCL2 mRNA | 17498896 |
D008770 | Methylnitrosourea | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | 16822543 |
D008770 | Methylnitrosourea | Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | 16822543 |
D008770 | Methylnitrosourea | IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] | 16822543 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CCL2 protein | 16822543 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CCL2 mRNA | 17412507 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CCL2 mRNA]" | 25406165 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CCL2 mRNA" | 25406165 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA" | 22746536|2727780 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 22746536 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 22746536 |
D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA]" | 27277809 |
D008797 | Metyrapone | Metyrapone inhibits the reaction [Ozone results in increased expression of CCL2 mRNA] | 27037194 |
D008797 | Metyrapone | Metyrapone inhibits the reaction [Ozone results in increased expression of CCL2 protein] | 27037194 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Atorvastatin Calcium results in decreased expression of CCL2 mRNA] | 12117737 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [cerivastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA]] | 16321392 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737|1632139 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CCL2 mRNA] | 12117737 |
C089950 | MF59 oil emulsion | MF59 oil emulsion results in increased secretion of CCL2 protein | 18390722 |
D015735 | Mifepristone | [Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 mRNA | 18606702 |
D015735 | Mifepristone | [Mifepristone binds to and results in decreased activity of PGR protein] which results in increased expression of CCL2 protein | 18606702 |
D015735 | Mifepristone | Mifepristone results in decreased expression of CCL2 mRNA | 25972201 |
D000451 | Mineralocorticoid Receptor Antagonists | "Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein]" | 21135038 |
D008911 | Minocycline | Minocycline results in decreased expression of CCL2 protein | 20116850 |
D008911 | Minocycline | Minocycline inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
D016685 | Mitomycin | Dexamethasone inhibits the reaction [Mitomycin results in increased expression of CCL2 mRNA] | 20002897 |
D016685 | Mitomycin | Dexamethasone inhibits the reaction [Mitomycin results in increased secretion of CCL2 protein] | 20002897 |
D016685 | Mitomycin | Mitomycin results in increased expression of CCL2 mRNA | 20002897 |
D016685 | Mitomycin | Mitomycin results in increased secretion of CCL2 protein | 20002897 |
C060893 | MK-886 | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 mRNA" | 22135674 |
C060893 | MK-886 | "[13-hydroperoxy-9,11-octadecadienoic acid co-treated with MK-886] results in increased expression of CCL2 protein" | 22135674 |
C502230 | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | "Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Fructose results in increased secretion of CCL2 protein]" | 19158351 |
C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in increased expression of CCL2 mRNA | 27384973 |
D016686 | Monocrotaline | Monocrotaline results in increased expression of CCL2 mRNA | 25051504 |
D016686 | Monocrotaline | Monocrotaline results in increased expression of CCL2 protein | 25051504 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CCL2 mRNA | 16507463|2210804 |
C093875 | montelukast | montelukast inhibits the reaction [CCL2 protein results in increased abundance of Calcium] | 16771778 |
C008548 | morin | Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
C008548 | morin | [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
C008548 | morin | morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 25698669 |
C008548 | morin | morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 25698669 |
C008548 | morin | morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] | 25698669 |
D009020 | Morphine | Morphine results in increased secretion of CCL2 protein | 20178837 |
C523799 | MRK 003 | MRK 003 results in decreased expression of CCL2 mRNA | 21169257 |
C523799 | MRK 003 | CCL2 results in increased susceptibility to MRK 003 | 19903844 |
C500085 | muraglitazar | muraglitazar results in decreased expression of CCL2 mRNA | 21515302 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 protein | 17720292 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | 18955075 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | 8796382 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 protein | 9187966 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CCL2 mRNA | 18988085|2761761 |
D009173 | Mycophenolic Acid | Mycophenolic Acid inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 17624267 |
D009173 | Mycophenolic Acid | Mycophenolic Acid inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 17624267 |
D009183 | Mycotoxins | Mycotoxins results in decreased expression of CCL2 mRNA | 19818335 |
C008577 | myricitrin | myricitrin inhibits the reaction [APOE gene mutant form results in increased expression of CCL2 protein] | 23639522 |
C097963 | N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin | "N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]" | 20354174 |
C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LEP protein results in increased expression of CCL2] | 11342529 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 11230753 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] | 11230753 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 11230753 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CCL2 protein] | 18096868 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 11230753 |
C496401 | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide | N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 26526764 |
D009267 | Naled | Naled results in decreased expression of CCL2 | 21788198 |
D009270 | Naloxone | Naloxone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17084265 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased secretion of CCL2 protein" | 19041333 |
D037742 | Nanotubes, Carbon | "[Nanotubes, Carbon co-treated with calfactant] results in increased expression of CCL2 mRNA" | 23026733 |
D037742 | Nanotubes, Carbon | "[Nanotubes, Carbon co-treated with calfactant] results in increased expression of CCL2 protein" | 23026733 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of CCL2 mRNA" | 23634900 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2 mRNA" | 24389112|2668331 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CCL2 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL2 mRNA]" | 26091108 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2" | 25510677 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2 mRNA" | 22293422|2314889 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased secretion of CCL2 protein" | 19371758|2208185 |
D037742 | Nanotubes, Carbon | "[TBX21 gene mutant form results in increased susceptibility to Nanotubes, Carbon] which results in increased expression of CCL2 protein" | 24499286 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2 mRNA" | 19836432|2491129 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2 mRNA" | 23845593 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CCL2 protein" | 23845593 |
C031721 | naphthalene | naphthalene results in increased expression of CCL2 mRNA | 18978301 |
D009281 | Naphthalenes | Naphthalenes results in increased expression of CCL2 protein | 17337753 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA | 21037076|2692128 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CCL2 protein | 22094456 |
D015058 | 1-Naphthylisothiocyanate | F2R protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA] | 21037076 |
D015058 | 1-Naphthylisothiocyanate | F3 protein promotes the reaction [1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA] | 21037076 |
D015058 | 1-Naphthylisothiocyanate | [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of CCL2 mRNA | 21356363 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CCL2 mRNA | 25051504 |
D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of CCL2 protein | 25051504 |
D009288 | Naproxen | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
D009288 | Naproxen | Naproxen inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
C005273 | naringenin | "[Cholesterol, Dietary co-treated with naringenin] affects the expression of CCL2 mRNA" | 11396955 |
C005273 | naringenin | naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of CCL2]] | 23782265 |
C005274 | naringin | "naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 22965302 |
C005274 | naringin | "naringin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]" | 22965302 |
C005274 | naringin | "[Cholesterol, Dietary co-treated with naringin] affects the expression of CCL2 mRNA" | 11396955 |
C017096 | n-butoxyethanol | n-butoxyethanol results in increased expression of CCL2 mRNA | 19812364 |
D000068577 | Nebivolol | Nebivolol results in decreased expression of CCL2 mRNA | 17467819 |
D000068577 | Nebivolol | Nebivolol results in decreased secretion of CCL2 protein | 17310107|1746781 |
D019888 | Nelfinavir | diphenyleneiodonium inhibits the reaction [Nelfinavir results in increased expression of CCL2 protein] | 17668557 |
D019888 | Nelfinavir | Nelfinavir results in increased expression of CCL2 protein | 17668557 |
C002701 | neocuproine | "neocuproine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 23604539 |
C002701 | neocuproine | "neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]]" | 23604539 |
C015380 | neoechinulin | neoechinulin results in decreased expression of CCL2 mRNA | 19818335 |
C490266 | neoechinulin A | neoechinulin A results in decreased expression of CCL2 mRNA | 19818335 |
C080840 | N(G)-nitroarginine-4-nitroanilide | N(G)-nitroarginine-4-nitroanilide analog inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
D009525 | Niacin | Niacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 18550065 |
D009525 | Niacin | Niacin results in decreased expression of CCL2 protein | 18550065 |
D009525 | Niacin | Niacin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 20167660 |
D009525 | Niacin | Niacin results in decreased expression of CCL2 mRNA | 20167660 |
D009525 | Niacin | Niacin results in decreased expression of CCL2 protein | 19420110 |
D009532 | Nickel | Nickel results in increased expression of CCL2 mRNA | 25583101 |
D009532 | Nickel | Nickel results in increased secretion of CCL2 protein | 24840272 |
D009532 | Nickel | CCL2 protein affects the reaction [TBX21 gene mutant form results in increased susceptibility to Nickel analog] | 24499286 |
D009532 | Nickel | CCL2 protein affects the reaction [[TBX21 gene mutant form results in increased susceptibility to Nickel analog] which results in increased expression of MUC5AC mRNA] | 24499286 |
D009532 | Nickel | Nickel analog results in decreased expression of CCL2 mRNA | 25144474 |
D009532 | Nickel | [TBX21 gene mutant form results in increased susceptibility to Nickel analog] which results in increased expression of CCL2 protein | 24499286 |
D009532 | Nickel | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 23503329 |
D009532 | Nickel | [Zinc co-treated with Nickel co-treated with Cobalt] affects the reaction [Dietary Fats affects the expression of CCL2 mRNA] | 23503329 |
D009532 | Nickel | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 23503329 |
D009532 | Nickel | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 mRNA]] | 22700867 |
D009532 | Nickel | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]] | 22700867 |
D009532 | Nickel | Acetylcysteine inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein]] | 22700867 |
D009532 | Nickel | Nickel analog results in increased expression of CCL2 mRNA | 22700867 |
D009532 | Nickel | Nickel analog results in increased expression of CCL2 protein | 22700867 |
D009532 | Nickel | PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 mRNA] | 22700867 |
D009532 | Nickel | PDGFB protein promotes the reaction [Nickel analog results in increased expression of CCL2 protein] | 22700867 |
C022838 | nickel chloride | "nickel chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]" | 23090859 |
C022838 | nickel chloride | nickel chloride results in decreased secretion of CCL2 protein | 18437699 |
C022838 | nickel chloride | nickel chloride results in increased expression of CCL2 mRNA | 17312168 |
C022838 | nickel chloride | nickel chloride results in increased secretion of CCL2 protein | 25458486 |
C022838 | nickel chloride | nickel chloride results in decreased expression of CCL2 mRNA | 12839937 |
C037473 | nickel hydroxide (II) | nickel hydroxide (II) analog results in increased expression of CCL2 mRNA | 20864429 |
C028007 | nickel monoxide | nickel monoxide results in increased expression of CCL2 mRNA | 19167457 |
C017557 | nickel subsulfide | nickel subsulfide results in decreased expression of CCL2 mRNA | 12760830 |
C029938 | nickel sulfate | [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of CCL2 mRNA | 18832182 |
C029938 | nickel sulfate | nickel sulfate results in decreased expression of CCL2 mRNA | 17374397 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of CCL2 mRNA | 12060402|1558537 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of CCL2 mRNA | 16100012|1616674 |
D009534 | Niclosamide | Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 24561310 |
D009534 | Niclosamide | Niclosamide results in decreased expression of CCL2 | 21788198 |
D009538 | Nicotine | Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22093924 |
D009538 | Nicotine | Nicotine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22093924 |
D009538 | Nicotine | Nicotine results in decreased expression of CCL2 mRNA | 22093924 |
D009538 | Nicotine | Nicotine results in decreased secretion of CCL2 protein | 22093924 |
D009538 | Nicotine | ZFP36 mutant form inhibits the reaction [Nicotine results in decreased expression of CCL2 mRNA] | 22093924 |
D009538 | Nicotine | Mecamylamine inhibits the reaction [Nicotine results in decreased expression of CCL2 mRNA] | 15135227 |
D009538 | Nicotine | Nicotine results in decreased expression of CCL2 mRNA | 15135227 |
D009538 | Nicotine | Nicotine results in decreased expression of CCL2 protein | 15976189 |
D009543 | Nifedipine | Nifedipine inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 15018304 |
C012655 | nimesulide | nimesulide results in decreased expression of CCL2 protein | 17380299 |
C012655 | nimesulide | [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CCL2 mRNA | 22561872 |
C012655 | nimesulide | nimesulide inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 20039930 |
C012655 | nimesulide | nimesulide inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 20039930 |
C007350 | nitrofen | nitrofen results in increased expression of CCL2 mRNA | 22595559 |
C007350 | nitrofen | nitrofen results in increased expression of CCL2 protein | 15110079|2259555 |
D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in decreased expression of CCL2 mRNA | 27206323 |
D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased expression of CCL2 mRNA | 10715624 |
D009585 | Nitrogen Dioxide | Nitrogen Dioxide results in increased expression of CCL2 protein | 11498801 |
D009599 | Nitroprusside | [Nitroprusside co-treated with TNF co-treated with IFNG] results in increased expression of CCL2 mRNA | 15153526 |
D015112 | 4-Nitroquinoline-1-oxide | 4-Nitroquinoline-1-oxide results in increased expression of CCL2 mRNA | 22561872 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of CCL2 mRNA | 17616710 |
C038405 | nivalenol | nivalenol results in increased expression of CCL2 mRNA | 24793808 |
C038405 | nivalenol | [deoxynivalenol co-treated with nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | [deoxynivalenol co-treated with nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | [deoxynivalenol co-treated with nivalenol] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | [nivalenol co-treated with fumonisin B1] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | [nivalenol co-treated with Zearalenone] results in increased expression of CCL2 mRNA | 23688591 |
C038405 | nivalenol | nivalenol results in increased expression of CCL2 mRNA | 23688591 |
C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL2 mRNA | 27935865 |
C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA | 27935865 |
C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of CCL2 mRNA" | 19013360 |
D015739 | Nocodazole | Nocodazole results in increased expression of CCL2 protein | 20116850 |
C017573 | nonane | nonane results in increased expression of CCL2 protein | 15451557 |
C010615 | Nonidet P-40 | Nonidet P-40 results in increased expression of CCL2 mRNA | 26552463 |
C025256 | nonylphenol | fulvestrant inhibits the reaction [nonylphenol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] | 10614622 |
C025256 | nonylphenol | nonylphenol inhibits the reaction [IL1A protein promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to CCL2 promoter]] | 10614622 |
C025256 | nonylphenol | nonylphenol inhibits the reaction [IL1A protein results in increased expression of CCL2 mRNA] | 10614622 |
C025256 | nonylphenol | nonylphenol inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein] | 10614622 |
C072936 | notoginsenoside R1 | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25472953 |
C072936 | notoginsenoside R1 | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 23170834 |
C464660 | obeticholic acid | obeticholic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 mRNA] | 27865854 |
D019787 | Linoleic Acid | Linoleic Acid results in increased expression of CCL2 protein | 16305726 |
C118580 | octylmethoxycinnamate | octylmethoxycinnamate results in decreased expression of CCL2 mRNA | 23397585 |
C437965 | olmesartan | olmesartan inhibits the reaction [Cholesterol results in increased expression of CCL2 protein] | 16148612 |
D015525 | Fatty Acids, Omega-3 | "Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL2 mRNA]" | 15681167 |
C002771 | Omite | Omite results in decreased expression of CCL2 | 21788198 |
C105488 | ONO 1301 | "ONO 1301 inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of CCL2 mRNA]" | 28887131 |
C000592118 | ONO-8430506 | ONO-8430506 results in decreased expression of CCL2 protein | 26037280 |
C016340 | o,p'-DDT | "o,p'-DDT results in decreased expression of CCL2 mRNA" | 18204070 |
D009942 | Organometallic Compounds | Organometallic Compounds results in decreased expression of CCL2 protein | 22173130 |
D010047 | Ovalbumin | MYD88 gene mutant form inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D010047 | Ovalbumin | [Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein | 26882889 |
D010047 | Ovalbumin | Ovalbumin results in increased expression of CCL2 mRNA | 12388339|1279400 |
D010047 | Ovalbumin | PH 163 inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
D010047 | Ovalbumin | Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D010047 | Ovalbumin | TLR2 gene mutant form promotes the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D010047 | Ovalbumin | TLR4 gene mutant form promotes the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D010047 | Ovalbumin | verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
D010047 | Ovalbumin | zileuton inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
D019815 | Oxalic Acid | Oxalic Acid results in increased expression of CCL2 mRNA | 24145091 |
D019815 | Oxalic Acid | resveratrol inhibits the reaction [Oxalic Acid results in increased expression of CCL2 mRNA] | 24145091 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of CCL2 mRNA | 25729387 |
C030110 | oxaliplatin | oxaliplatin results in increased expression of CCL2 mRNA | 25729387 |
D010081 | Oxazolone | Oxazolone results in decreased expression of CCL2 mRNA | 17374397 |
D010081 | Oxazolone | Oxazolone results in increased expression of CCL2 mRNA | 15585374 |
D010081 | Oxazolone | Oxazolone results in increased expression of CCL2 mRNA | 19647056 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 mRNA | 22711276 |
D010100 | Oxygen | Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22711276 |
D010100 | Oxygen | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22711276 |
D010100 | Oxygen | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 23452621 |
D010100 | Oxygen | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 23452621 |
D010100 | Oxygen | Oxygen affects the reaction [AHR protein results in decreased expression of CCL2 mRNA] | 27103661 |
D010100 | Oxygen | Oxygen deficiency inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 14652683 |
D010100 | Oxygen | Oxygen deficiency inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 14652683 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of CCL2 mRNA | 14652683 |
D010100 | Oxygen | Oxygen deficiency results in decreased secretion of CCL2 protein | 14652683 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 mRNA | 23452621 |
D010100 | Oxygen | Oxygen results in increased expression of CCL2 mRNA | 27103661 |
D010100 | Oxygen | ARNT gene mutant form inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 20412331 |
D010100 | Oxygen | CCL2 results in increased susceptibility to Oxygen deficiency | 23043544 |
D010100 | Oxygen | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Oxygen results in increased expression of CCL2 mRNA] | 25203536 |
D010100 | Oxygen | Oxygen deficiency results in decreased expression of CCL2 mRNA | 23539316 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 mRNA | 18436887|2041233 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 protein | 23043544 |
D010100 | Oxygen | Oxygen results in increased expression of CCL2 mRNA | 10781441|2253528 |
D010100 | Oxygen | Oxygen results in increased expression of CCL2 protein | 11498801 |
D010100 | Oxygen | R 59949 inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | 23043544 |
D010100 | Oxygen | Valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 18436887 |
D010100 | Oxygen | cobaltous chloride inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | 18635243|1927835 |
D010100 | Oxygen | deguelin promotes the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22745725 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein | 18803305 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 mRNA | 22745725 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CCL2 protein | 18635243|1927835 |
D010100 | Oxygen | Oxygen results in increased expression of CCL2 mRNA | 18941502 |
D010100 | Oxygen | Oxygen results in increased expression of CCL2 protein | 18941502 |
D010100 | Oxygen | phenylmethylpyrazolone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | 18803305 |
D010100 | Oxygen | Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein] | 18941502 |
D010100 | Oxygen | SDC2 protein promotes the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | 18803305 |
D010117 | Oxypurinol | Oxypurinol results in increased expression of CCL2 mRNA | 26641773 |
D010118 | Oxytetracycline | Oxytetracycline results in decreased expression of CCL2 protein | 20116850 |
D010126 | Ozone | Ozone results in increased expression of CCL2 mRNA | 27206323 |
D010126 | Ozone | [Acetaminophen co-treated with Ozone] results in increased expression of CCL2 mRNA | 20123758 |
D010126 | Ozone | CPE gene mutant form promotes the reaction [Ozone results in increased expression of CCL2 protein] | 16002559 |
D010126 | Ozone | Endotoxins promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | 12217210 |
D010126 | Ozone | [Ozone co-treated with Acetaminophen] results in increased expression of CCL2 protein | 20123758 |
D010126 | Ozone | [Ozone co-treated with NOTCH3 gene mutant form] affects the expression of CCL2 mRNA | 25658374 |
D010126 | Ozone | Ozone inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 20123758 |
D010126 | Ozone | Ozone results in increased expression of CCL2 mRNA | 12217210|1276305 |
D010126 | Ozone | Ozone results in increased expression of CCL2 protein | 11498801|1600255 |
D010126 | Ozone | pyrazolanthrone promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | 17460151 |
D010126 | Ozone | Metyrapone inhibits the reaction [Ozone results in increased expression of CCL2 mRNA] | 27037194 |
D010126 | Ozone | Metyrapone inhibits the reaction [Ozone results in increased expression of CCL2 protein] | 27037194 |
D010126 | Ozone | [Ozone co-treated with Particulate Matter] results in increased expression of CCL2 mRNA | 23805001 |
D010126 | Ozone | Ozone results in decreased expression of CCL2 mRNA | 23805001 |
D010126 | Ozone | Ozone results in increased expression of CCL2 mRNA | 16716893|2272790 |
D010126 | Ozone | Ozone results in increased expression of CCL2 protein | 27037194 |
C102487 | pachymic acid | pachymic acid analog inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
C102487 | pachymic acid | pachymic acid analog inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 28578904 |
D017239 | Paclitaxel | CCL2 results in increased susceptibility to Paclitaxel | 21187454 |
C005413 | palmatine | palmatine results in decreased expression of CCL2 protein | 20116850 |
D010168 | Palmitates | "4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline inhibits the reaction [Palmitates results in increased secretion of CCL2 protein]" | 18303122 |
D010168 | Palmitates | Acetylcysteine inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D010168 | Palmitates | BAY 11-7085 inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D010168 | Palmitates | GW 501516 inhibits the reaction [Palmitates results in increased expression of CCL2 mRNA] | 21966476 |
D010168 | Palmitates | Palmitates results in increased expression of and results in increased secretion of CCL2 protein | 18303122 |
D010168 | Palmitates | Palmitates results in increased expression of CCL2 mRNA | 21966476 |
D010168 | Palmitates | pyrazolanthrone inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D010168 | Palmitates | [Sucrose co-treated with Palmitates] results in increased expression of CCL2 mRNA | 26895660 |
D010168 | Palmitates | TNF protein promotes the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
D019308 | Palmitic Acid | Palmitic Acid results in increased expression of CCL2 mRNA | 25614714 |
D019308 | Palmitic Acid | Palmitic Acid results in increased expression of CCL2 protein | 25614714 |
D019308 | Palmitic Acid | Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25614714 |
D019308 | Palmitic Acid | Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 protein] | 25614714 |
D019308 | Palmitic Acid | AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D019308 | Palmitic Acid | Metformin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D019308 | Palmitic Acid | Palmitic Acid results in increased expression of CCL2 mRNA | 25108154 |
D019308 | Palmitic Acid | resveratrol inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D019308 | Palmitic Acid | Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
D010269 | Paraquat | Paraquat affects the expression of CCL2 mRNA | 26345256 |
D010269 | Paraquat | Paraquat results in increased expression of CCL2 mRNA | 16324872 |
D010269 | Paraquat | Ambroxol affects the reaction [Paraquat results in increased expression of CCL2 mRNA] | 21921364 |
D010269 | Paraquat | [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased secretion of CCL2 protein | 24376630 |
D010269 | Paraquat | Paraquat results in increased expression of CCL2 mRNA | 21921364 |
D010269 | Paraquat | SB 203580 inhibits the reaction [[Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased secretion of CCL2 protein] | 24376630 |
C084656 | paricalcitol | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | 20720404 |
C084656 | paricalcitol | paricalcitol results in decreased expression of CCL2 protein | 20720404 |
C084656 | paricalcitol | paricalcitol results in increased expression of CCL2 mRNA | 25037058 |
C084656 | paricalcitol | [paricalcitol co-treated with Enalapril] results in decreased expression of CCL2 protein | 17513326 |
C002669 | parthenolide | parthenolide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 22748497 |
C002669 | parthenolide | parthenolide inhibits the reaction [resveratrol results in decreased expression of CCL2 mRNA] | 22748497 |
C002669 | parthenolide | parthenolide inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
C002669 | parthenolide | parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C002669 | parthenolide | parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | 15728586 |
D052638 | Particulate Matter | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein] | 10919993 |
D052638 | Particulate Matter | Glutathione inhibits the reaction [[Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
D052638 | Particulate Matter | [Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased expression of CCL2 mRNA | 10919993 |
D052638 | Particulate Matter | [Particulate Matter analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein | 10919993 |
D052638 | Particulate Matter | Particulate Matter analog results in decreased expression of CCL2 mRNA | 10359894|1091999 |
D052638 | Particulate Matter | Particulate Matter analog results in decreased secretion of CCL2 protein | 10359894|1091999 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of CCL2 protein | 28189646 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 mRNA | 17450221|2030732 |
D052638 | Particulate Matter | Particulate Matter results in increased secretion of CCL2 protein | 17618502|2080120 |
D052638 | Particulate Matter | SB 203580 inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein] | 10919993 |
D052638 | Particulate Matter | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein]] | 10919993 |
D052638 | Particulate Matter | [Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CCL2 mRNA | 28013216 |
D052638 | Particulate Matter | CCL2 protein affects the reaction [TBX21 gene mutant form results in increased susceptibility to Particulate Matter] | 24499286 |
D052638 | Particulate Matter | CCL2 protein affects the reaction [[TBX21 gene mutant form results in increased susceptibility to Particulate Matter] which results in increased expression of MUC5AC mRNA] | 24499286 |
D052638 | Particulate Matter | MYD88 gene mutant form inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein] | 23896513 |
D052638 | Particulate Matter | OVAL protein promotes the reaction [Particulate Matter results in increased expression of CCL2 protein] | 23896513 |
D052638 | Particulate Matter | "Particulate Matter analog promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12832678 |
D052638 | Particulate Matter | "Particulate Matter analog promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 23896513 |
D052638 | Particulate Matter | Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17076685 |
D052638 | Particulate Matter | Particulate Matter inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17076685 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of CCL2 mRNA | 25144474 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 mRNA | 21708214|2363800 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 protein | 12684091|1762018 |
D052638 | Particulate Matter | Particulate Matter results in increased secretion of CCL2 protein | 23896513|2396274 |
D052638 | Particulate Matter | [Polycyclic Aromatic Hydrocarbons co-treated with Particulate Matter] results in increased expression of CCL2 protein | 19654922 |
D052638 | Particulate Matter | [TBX21 gene mutant form results in increased susceptibility to Particulate Matter] which results in increased expression of CCL2 protein | 24499286 |
D052638 | Particulate Matter | TLR4 gene mutant form inhibits the reaction [Particulate Matter results in increased secretion of CCL2 protein] | 23896513 |
D052638 | Particulate Matter | Glucose promotes the reaction [Particulate Matter results in increased expression of CCL2 mRNA] | 19505525 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 mRNA | 19505525 |
D052638 | Particulate Matter | [Ozone co-treated with Particulate Matter] results in increased expression of CCL2 mRNA | 23805001 |
D052638 | Particulate Matter | Particulate Matter affects the expression of CCL2 mRNA | 26618301 |
D052638 | Particulate Matter | Particulate Matter results in decreased expression of CCL2 mRNA | 23805001 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 mRNA | 15866772|2380500 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CCL2 protein | 27539004 |
C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CCL2 mRNA" | 25510870 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with 2,4,5,2',5'-pentachlorobiphenyl] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]" | 26141388 |
C073402 | PD 123319 | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299 |
C509204 | PD168393 | PD168393 results in increased expression of and results in increased secretion of CCL2 protein | 21967610 |
C509204 | PD168393 | PD168393 results in increased expression of CCL2 mRNA | 21967610 |
C509204 | PD168393 | polydatin inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
C509204 | PD168393 | Quercetin inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
C509204 | PD168393 | resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
C509204 | PD168393 | PD168393 promotes the reaction [TGFA protein results in increased expression of CCL2 mRNA] | 21967610 |
D000068437 | Pemetrexed | [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of CCL2 mRNA | 22975265 |
D010400 | Penicillin G | [Penicillin G co-treated with Erythromycin] results in increased expression of CCL2 mRNA | 27503388 |
D010400 | Penicillin G | Penicillin G results in increased expression of CCL2 mRNA | 27503388 |
C046012 | pentanal | pentanal results in increased expression of CCL2 mRNA | 26079696 |
D010431 | Pentoxifylline | Pentoxifylline results in decreased secretion of CCL2 protein | 18617301 |
D010431 | Pentoxifylline | Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 19921414 |
D010431 | Pentoxifylline | Pentoxifylline results in decreased expression of CCL2 mRNA | 14993492 |
D010457 | Peptidoglycan | Peptidoglycan results in increased secretion of CCL2 protein | 15593098 |
C023036 | perfluorooctanoic acid | "Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of CCL2 mRNA]" | 23626681 |
C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of CCL2 mRNA | 23626681 |
D020913 | Perindopril | Perindopril results in decreased expression of CCL2 protein | 19840533 |
D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | 17191021 |
D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] | 17191021 |
C554945 | PF 956980 | PF 956980 inhibits the reaction [OSM protein results in increased expression of CCL2 mRNA] | 23968543 |
D015232 | Dinoprostone | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16784723 |
D015232 | Dinoprostone | Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
D015232 | Dinoprostone | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16784723 |
D015232 | Dinoprostone | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
D015232 | Dinoprostone | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]] | 21913898 |
D015232 | Dinoprostone | Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D015232 | Dinoprostone | Dinoprostone promotes the reaction [roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
D015232 | Dinoprostone | Dinoprostone results in decreased expression of CCL2 mRNA | 16303787 |
D015232 | Dinoprostone | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein]] | 25432964 |
C104857 | PH 163 | PH 163 inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 23724058 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20423518 |
D010634 | Phenobarbital | Phenobarbital affects the expression of CCL2 protein | 25051504 |
D019800 | Phenol | Phenol results in increased expression of CCL2 mRNA | 21907259 |
D010656 | Phenylephrine | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | 15721863 |
D010656 | Phenylephrine | parthenolide inhibits the reaction [Phenylephrine results in increased expression of CCL2 mRNA] | 15728586 |
D010656 | Phenylephrine | Phenylephrine results in increased expression of CCL2 mRNA | 15728586 |
D010656 | Phenylephrine | Phenylephrine results in increased expression of CCL2 protein | 15721863 |
C005435 | phenylmethylpyrazolone | "phenylmethylpyrazolone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 12954792 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased secretion of CCL2 protein] | 18803305 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CCL2 protein] | 18803305 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of CCL2 mRNA | 15948865 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of CCL2 protein | 19381132 |
D010672 | Phenytoin | Phenytoin results in increased expression of CCL2 protein | 14578793 |
D010693 | Phloretin | Phloretin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D010713 | Phosphatidylcholines | Phosphatidylcholines results in increased expression of CCL2 mRNA | 23911798 |
D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL3 mRNA] | 11937571 |
D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL4 mRNA] | 11937571 |
D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CCL5 mRNA] | 11937571 |
D010743 | Phospholipids | CCL2 protein promotes the reaction [Phospholipids results in increased expression of CXCL2 mRNA] | 11937571 |
D010743 | Phospholipids | CCL2 protein results in increased susceptibility to Phospholipids | 11937571 |
D010743 | Phospholipids | Phospholipids results in increased expression of CCL2 mRNA | 11937571 |
C043103 | phthalic anhydride | phthalic anhydride results in increased expression of CCL2 protein | 20219652 |
D048789 | Phytoestrogens | Phytoestrogens results in decreased expression of CCL2 protein | 24388399 |
C030614 | picolinic acid | picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 17665966 |
D010862 | Pilocarpine | Pilocarpine results in decreased expression of CCL2 protein | 19490431 |
D010862 | Pilocarpine | Pilocarpine results in increased expression of CCL2 mRNA | 15193289|1949043 |
D010862 | Pilocarpine | Pilocarpine results in increased expression of CCL2 mRNA | 17971868 |
D010862 | Pilocarpine | Pilocarpine results in increased expression of CCL2 protein | 20034406 |
C060836 | pioglitazone | [pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
C060836 | pioglitazone | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CCL2 mRNA | 27935865 |
D010880 | Piperidines | Piperidines analog inhibits the reaction [CCL2 protein binds to CCR2 protein] | 10770925 |
D010880 | Piperidines | Piperidines analog inhibits the reaction [CCL2 protein results in increased uptake of Calcium] | 10843593 |
C006253 | pirinixic acid | pirinixic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 19693652 |
C006253 | pirinixic acid | pirinixic acid affects the expression of CCL2 mRNA | 16306350 |
C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL2 mRNA] | 15814532 |
C006253 | pirinixic acid | pirinixic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 16306350 |
C006253 | pirinixic acid | pirinixic acid inhibits the reaction [PNPLA2 gene mutant form results in increased expression of CCL2 mRNA] | 25285770 |
C006253 | pirinixic acid | pirinixic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16306350 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of CCL2 mRNA | 17888025|1835682 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of CCL2 protein | 17888025|1835682 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of CCL2 mRNA | 23811191|8764118 |
C108475 | pitavastatin | pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA] | 18323514 |
C108475 | pitavastatin | pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18323514 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL2 mRNA] | 23133493 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA] | 26332274 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CCL2 mRNA | 19627010 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CCL2 protein | 15976189 |
D010972 | Platelet Activating Factor | Foropafant inhibits the reaction [Platelet Activating Factor results in increased secretion of CCL2 protein] | 15149885 |
D010972 | Platelet Activating Factor | Platelet Activating Factor results in increased secretion of CCL2 protein | 15149885 |
D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls results in increased expression of CCL2 mRNA | 23397585 |
D011084 | Polycyclic Aromatic Hydrocarbons | [Polycyclic Aromatic Hydrocarbons co-treated with Particulate Matter] results in increased expression of CCL2 protein | 19654922 |
C058229 | polydatin | polydatin inhibits the reaction [leptomycin B results in increased secretion of CCL2 protein] | 21967610 |
C058229 | polydatin | "polydatin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C058229 | polydatin | polydatin inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
C058229 | polydatin | polydatin results in decreased expression of CCL2 mRNA | 21756928|2196761 |
C058229 | polydatin | polydatin results in decreased secretion of CCL2 protein | 21967610 |
C058229 | polydatin | polydatin inhibits the reaction [EGFR protein affects the expression of CCL2 mRNA] | 21967610 |
C058229 | polydatin | polydatin inhibits the reaction [EGFR protein affects the expression of CCL2 protein] | 21967610 |
D011092 | Polyethylene Glycols | [Silver analog co-treated with Polyethylene Glycols] results in increased secretion of CCL2 protein | 27021274 |
C060540 | polyhexamethyleneguanidine | polyhexamethyleneguanidine results in increased expression of CCL2 mRNA | 27989595 |
D011070 | Poly I-C | methyldithiocarbamate inhibits the reaction [Poly I-C results in increased secretion of CCL2 protein] | 24056979 |
D011070 | Poly I-C | Poly I-C results in increased secretion of CCL2 protein | 24056979 |
D011070 | Poly I-C | Poly I-C results in increased expression of CCL2 mRNA | 23939143 |
C043435 | polylactic acid-polyglycolic acid copolymer | polylactic acid-polyglycolic acid copolymer analog results in increased expression of CCL2 protein | 20851137 |
C008971 | polymarcine | polymarcine results in decreased expression of CCL2 | 21788198 |
D011112 | Polymyxin B | Polymyxin B inhibits the reaction [[Ovalbumin co-treated with Dust] results in increased expression of CCL2 protein] | 26882889 |
D011137 | Polystyrenes | Polystyrenes results in increased expression of CCL2 protein | 20851137 |
C467566 | pomalidomide | pomalidomide results in increased secretion of CCL2 protein | 15292067 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCL2 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CCL2 mRNA | 22079256|2271453 |
D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of CCL2 mRNA | 23608068 |
D017035 | Pravastatin | Pravastatin inhibits the reaction [lopinavir-ritonavir drug combination results in increased secretion of CCL2 protein] | 20884875 |
D017035 | Pravastatin | Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein] | 20884875 |
D017035 | Pravastatin | Pravastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA] | 18323514 |
D017035 | Pravastatin | Pravastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 18323514 |
D011239 | Prednisolone | Prednisolone results in decreased expression of CCL2 protein | 20116850 |
D011239 | Prednisolone | Prednisolone inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL2 mRNA] | 23133493 |
D011285 | Pregnenolone Carbonitrile | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in decreased expression of CCL2 mRNA] | 22698814 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of CCL2 mRNA | 22698814 |
D011339 | Probenecid | Probenecid analog results in increased expression of CCL2 mRNA | 24104198 |
D011339 | Probenecid | "1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CCL2 mRNA]" | 25406165 |
D011339 | Probenecid | "[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CCL2 mRNA" | 25406165 |
D011339 | Probenecid | Probenecid inhibits the reaction [Uric Acid results in increased expression of CCL2 protein] | 16113518 |
D011341 | Probucol | cilostazol promotes the reaction [Probucol inhibits the reaction [TNF protein results in increased expression of CCL2]] | 19967051 |
D011341 | Probucol | Probucol inhibits the reaction [TNF protein results in increased expression of CCL2] | 19967051 |
D011341 | Probucol | Probucol promotes the reaction [cilostazol inhibits the reaction [TNF protein results in increased expression of CCL2]] | 19967051 |
C045362 | prochloraz | prochloraz results in decreased expression of CCL2 | 21788198 |
C479580 | procyanidin B2 | procyanidin B2 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 25199697 |
C479581 | procyanidin B3 | [procyanidin B3 co-treated with Eicosapentaenoic Acid] inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22169119 |
C479581 | procyanidin B3 | procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22169119 |
D011374 | Progesterone | Progesterone inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein] | 22014880 |
D011374 | Progesterone | Progesterone affects the expression of CCL2 mRNA | 17251523 |
D011374 | Progesterone | Progesterone results in decreased expression of CCL2 mRNA | 21549006 |
D011374 | Progesterone | Progesterone results in decreased expression of CCL2 protein | 21549006 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of CCL2 mRNA | 21277368 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of CCL2 protein | 21277368 |
D011374 | Progesterone | Progesterone results in decreased expression of CCL2 mRNA | 20726854 |
C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | 16705055 |
C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299 |
C066229 | prolinedithiocarbamate | prolinedithiocarbamate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
D019840 | 2-Propanol | "2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL2 protein]" | 22020770 |
D019840 | 2-Propanol | "2-Propanol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]" | 22020770 |
D011419 | Propidium | Propidium results in decreased expression of CCL2 protein | 20116850 |
C005556 | propionaldehyde | propionaldehyde results in increased expression of CCL2 mRNA | 26079696 |
D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of CCL2 mRNA | 23397585 |
D011441 | Propylthiouracil | Propylthiouracil results in increased expression of CCL2 mRNA | 24780913 |
D011442 | Proscillaridin | Proscillaridin results in decreased expression of CCL2 protein | 20116850 |
D015237 | Dinoprost | [Dinoprost co-treated with epostane] results in increased expression of CCL2 mRNA | 21505051 |
D015237 | Dinoprost | Dinoprost results in increased expression of CCL2 mRNA | 21505051 |
D011464 | Epoprostenol | Epoprostenol results in increased expression of CCL2 protein | 15302794 |
C010313 | pseudocumene | pseudocumene results in increased expression of CCL2 protein | 17337753 |
C003243 | psicose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 17655880 |
C003243 | psicose | psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 17655880 |
D011691 | Puromycin | Puromycin results in decreased expression of CCL2 protein | 20116850 |
D011692 | Puromycin Aminonucleoside | fluvastatin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 mRNA] | 16452496 |
D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside affects the expression of CCL2 mRNA | 10867541 |
D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased expression of CCL2 mRNA | 16452496 |
D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased expression of CCL2 protein | 12813006 |
D011692 | Puromycin Aminonucleoside | Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 protein] | 12813006 |
C513428 | pyrachlostrobin | pyrachlostrobin results in decreased expression of CCL2 | 21788198 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Cyclosporine results in increased expression of CCL2 protein] | 23958496 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [NR1H4 gene mutant form promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA]] | 28505368 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Palmitates results in increased secretion of CCL2 protein] | 18303122 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein] | 23958496 |
C432165 | pyrazolanthrone | pyrazolanthrone promotes the reaction [Ozone results in increased expression of CCL2 mRNA] | 17460151 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C432165 | pyrazolanthrone | pyrazolanthrone results in decreased expression of CCL2 mRNA | 21176401|2338024 |
C428725 | pyridaben | pyridaben results in decreased expression of CCL2 | 21788198 |
C020972 | pyrrolidine dithiocarbamic acid | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 11006087 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [ALB protein results in increased expression of CCL2 mRNA] | 11961005 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IL17A protein results in increased expression of CCL2 mRNA] | 12016129 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 11006087 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18500357 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 mRNA] | 16129981 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrochloric Acid results in increased expression of CCL2 protein] | 16129981 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 12472797 |
D011765 | Pyruvaldehyde | epigallocatechin gallate inhibits the reaction [Pyruvaldehyde results in increased expression of CCL2 protein] | 22101032 |
D011765 | Pyruvaldehyde | Pyruvaldehyde results in increased expression of CCL2 protein | 22101032 |
C024631 | pyrvinium | pyrvinium results in decreased expression of CCL2 protein | 20116850 |
D011791 | Quartz | Quartz results in increased expression of CCL2 mRNA | 27381660 |
D011791 | Quartz | Quartz results in increased expression of CCL2 mRNA | 19836432 |
D011794 | Quercetin | "Quercetin analog inhibits the reaction [[24-hydroxycholesterol co-treated with 27-hydroxycholesterol co-treated with cholest-5-en-3 beta,7 alpha-diol] results in increased expression of CCL2 mRNA]" | 24802026 |
D011794 | Quercetin | Quercetin analog inhibits the reaction [24-hydroxycholesterol results in increased expression of CCL2 mRNA] | 24802026 |
D011794 | Quercetin | Quercetin analog inhibits the reaction [27-hydroxycholesterol results in increased expression of CCL2 mRNA] | 24802026 |
D011794 | Quercetin | "Quercetin analog inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased expression of CCL2 mRNA]" | 24802026 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 9292787 |
D011794 | Quercetin | "Quercetin inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with TNF protein] results in increased expression of CCL2 mRNA]" | 17880982 |
D011794 | Quercetin | "Quercetin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21371465 |
D011794 | Quercetin | Quercetin inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
D011794 | Quercetin | Quercetin inhibits the reaction [S100B protein results in increased expression of CCL2 mRNA] | 17103373 |
D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 18489909|9292787 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16794257|1848990 |
D011794 | Quercetin | Quercetin results in decreased expression of CCL2 mRNA | 21756928|2196761 |
D011794 | Quercetin | Quercetin results in decreased secretion of CCL2 protein | 17191019|2081677 |
D011794 | Quercetin | Quercetin results in increased expression of CCL2 mRNA | 21371465 |
D011794 | Quercetin | Quercetin results in increased secretion of CCL2 protein | 21371465 |
D011794 | Quercetin | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Quercetin results in decreased expression of CCL2 mRNA]" | 24465016 |
D011794 | Quercetin | Quercetin affects the reaction [CCL2 protein affects the activity of PTGS2 protein] | 20361964 |
D011794 | Quercetin | Quercetin inhibits the reaction [Calcium Chloride results in increased expression of CCL2 protein] | 22728078 |
D011794 | Quercetin | Quercetin inhibits the reaction [CCL2 protein affects the abundance of A2-E (N-retinylidene-N-retinylethanolamine)] | 20361964 |
D011794 | Quercetin | Quercetin inhibits the reaction [CCL2 protein affects the expression of BAX mRNA] | 20361964 |
D011794 | Quercetin | Quercetin inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 24465016|2561471 |
D011794 | Quercetin | Quercetin inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 24465016|2561471 |
D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22210036 |
D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22869926 |
D011794 | Quercetin | Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25614714 |
D011794 | Quercetin | Quercetin inhibits the reaction [Palmitic Acid results in increased expression of CCL2 protein] | 25614714 |
D011794 | Quercetin | Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | 19735175 |
D011794 | Quercetin | Quercetin results in decreased expression of CCL2 mRNA | 24465016 |
D011794 | Quercetin | Quercetin results in decreased expression of CCL2 protein | 16794257 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased secretion of CCL2 protein] | 26766292 |
D011794 | Quercetin | Quercetin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 10541287 |
D011794 | Quercetin | Quercetin results in decreased expression of CCL2 mRNA | 10925121 |
D011794 | Quercetin | Quercetin results in decreased expression of CCL2 protein | 11053056 |
D011794 | Quercetin | Quercetin inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 20943792 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 20943792 |
C004532 | quinone | quinone results in increased expression of CCL2 protein | 17572062 |
C470613 | quinoxyfen | quinoxyfen results in decreased expression of CCL2 | 21788198 |
C058544 | R 59949 | R 59949 inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 protein] | 23043544 |
D020849 | Raloxifene Hydrochloride | fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in decreased activity of CCL2 protein] | 17006379 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of CCL2 mRNA | 14699072 |
D020849 | Raloxifene Hydrochloride | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | 19059307 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in decreased activity of CCL2 protein | 17006379 |
D017257 | Ramipril | [Simvastatin co-treated with Ramipril] results in decreased expression of CCL2 protein | 15184351 |
D011929 | Razoxane | Razoxane inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA] | 19915844 |
D017382 | Reactive Oxygen Species | RAC1 protein promotes the reaction [Reactive Oxygen Species promotes the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 14576080 |
D017382 | Reactive Oxygen Species | Reactive Oxygen Species promotes the reaction [TNF protein results in increased expression of CCL2 mRNA] | 14576080 |
D017382 | Reactive Oxygen Species | [Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased secretion of CCL2 protein | 24376630 |
D017382 | Reactive Oxygen Species | SB 203580 inhibits the reaction [[Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased secretion of CCL2 protein] | 24376630 |
C100036 | resmethrin | resmethrin results in decreased expression of CCL2 | 21788198 |
C518399 | resolvin D1 | resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21724996 |
C518399 | resolvin D1 | t-butyloxycarbonyl-methionyl-leucyl-phenylalanine inhibits the reaction [resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21724996 |
C545423 | resolvin D2 | resolvin D2 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21724996 |
C059514 | resveratrol | garcinol promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 22748497 |
C059514 | resveratrol | garcinol promotes the reaction [resveratrol results in decreased expression of CCL2 mRNA] | 22748497 |
C059514 | resveratrol | parthenolide inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 22748497 |
C059514 | resveratrol | parthenolide inhibits the reaction [resveratrol results in decreased expression of CCL2 mRNA] | 22748497 |
C059514 | resveratrol | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | 17191021 |
C059514 | resveratrol | Pertussis Toxin inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]] | 17191021 |
C059514 | resveratrol | [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 24436987|2451350 |
C059514 | resveratrol | [resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 24436987|2451350 |
C059514 | resveratrol | resveratrol inhibits the reaction [7-ketocholesterol results in increased expression of CCL2 protein] | 24895526 |
C059514 | resveratrol | resveratrol inhibits the reaction [CCL2 protein affects the localization of Calcium] | 16212921 |
C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 24436987 |
C059514 | resveratrol | resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 24436987 |
C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 17191021|2053135 |
C059514 | resveratrol | resveratrol inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] | 17191021|2053135 |
C059514 | resveratrol | "resveratrol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 21371465|2458490 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24584901|2470711 |
C059514 | resveratrol | resveratrol inhibits the reaction [lipoteichoic acid results in increased secretion of CCL2 protein] | 23981542 |
C059514 | resveratrol | resveratrol inhibits the reaction [Oxalic Acid results in increased expression of CCL2 mRNA] | 24145091 |
C059514 | resveratrol | resveratrol inhibits the reaction [PD168393 results in increased expression of CCL2 mRNA] | 21967610 |
C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 22748497 |
C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22414048 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 mRNA | 21371465|2175692 |
C059514 | resveratrol | resveratrol results in decreased secretion of CCL2 protein | 21967610|2366123 |
C059514 | resveratrol | sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | 20531350 |
C059514 | resveratrol | resveratrol analog results in decreased expression of CCL2 mRNA | 15652768 |
C059514 | resveratrol | [resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CCL2 mRNA | 16806235 |
C059514 | resveratrol | resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CCL2 mRNA] | 21530968 |
C059514 | resveratrol | resveratrol inhibits the reaction [Calcium Chloride results in increased phosphorylation of CCL2 protein] | 21530968 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19293636|2071290 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19279313|1929363 |
C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 22118570 |
C059514 | resveratrol | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | 17374693 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 protein | 17872969 |
C059514 | resveratrol | resveratrol results in decreased secretion of CCL2 protein | 23514766 |
C059514 | resveratrol | resveratrol inhibits the reaction [Hydrogen Peroxide results in increased secretion of CCL2 protein] | 26766292 |
C059514 | resveratrol | "resveratrol affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]" | 15734790 |
C059514 | resveratrol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 mRNA] | 25833014 |
C059514 | resveratrol | resveratrol inhibits the reaction [[Cholesterol co-treated with Ergosterol] results in increased expression of CCL2 protein] | 25833014 |
C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 protein] | 25025298 |
C059514 | resveratrol | resveratrol inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 24513509 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 mRNA | 20050970|2342859 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 protein | 20709957|2401239 |
C059514 | resveratrol | resveratrol results in decreased secretion of CCL2 protein | 20050970 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 mRNA | 23419489 |
C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 21852083 |
C059514 | resveratrol | resveratrol inhibits the reaction [AGT protein modified form results in increased secretion of CCL2 protein] | 20709957 |
C059514 | resveratrol | resveratrol inhibits the reaction [CXCL8 protein results in increased secretion of CCL2 protein] | 23661232 |
C059514 | resveratrol | resveratrol inhibits the reaction [EGFR protein affects the expression of CCL2 mRNA] | 21967610 |
C059514 | resveratrol | resveratrol inhibits the reaction [EGFR protein affects the expression of CCL2 protein] | 21967610 |
C059514 | resveratrol | resveratrol inhibits the reaction [IFNG protein results in increased secretion of CCL2 protein] | 23661232 |
C059514 | resveratrol | resveratrol inhibits the reaction [IL6 protein results in increased secretion of CCL2 protein] | 23661232 |
C059514 | resveratrol | resveratrol inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 10910059|1829109 |
C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 18291098|2094379 |
C059514 | resveratrol | resveratrol results in decreased expression of CCL2 | 22857612 |
D015474 | Isotretinoin | Isotretinoin results in decreased expression of CCL2 mRNA | 15972972 |
D012293 | Rifampin | Rifampin results in decreased expression of CCL2 mRNA | 25051504 |
D019438 | Ritonavir | diphenyleneiodonium inhibits the reaction [Ritonavir results in increased expression of CCL2 protein] | 17668557 |
D019438 | Ritonavir | Pravastatin inhibits the reaction [Ritonavir results in increased secretion of CCL2 protein] | 20884875 |
D019438 | Ritonavir | Ritonavir results in decreased expression of CCL2 | 26626330 |
D019438 | Ritonavir | Ritonavir results in increased expression of CCL2 protein | 17668557 |
D019438 | Ritonavir | Ritonavir results in increased secretion of CCL2 protein | 20884875 |
C116926 | rofecoxib | rofecoxib results in increased expression of CCL2 mRNA | 17070997 |
C424423 | Roflumilast | Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]] | 21913898 |
C424423 | Roflumilast | Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
C424423 | Roflumilast | Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
C424423 | Roflumilast | Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21913898 |
C517734 | roflumilast N-oxide | Dinoprostone promotes the reaction [roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21913898 |
C517734 | roflumilast N-oxide | roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] | 21913898 |
D020889 | Rolipram | Rolipram inhibits the reaction [Oxygen results in increased expression of CCL2 protein] | 18941502 |
C089730 | rosiglitazone | [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | 21268089 |
C089730 | rosiglitazone | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 16054899 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 19147827 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Ceruletide results in increased expression of CCL2 mRNA] | 17463185 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 mRNA] | 28611668 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of CCL2 protein] | 28611668 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Ethanol results in increased expression of CCL2 mRNA] | 22173916 |
C089730 | rosiglitazone | rosiglitazone results in decreased expression of CCL2 mRNA | 16306350|1739446 |
C089730 | rosiglitazone | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
C089730 | rosiglitazone | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 18413206 |
C089730 | rosiglitazone | rosiglitazone results in decreased expression of CCL2 mRNA | 17394460|2151530 |
C089730 | rosiglitazone | rosiglitazone results in increased expression of CCL2 mRNA | 20623750 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [IFNG protein results in increased expression of CCL2 mRNA] | 12584205 |
D000068718 | Rosuvastatin Calcium | Rosuvastatin Calcium results in decreased expression of CCL2 mRNA | 15681303 |
D012402 | Rotenone | Rotenone results in decreased expression of CCL2 | 21788198 |
D012431 | Rutin | "Rutin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21756928 |
D012431 | Rutin | Rutin results in decreased expression of CCL2 mRNA | 21756928|2196761 |
D012431 | Rutin | Rutin results in decreased secretion of CCL2 protein | 21967610 |
D012431 | Rutin | Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 25478064 |
D012431 | Rutin | Rutin inhibits the reaction [leptomycin B inhibits the reaction [TGFA protein results in decreased secretion of CCL2 protein]] | 21967610 |
C025759 | saikosaponin | saikosaponin inhibits the reaction [Acetaminophen results in increased expression of CCL2 mRNA] | 25265579 |
D020156 | Salicylic Acid | Salicylic Acid inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] | 25108154 |
C010327 | salinomycin | salinomycin results in decreased expression of CCL2 mRNA | 19682730 |
D000068299 | Salmeterol Xinafoate | Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 15531761 |
C496827 | salubrinal | salubrinal inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
C496827 | salubrinal | salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C064294 | sarpogrelate | sarpogrelate results in decreased expression of CCL2 protein | 18235151 |
C064294 | sarpogrelate | sarpogrelate inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CCL2 protein] | 26824242 |
C064294 | sarpogrelate | sarpogrelate inhibits the reaction [CCL2 protein results in increased activity of Serotonin] | 11455205 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [chlorobenzene results in increased expression of CCL2 protein] | 18645721 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA] | 24104198 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Folic Acid deficiency results in increased expression of and results in increased secretion of CCL2 protein] | 19152916 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Folic Acid deficiency results in increased expression of CCL2 mRNA] | 19152916 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16143069|1765588 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein] | 19132243 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 16143069 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | 12016129 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein] | 10919993 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [TNF results in increased expression of CCL2 protein] | 19020780 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein] | 10919993 |
C093642 | SB 203580 | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dermatophagoides pteronyssinus antigen p 1 results in increased secretion of CCL2 protein]] | 10919993 |
C093642 | SB 203580 | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Particulate Matter analog results in decreased secretion of CCL2 protein]] | 10919993 |
C093642 | SB 203580 | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein]] | 10919993 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of CCL2 mRNA] | 28329830 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20712904 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [[Paraquat results in increased abundance of Reactive Oxygen Species] which results in increased secretion of CCL2 protein] | 24376630 |
C093642 | SB 203580 | "SB 203580 inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 19265715 |
C093642 | SB 203580 | SB 203580 inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C477523 | SC 514 | SC 514 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
C115461 | SC 560 | SC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of CCL2 protein] | 25432964 |
C587178 | SCH772984 | SCH772984 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C018145 | scoparone | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 16376386 |
C018145 | scoparone | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein] | 16376386 |
D064586 | Selenic Acid | Selenic Acid promotes the reaction [LIF protein results in increased expression of CCL2] | 22366233 |
D012643 | Selenium | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | 21481475 |
D012643 | Selenium | Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16143069 |
D012643 | Selenium | Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] | 16143069 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CCL2 mRNA" | 24160326 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CCL2 mRNA" | 23917077 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CCL2 protein" | 17200189|2151441 |
D017632 | Asbestos, Serpentine | "PRKDC affects the reaction [Asbestos, Serpentine results in increased expression of CCL2 protein]" | 17200189 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CCL2 mRNA" | 10923243 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased expression of CCL2 protein" | 10923243 |
D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in increased secretion of CCL2 protein" | 10923243 |
D017632 | Asbestos, Serpentine | "IL1B protein promotes the reaction [Asbestos, Serpentine results in increased expression of CCL2 mRNA]" | 10923243 |
D017632 | Asbestos, Serpentine | "IL1B protein promotes the reaction [Asbestos, Serpentine results in increased secretion of CCL2 protein]" | 10923243 |
D017632 | Asbestos, Serpentine | "TNF protein promotes the reaction [Asbestos, Serpentine results in increased expression of CCL2 mRNA]" | 10923243 |
D017632 | Asbestos, Serpentine | "TNF protein promotes the reaction [Asbestos, Serpentine results in increased secretion of CCL2 protein]" | 10923243 |
C009250 | sevoflurane | sevoflurane results in decreased expression of CCL2 mRNA | 15564938 |
D022641 | Shiga Toxin 2 | CAP18 lipopolysaccharide-binding protein inhibits the reaction [[Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21731756 |
D022641 | Shiga Toxin 2 | [Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA | 21731756 |
D012822 | Silicon Dioxide | CCR2 promotes the reaction [Silicon Dioxide results in increased secretion of CCL2 protein] | 26163174 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CCL2 mRNA | 23806026|2589566 |
D012822 | Silicon Dioxide | Silicon Dioxide results in decreased secretion of CCL2 protein | 22300531 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 mRNA | 26163174 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 protein | 26163174 |
D012822 | Silicon Dioxide | AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 22273745 |
D012822 | Silicon Dioxide | AHR protein affects the reaction [Silicon Dioxide results in increased secretion of CCL2 protein] | 22273745 |
D012822 | Silicon Dioxide | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein | 22155353 |
D012822 | Silicon Dioxide | IL10 protein inhibits the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein]] | 22273745 |
D012822 | Silicon Dioxide | IL10 protein inhibits the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 22273745 |
D012822 | Silicon Dioxide | IL1B protein affects the reaction [Silicon Dioxide analog results in increased expression of CCL2 mRNA] | 25388157 |
D012822 | Silicon Dioxide | IL1B protein affects the reaction [Silicon Dioxide results in increased secretion of CCL2 protein] | 23640035 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of CCL2 mRNA | 25388157 |
D012822 | Silicon Dioxide | [Silicon Dioxide co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein | 22273745 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 mRNA | 19073995|2322117 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 protein | 27428020 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased secretion of CCL2 protein | 22273745|2364003 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 mRNA | 22431001 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CCL2 protein | 21602193|2286100 |
D012834 | Silver | [Silver analog co-treated with Citric Acid] results in increased secretion of CCL2 protein | 27021274 |
D012834 | Silver | [Silver analog co-treated with Polyethylene Glycols] results in increased secretion of CCL2 protein | 27021274 |
D012838 | Silymarin | Silymarin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 24707119 |
D019821 | Simvastatin | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA]] | 16321392 |
D019821 | Simvastatin | Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA]] | 12117737|1632139 |
D019821 | Simvastatin | Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CCL2 mRNA] | 12117737 |
D019821 | Simvastatin | [Simvastatin co-treated with Ramipril] results in decreased expression of CCL2 protein | 15184351 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | 19225232 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | 16321392|2126808 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [IFNG results in increased secretion of CCL2 protein] | 16321392 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 15824212|1644322 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [TNF results in increased expression of CCL2 mRNA] | 12117737|1632139 |
D019821 | Simvastatin | Simvastatin inhibits the reaction [TNF results in increased secretion of CCL2 protein] | 16321392 |
D019821 | Simvastatin | Simvastatin results in decreased expression of and results in decreased secretion of CCL2 protein | 12117737 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 mRNA | 12117737|1678169 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 protein | 12117737|1518435 |
D019821 | Simvastatin | Simvastatin results in decreased susceptibility to CCL2 protein | 15781755 |
D019821 | Simvastatin | [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | 19225232 |
D019821 | Simvastatin | Simvastatin affects the expression of CCL2 mRNA | 12818400 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 mRNA | 19262002 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 mRNA | 15855201|1641439 |
D019821 | Simvastatin | Simvastatin results in decreased expression of CCL2 protein | 17449418|1830914 |
C439060 | sirtinol | sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] | 20531350 |
D012855 | Sitosterols | Sitosterols results in decreased expression of CCL2 mRNA | 25614126 |
C424127 | SL 327 | SL 327 results in decreased expression of CCL2 mRNA | 20050970 |
C424127 | SL 327 | SL 327 results in decreased secretion of CCL2 protein | 20050970 |
D012906 | Smoke | Smoke results in increased expression of CCL2 mRNA | 21235221 |
D012906 | Smoke | Smoke results in increased expression of CCL2 mRNA | 23306164 |
D012906 | Smoke | Smoke results in increased expression of CCL2 protein | 23306164 |
D012906 | Smoke | Smoke results in decreased expression of CCL2 protein | 15976189 |
D012906 | Smoke | Smoke results in increased expression of CCL2 mRNA | 20864625 |
D012906 | Smoke | Smoke results in increased secretion of CCL2 protein | 17041012 |
C118258 | SN50 peptide | SN50 peptide inhibits the reaction [melamine results in increased expression of CCL2 mRNA] | 22915474 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [ALB protein results in increased expression of CCL2 protein] | 11340305 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 mRNA] | 11340305 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Amiloride results in decreased expression of CCL2 protein] | 11340305 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 11340305 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | 11340305 |
D012964 | Sodium | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | 11340305 |
C017947 | sodium arsenite | Enalapril inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
C017947 | sodium arsenite | ERN1 affects the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
C017947 | sodium arsenite | HIF1A affects the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CCL2 mRNA | 12016162|1276083 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CCL2 mRNA | 15689417|2271453 |
C017947 | sodium arsenite | sodium arsenite results in increased secretion of CCL2 protein | 15689417|2897348 |
C017947 | sodium arsenite | Valsartan inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
C017947 | sodium arsenite | XBP1 affects the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
C017947 | sodium arsenite | [APOE gene mutant form affects the susceptibility to sodium arsenite] which results in increased expression of CCL2 protein | 19682479 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CCL2 mRNA | 21911445|2884399 |
C017947 | sodium arsenite | Allopurinol inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
C017947 | sodium arsenite | Atorvastatin Calcium inhibits the reaction [sodium arsenite results in increased expression of CCL2 protein] | 25058445 |
C017947 | sodium arsenite | CAT protein inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
C017947 | sodium arsenite | Dimethyl Sulfoxide inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
C017947 | sodium arsenite | N(G)-nitroarginine-4-nitroanilide analog inhibits the reaction [sodium arsenite results in increased expression of CCL2 mRNA] | 15689417 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CCL2 mRNA | 15689417 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CCL2 protein | 25058445 |
C016104 | sodium bichromate | sodium bichromate affects the secretion of CCL2 protein | 17685462 |
C016104 | sodium bichromate | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein] | 17685462 |
C016104 | sodium bichromate | sodium bichromate results in decreased expression of CCL2 mRNA | 12760830|1768546 |
C025364 | sodium borohydride | "sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]]" | 21130106 |
C032706 | sodium chlorate | sodium chlorate inhibits the reaction [CCL2 protein results in increased activity of CCR2 protein] | 23408426 |
D012965 | Sodium Chloride | Sodium Chloride results in increased expression of CCL2 mRNA | 23634900 |
D017673 | Sodium Chloride, Dietary | "[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 mRNA" | 21135038 |
D017673 | Sodium Chloride, Dietary | "[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein" | 21135038 |
D017673 | Sodium Chloride, Dietary | "Mineralocorticoid Receptor Antagonists inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride, Dietary] results in increased expression of CCL2 protein]" | 21135038 |
D020358 | Sodium Cholate | [eicosapentaenoic acid ethyl ester co-treated with Sodium Cholate co-treated with Dietary Fats] results in increased expression of CCL2 mRNA | 23665937 |
D020358 | Sodium Cholate | [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of CCL2 mRNA | 26606054 |
D012967 | Sodium Dodecyl Sulfate | Sodium Dodecyl Sulfate results in decreased expression of CCL2 mRNA | 20713136 |
D012969 | Sodium Fluoride | [Sodium Fluoride co-treated with arsenic trioxide] results in increased expression of CCL2 protein | 22422340 |
D012969 | Sodium Fluoride | Sodium Fluoride inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | 22422340 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CCL2 mRNA | 22422340 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CCL2 protein | 22422340 |
D053260 | Soot | Soot results in decreased expression of CCL2 mRNA | 23634900 |
D053260 | Soot | Soot results in increased expression of CCL2 mRNA | 24669321 |
D053260 | Soot | Soot results in increased expression of CCL2 mRNA | 22461453|2655175 |
C508135 | spirodiclofen | spirodiclofen results in decreased expression of CCL2 | 21788198 |
C000602674 | SPL-334 | SPL-334 inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 26209236 |
C559087 | SR 1078 | SR 1078 results in increased expression of CCL2 mRNA | 28698385 |
C110630 | SR 144528 | "SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 mRNA]]" | 10218491 |
C110630 | SR 144528 | "SR 144528 inhibits the reaction [CNR2 protein promotes the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CCL2 protein]]" | 10218491 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin inhibits the reaction [4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein]] | 21832210 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin results in increased secretion of CCL2 protein | 21832210 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Dietary Fats results in increased secretion of CCL2 protein]] | 22193921 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased secretion of CCL2 protein] | 20667508 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin results in increased secretion of CCL2 protein | 20667508 |
C031183 | stearic acid | resveratrol inhibits the reaction [stearic acid results in increased expression of CCL2 mRNA] | 17374693 |
C031183 | stearic acid | stearic acid results in increased expression of CCL2 mRNA | 17374693 |
D013311 | Streptozocin | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein] | 21832210 |
D013311 | Streptozocin | CCL2 affects the susceptibility to Streptozocin | 16374426 |
D013311 | Streptozocin | [Dietary Fats co-treated with Streptozocin] results in increased expression of CCL2 protein | 27769711 |
D013311 | Streptozocin | EPHX2 gene mutant form inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein] | 21832210 |
D013311 | Streptozocin | esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of CCL2 protein] | 27769711 |
D013311 | Streptozocin | stannous mesoporphyrin inhibits the reaction [4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased secretion of CCL2 protein]] | 21832210 |
D013311 | Streptozocin | Streptozocin results in increased expression of CCL2 | 16374426 |
D013311 | Streptozocin | Streptozocin results in increased secretion of CCL2 protein | 21832210 |
D013311 | Streptozocin | Mycophenolic Acid inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 17624267 |
D013311 | Streptozocin | Mycophenolic Acid inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 17624267 |
D013311 | Streptozocin | PD 123319 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299 |
D013311 | Streptozocin | Pentoxifylline inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 19921414 |
D013311 | Streptozocin | procyanidin B2 inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 25199697 |
D013311 | Streptozocin | prolinedithiocarbamate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299 |
D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 24513509 |
D013311 | Streptozocin | rosiglitazone inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 18413206 |
D013311 | Streptozocin | Streptozocin results in increased expression of CCL2 mRNA | 15284299|1668480 |
D013311 | Streptozocin | Streptozocin results in increased expression of CCL2 protein | 17624267|1899990 |
D013311 | Streptozocin | Valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299|1762426 |
D013311 | Streptozocin | Valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 17624267 |
D013311 | Streptozocin | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 16684804 |
D013311 | Streptozocin | 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 23611540 |
D010042 | Ouabain | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]" | 11340305 |
D010042 | Ouabain | Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | 11340305 |
D010042 | Ouabain | Ouabain results in increased expression of CCL2 mRNA | 11340305 |
D010042 | Ouabain | Ouabain results in increased expression of CCL2 protein | 11340305 |
D010042 | Ouabain | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA] | 11340305 |
D010042 | Ouabain | Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] | 11340305 |
D013328 | Strophanthins | Strophanthins results in decreased expression of CCL2 protein | 20116850 |
C041711 | St. Thomas' Hospital cardioplegic solution | St. Thomas' Hospital cardioplegic solution results in increased expression of CCL2 mRNA | 16214533 |
D020058 | Styrene | Styrene results in increased expression of CCL2 mRNA | 15212811 |
D020058 | Styrene | Styrene results in increased expression of CCL2 protein | 15212811|1799325 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA | 26378955 |
D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA | 21641980 |
D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA | 26378955 |
D013395 | Sucrose | [Sucrose co-treated with Palmitates] results in increased expression of CCL2 mRNA | 26895660 |
D013427 | Sulfapyridine | Sulfapyridine results in decreased secretion of CCL2 protein | 12231210 |
D012460 | Sulfasalazine | Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA] | 17449585 |
C016766 | sulforafan | sulforafan results in increased expression of CCL2 mRNA | 26833863 |
C016766 | sulforafan | sulforafan inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA] | 23958496 |
C016766 | sulforafan | sulforafan inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
C016766 | sulforafan | "sulforafan inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]" | 21130106 |
D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of CCL2 protein | 27565714 |
D018170 | Sumatriptan | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
D018170 | Sumatriptan | Sumatriptan affects the reaction [Capsaicin results in increased expression of CCL2 protein] | 22150557 |
C074269 | Sunphenon | "Sunphenon inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]" | 24378064 |
C074269 | Sunphenon | Sunphenon results in increased expression of CCL2 mRNA | 24378064 |
D013481 | Superoxides | Superoxides affects the reaction [Fructose results in increased secretion of CCL2 protein] | 19158351 |
D013481 | Superoxides | "1,3-dimethylthiourea inhibits the reaction [Superoxides results in increased expression of CCL2 mRNA]" | 8856246 |
D013481 | Superoxides | Superoxides results in increased expression of CCL2 mRNA | 8856246 |
D016559 | Tacrolimus | 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein] | 23958496 |
D016559 | Tacrolimus | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]" | 23958496 |
D016559 | Tacrolimus | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]" | 23958496 |
D016559 | Tacrolimus | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein] | 23958496 |
D016559 | Tacrolimus | salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | sulforafan inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 23958496 |
D016559 | Tacrolimus | Tacrolimus results in increased expression of CCL2 mRNA | 23958496 |
D016559 | Tacrolimus | pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] | 12472797 |
D016559 | Tacrolimus | Tacrolimus results in increased expression of CCL2 mRNA | 12472797 |
C030192 | tagatose | tagatose results in increased secretion of CCL2 protein | 19158351 |
D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of CCL2 mRNA | 19059307 |
D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Dietary Fats results in increased expression of CCL2 mRNA] | 23038002 |
D013629 | Tamoxifen | Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CCL2 mRNA] | 23038002 |
D013656 | Taurocholic Acid | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA] | 21224055 |
D013656 | Taurocholic Acid | NR1H4 gene mutant form promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA] | 28505368 |
D013656 | Taurocholic Acid | pyrazolanthrone inhibits the reaction [NR1H4 gene mutant form promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA]] | 28505368 |
D013656 | Taurocholic Acid | Taurocholic Acid results in increased expression of CCL2 mRNA | 21224055 |
C046832 | t-butyloxycarbonyl-methionyl-leucyl-phenylalanine | t-butyloxycarbonyl-methionyl-leucyl-phenylalanine inhibits the reaction [resolvin D1 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]] | 21724996 |
C041348 | tcdA protein, Clostridium difficile | "astressin-2B inhibits the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA]" | 16920976 |
C041348 | tcdA protein, Clostridium difficile | "CRHR2 protein affects the reaction [tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA]" | 16920976 |
C041348 | tcdA protein, Clostridium difficile | "tcdA protein, Clostridium difficile results in increased expression of CCL2 mRNA" | 16920976 |
C084178 | telmisartan | telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22124178 |
C084178 | telmisartan | telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 22124178 |
C084178 | telmisartan | telmisartan results in decreased expression of CCL2 protein | 17922026 |
C047246 | temozolomide | CCL2 mRNA affects the susceptibility to temozolomide | 16365179 |
C047246 | temozolomide | temozolomide affects the activity of CCL2 protein | 17522861 |
C047246 | temozolomide | temozolomide results in decreased expression of CCL2 protein | 17522861 |
C076852 | terameprocol | terameprocol inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to CCL2 promoter]] | 21138578 |
C076852 | terameprocol | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 19133137|2113857 |
C076852 | terameprocol | terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 19133137|2113857 |
C041359 | terbinafine | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] | 16784723 |
C041359 | terbinafine | Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
C041359 | terbinafine | PTGER2 protein promotes the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
C041359 | terbinafine | PTGER3 protein promotes the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 16784723 |
C041359 | terbinafine | terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 16784723 |
C041359 | terbinafine | terbinafine inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 16784723 |
C501362 | terutroban | terutroban results in decreased expression of CCL2 mRNA | 20332187 |
C501413 | tesaglitazar | tesaglitazar results in decreased expression of CCL2 mRNA | 21515302 |
D013739 | Testosterone | Testosterone results in increased expression of CCL2 mRNA | 15788153 |
D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | 21441140 |
D013749 | Tetrachlorodibenzodioxin | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | 22262711 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [Dimethyl Sulfoxide results in increased secretion of CCL2 protein] | 26860701 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | 23397585 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | 19372248|2144114 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased secretion of CCL2 protein | 21685244 |
D013749 | Tetrachlorodibenzodioxin | [Chlorodiphenyl (54% Chlorine) co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCL2 | 24582691 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CCL2 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CCL2 mRNA | 16054899 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCL2 mRNA | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 16054899 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein] | 21858153 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CCL2 mRNA | 15591033|1605489 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of and results in increased secretion of CCL2 protein | 24154488 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | 17320037|1860642 |
D013749 | Tetrachlorodibenzodioxin | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] | 21215274 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | 19692669|2095900 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA | 19265715 |
C005806 | tetrachloroisophthalonitrile | tetrachloroisophthalonitrile results in decreased expression of CCL2 | 21788198 |
D013755 | Tetradecanoylphorbol Acetate | "5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA]" | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | eriodictyol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein | 17685462 |
D013755 | Tetradecanoylphorbol Acetate | kaempferol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 16376386 |
D013755 | Tetradecanoylphorbol Acetate | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein] | 16376386 |
D013755 | Tetradecanoylphorbol Acetate | sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein] | 17685462 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein | 17572062 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | 16376386|2043863 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein | 16376386 |
D013755 | Tetradecanoylphorbol Acetate | withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
D013755 | Tetradecanoylphorbol Acetate | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 19945525 |
D013755 | Tetradecanoylphorbol Acetate | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 19945525 |
D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA | 19063610|1994552 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 mRNA | 25613284 |
C009424 | tetramethrin | tetramethrin results in decreased expression of CCL2 | 21788198 |
C019107 | tetramethylthiourea | tetramethylthiourea results in decreased expression of CCL2 mRNA | 11128050 |
C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Copper Sulfate results in increased expression of CCL2 mRNA] | 24225134 |
C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Copper Sulfate results in increased expression of CCL2 protein] | 24225134 |
C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 mRNA] | 15541506 |
C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CCL2 protein] | 15541506 |
C020809 | tetrathiomolybdate | "tetrathiomolybdate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 mRNA]" | 21724870 |
C020809 | tetrathiomolybdate | "tetrathiomolybdate inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of and results in increased expression of CCL2 protein]" | 21724870 |
D013792 | Thalidomide | Thalidomide analog results in decreased expression of CCL2 mRNA | 20525221 |
D013792 | Thalidomide | Thalidomide results in decreased expression of CCL2 | 21788198 |
D019284 | Thapsigargin | Thapsigargin results in increased expression of CCL2 mRNA | 18951912 |
D019284 | Thapsigargin | Thapsigargin inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] | 18799549 |
D019284 | Thapsigargin | Thapsigargin inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 18799549 |
D019284 | Thapsigargin | Thapsigargin results in increased expression of CCL2 mRNA | 8764118 |
D019284 | Thapsigargin | Thapsigargin results in decreased expression of CCL2 mRNA | 20830808 |
D013806 | Theophylline | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of CCL2 protein | 18951874 |
C475227 | thieno(2,3-c)isoquinolin-5-one | "thieno(2,3-c)isoquinolin-5-one results in decreased expression of CCL2 mRNA" | 17438151|1912464 |
D013853 | Thioacetamide | Thioacetamide results in increased secretion of CCL2 protein | 27605418 |
D013853 | Thioacetamide | "Iron, Dietary affects the reaction [Thioacetamide affects the expression of CCL2 mRNA]" | 18032466 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of CCL2 mRNA | 19389872|2505150 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of CCL2 protein | 25051504 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of CCL2 mRNA] | 22488045 |
C027971 | thiodicarb | thiodicarb results in decreased expression of CCL2 | 21788198 |
D013864 | Thioglycolates | ADIPOQ gene affects the reaction [Thioglycolates results in increased secretion of CCL2 protein] | 18628355 |
D013864 | Thioglycolates | CCL2 gene affects the susceptibility to Thioglycolates | 19641140 |
D013864 | Thioglycolates | [CCL2 gene affects the susceptibility to Thioglycolates] which affects the secretion of CCL7 protein | 19641140 |
D013864 | Thioglycolates | Thioglycolates results in increased secretion of CCL2 protein | 18628355|1964114 |
D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in increased expression of CCL2 protein | 20931265 |
D013893 | Thiram | Thiram results in decreased expression of CCL2 | 21788198 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX promotes the reaction [Vehicle Emissions analog results in increased expression of CCL2 mRNA] | 25620054 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX results in increased expression of CCL2 mRNA | 25620054 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [Dipyridamole inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]] | 20940016 |
D008625 | Tiopronin | Tiopronin inhibits the reaction [chlorobenzene results in increased secretion of CCL2 protein] | 19800902 |
D014025 | Titanium | Titanium results in increased expression of CCL2 mRNA | 16392133 |
D014025 | Titanium | Titanium results in increased secretion of CCL2 protein | 16392133 |
D014025 | Titanium | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 20682337|2544633 |
D014025 | Titanium | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 25446332 |
D014025 | Titanium | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 25446332 |
D014025 | Titanium | Titanium promotes the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 25446332 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CCL2 mRNA | 19695317|2234229 |
C009495 | titanium dioxide | titanium dioxide results in increased secretion of CCL2 protein | 25526690 |
C009495 | titanium dioxide | "titanium dioxide promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]" | 27216632 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CCL2 mRNA | 19464567|2125934 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CCL2 protein | 19464567 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CCL2 | 22939914 |
C009495 | titanium dioxide | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | acetovanillone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | epigallocatechin gallate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | prolinedithiocarbamate inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | pyrazolanthrone inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | SB 203580 inhibits the reaction [titanium dioxide results in increased expression of CCL2 mRNA] | 23380242 |
C009495 | titanium dioxide | titanium dioxide results in increased expression of CCL2 mRNA | 23380242 |
C402696 | TMC 120A | TMC 120A results in decreased expression of CCL2 mRNA | 19818335 |
C402696 | TMC 120A | TMC 120A results in increased expression of CCL2 mRNA | 19818335 |
C423915 | TO-901317 | TO-901317 inhibits the reaction [IFNG promotes the reaction [STAT1 protein binds to CCL2 promoter]] | 21268089 |
C423915 | TO-901317 | TO-901317 inhibits the reaction [IFNG results in increased expression of CCL2 mRNA] | 21268089 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in decreased secretion of CCL2 protein | 28065790 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased secretion of CCL2 protein | 25800949 |
D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CCL2 mRNA | 24096154 |
D014028 | Tobacco Smoke Pollution | [APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CCL2 protein | 24096154 |
D014028 | Tobacco Smoke Pollution | NFE2L2 protein affects the reaction [Tobacco Smoke Pollution affects the expression of CCL2 mRNA] | 20133372 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of CCL2 mRNA | 20133372 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution deficiency inhibits the reaction [[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of CCL2 protein] | 24096154 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of and results in increased secretion of CCL2 protein | 24752502|2660913 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CCL2 mRNA | 24752502 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of and results in increased secretion of CCL2 protein | 27818348 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CCL2 mRNA | 23967268 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CCL2 protein | 24632068|2779374 |
C479163 | tofacitinib | Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL2 protein]] | 22121136 |
C479163 | tofacitinib | tofacitinib inhibits the reaction [OSM protein results in increased expression of CCL2 mRNA] | 23968543 |
C479163 | tofacitinib | tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 22121136 |
C479163 | tofacitinib | tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 22121136 |
C479163 | tofacitinib | tofacitinib results in decreased expression of CCL2 mRNA | 25398374 |
C056583 | tolmetin glucuronide | tolmetin glucuronide analog results in increased expression of CCL2 mRNA | 24104198 |
D014050 | Toluene | Toluene results in increased expression of CCL2 mRNA | 28245982 |
D014051 | Toluene 2,4-Diisocyanate | "CCL2 protein promotes the reaction [Toluene 2,4-Diisocyanate results in increased secretion of ENPP2 protein]" | 26072274 |
D014051 | Toluene 2,4-Diisocyanate | "Toluene 2,4-Diisocyanate results in increased expression of CCL2 mRNA" | 19647056 |
D014051 | Toluene 2,4-Diisocyanate | "Toluene 2,4-Diisocyanate results in increased expression of CCL2 protein" | 20219652 |
D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of CCL2 mRNA | 25729387 |
D019772 | Topotecan | Topotecan results in increased expression of CCL2 mRNA | 25729387 |
D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 11698246 |
D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 11698246 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Chloroquine results in increased expression of CCL2 mRNA] | 15139008 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA] | 16600694 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein] | 16600694 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL17A protein results in increased expression of CCL2 mRNA] | 12016129 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 18706406 |
D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in decreased expression of CCL2 mRNA | 12846738 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CCL2 mRNA" | 19682533 |
D014212 | Tretinoin | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA | 19828696 |
D014212 | Tretinoin | [arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL2 protein | 19828696 |
D014212 | Tretinoin | KAT2B protein promotes the reaction [Tretinoin results in increased expression of CCL2 mRNA] | 28053092 |
D014212 | Tretinoin | [Tretinoin co-treated with arsenic trioxide] results in increased expression of CCL2 mRNA | 15894607 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 mRNA | 16054129 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 protein | 12431242 |
D014212 | Tretinoin | Tretinoin results in increased expression of CCL2 mRNA | 15894607|1721838 |
D014212 | Tretinoin | Tretinoin results in increased expression of CCL2 protein | 17118196|1982869 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 mRNA | 16412693 |
D014212 | Tretinoin | Tretinoin results in decreased secretion of CCL2 protein | 16096774 |
D014212 | Tretinoin | Tretinoin inhibits the reaction [Puromycin Aminonucleoside results in increased expression of CCL2 protein] | 12813006 |
D014212 | Tretinoin | Tretinoin results in decreased expression of CCL2 mRNA | 12969142 |
D014212 | Tretinoin | "Tretinoin promotes the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 protein]" | 21130106 |
D014221 | Triamcinolone | Triamcinolone results in decreased expression of CCL2 protein | 20116850 |
D014255 | Trichothecenes | Trichothecenes results in increased expression of CCL2 mRNA | 24793808 |
C467051 | trifloxystrobin | trifloxystrobin results in decreased expression of CCL2 | 21788198 |
C053549 | triflumizol | triflumizol results in decreased expression of CCL2 | 21788198 |
C540456 | trikatu | trikatu inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA] | 27613480 |
C540456 | trikatu | trikatu inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein] | 27613480 |
C540456 | trikatu | trikatu inhibits the reaction [Freund's Adjuvant results in increased secretion of CCL2 protein] | 27613480 |
C046488 | trimethyltin | trimethyltin results in increased expression of CCL2 mRNA | 21435392|2400288 |
D014302 | Trinitrobenzenesulfonic Acid | icilin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 protein] | 23596210 |
D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA | 17982090 |
D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CCL2 protein | 23596210 |
D014302 | Trinitrobenzenesulfonic Acid | Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA] | 17449585 |
D014302 | Trinitrobenzenesulfonic Acid | Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA] | 17449585 |
D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of CCL2 mRNA | 17449585 |
D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of CCL2 mRNA | 21346803 |
C030665 | triphenyltin | triphenyltin results in increased expression of CCL2 mRNA | 12788061 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of CCL2 mRNA" | 26179874 |
C057693 | troglitazone | [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA | 20847119 |
C057693 | troglitazone | troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]] | 20847119 |
C057693 | troglitazone | troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA] | 20847119 |
C057693 | troglitazone | troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 15531761 |
C057693 | troglitazone | troglitazone results in decreased expression of CCL2 mRNA | 19140230 |
C057693 | troglitazone | troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein] | 17719033 |
C057693 | troglitazone | troglitazone results in decreased expression of CCL2 mRNA | 12468449 |
C057693 | troglitazone | troglitazone results in decreased expression of CCL2 mRNA | 21515302 |
C057693 | troglitazone | troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] | 10802155|1273264 |
C057693 | troglitazone | troglitazone inhibits the reaction [TNF protein results in increased secretion of CCL2 mRNA] | 10690939 |
C057693 | troglitazone | troglitazone inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] | 10690939|1080215 |
C080163 | trovafloxacin | trovafloxacin promotes the reaction [TNF protein results in increased expression of CCL2 protein] | 19638433 |
C002802 | tungsten carbide | [tungsten carbide co-treated with Cobalt] results in decreased expression of CCL2 mRNA | 18078969 |
D017973 | Tungsten Compounds | Tungsten Compounds results in decreased expression of CCL2 mRNA | 28666766 |
D014415 | Tunicamycin | Tunicamycin results in decreased expression of CCL2 mRNA | 22378314 |
D014415 | Tunicamycin | Tunicamycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein] | 18799549 |
C113580 | U 0126 | U 0126 inhibits the reaction [Allopurinol results in increased expression of CCL2 mRNA] | 26641773 |
C113580 | U 0126 | U 0126 inhibits the reaction [Diclofenac analog results in increased expression of CCL2 mRNA] | 24104198 |
C113580 | U 0126 | U 0126 inhibits the reaction [IL17A protein results in increased expression of CCL2 protein] | 12016129 |
C113580 | U 0126 | U 0126 results in decreased secretion of CCL2 protein | 23661232 |
C113580 | U 0126 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C113580 | U 0126 | U 0126 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] | 20354174 |
C113580 | U 0126 | U 0126 inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] | 24530660 |
C113580 | U 0126 | U 0126 inhibits the reaction [diphenylarsinic acid results in increased secretion of CCL2 protein] | 28087833 |
C113580 | U 0126 | U 0126 results in decreased expression of CCL2 mRNA | 20050970 |
C113580 | U 0126 | U 0126 results in decreased secretion of CCL2 protein | 20050970 |
C022884 | undecane | undecane results in increased expression of CCL2 protein | 17337753 |
D014501 | Uranium | Uranium results in decreased expression of CCL2 mRNA | 17566059 |
D014501 | Uranium | Uranium results in decreased expression of CCL2 protein | 16854789 |
D014527 | Uric Acid | Allopurinol inhibits the reaction [[Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein] | 19158351 |
D014527 | Uric Acid | [Fructose co-treated with Uric Acid] results in increased secretion of CCL2 protein | 19158351 |
D014527 | Uric Acid | Uric Acid results in increased secretion of CCL2 protein | 19158351 |
D014527 | Uric Acid | Probenecid inhibits the reaction [Uric Acid results in increased expression of CCL2 protein] | 16113518 |
D014527 | Uric Acid | Uric Acid results in increased expression of CCL2 protein | 16113518 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL2 mRNA]] | 21146893 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased expression of CCL2 mRNA | 24312631 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CCL2 mRNA] | 21146893 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL2 protein] | 21146893 |
D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22711276 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCL2 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CCL2 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CCL2 mRNA | 24935251|2627250 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CCL2 mRNA | 23179753|2718838 |
D000068756 | Valsartan | [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | 19225232 |
D000068756 | Valsartan | Valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 mRNA] | 16705055|1922523 |
D000068756 | Valsartan | Valsartan inhibits the reaction [AGT protein results in increased expression of CCL2 protein] | 16705055 |
D000068756 | Valsartan | Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]] | 19225232 |
D000068756 | Valsartan | Valsartan inhibits the reaction [sodium arsenite results in increased secretion of CCL2 protein] | 28973481 |
D000068756 | Valsartan | Valsartan inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 18436887 |
D000068756 | Valsartan | Valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 15284299|1762426 |
D000068756 | Valsartan | Valsartan inhibits the reaction [Streptozocin results in increased expression of CCL2 protein] | 17624267 |
D014638 | Vanadates | Vanadates results in decreased expression of CCL2 mRNA | 22714537 |
D014638 | Vanadates | Vanadates results in increased expression of CCL2 mRNA | 19063610 |
C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of CCL2 mRNA | 16330358 |
C034028 | vanadyl sulfate | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CCL2 mRNA] | 16684804 |
D001335 | Vehicle Emissions | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein] | 10919993 |
D001335 | Vehicle Emissions | cobaltiprotoporphyrin inhibits the reaction [Vehicle Emissions analog results in increased expression of CCL2 mRNA] | 25620054 |
D001335 | Vehicle Emissions | Glutathione inhibits the reaction [[Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein] | 10919993 |
D001335 | Vehicle Emissions | HMOX1 protein inhibits the reaction [Vehicle Emissions analog results in increased expression of CCL2 mRNA] | 25620054 |
D001335 | Vehicle Emissions | SB 203580 inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein] | 10919993 |
D001335 | Vehicle Emissions | SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vehicle Emissions analog results in decreased secretion of CCL2 protein]] | 10919993 |
D001335 | Vehicle Emissions | tin protoporphyrin IX promotes the reaction [Vehicle Emissions analog results in increased expression of CCL2 mRNA] | 25620054 |
D001335 | Vehicle Emissions | [Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased expression of CCL2 mRNA | 10919993 |
D001335 | Vehicle Emissions | [Vehicle Emissions analog co-treated with Dermatophagoides pteronyssinus antigen p 1] results in increased secretion of CCL2 protein | 10919993 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in decreased expression of CCL2 mRNA | 10359894|1091999 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in decreased secretion of CCL2 protein | 10359894|1091999 |
D001335 | Vehicle Emissions | Vehicle Emissions analog results in increased expression of CCL2 mRNA | 25620054 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of CCL2 protein | 28189646 |
D001335 | Vehicle Emissions | [Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of CCL2 mRNA | 28013216 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CCL2 mRNA | 20307321 |
D001335 | Vehicle Emissions | "Vehicle Emissions analog promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]" | 12832678 |
D001335 | Vehicle Emissions | Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 17076685 |
D001335 | Vehicle Emissions | Vehicle Emissions inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] | 17076685 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CCL2 mRNA | 21920430 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CCL2 protein | 12684091|1762018 |
D001335 | Vehicle Emissions | AGER mutant form inhibits the reaction [Vehicle Emissions results in increased secretion of CCL2 protein] | 21087909 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of and results in increased secretion of CCL2 protein | 23897985 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CCL2 mRNA | 15866772|2098021 |
D001335 | Vehicle Emissions | Vehicle Emissions results in increased secretion of CCL2 protein | 21087909 |
C551177 | vemurafenib | CCL2 protein results in decreased susceptibility to vemurafenib | 26684239 |
C551177 | vemurafenib | vemurafenib results in increased expression of CCL2 mRNA | 26684239 |
C551177 | vemurafenib | vemurafenib results in increased secretion of CCL2 protein | 26684239 |
C059141 | verlukast | verlukast inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
D014747 | Vinblastine | Vinblastine results in increased expression of CCL2 mRNA | 20624997 |
D014750 | Vincristine | Vincristine results in increased expression of CCL2 mRNA | 23649840 |
D014750 | Vincristine | Vincristine results in increased expression of CCL2 mRNA | 20624997 |
D014801 | Vitamin A | Vitamin A results in decreased expression of CCL2 protein | 16988133 |
D014801 | Vitamin A | Vitamin A affects the expression of CCL2 protein | 25051504 |
D014801 | Vitamin A | Vitamin A results in increased expression of CCL2 mRNA | 25051504 |
D009536 | Niacinamide | Niacinamide results in decreased expression of CCL2 protein | 14627904 |
D014805 | Vitamin B 12 | [Choline co-treated with Betaine co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CCL2 mRNA | 22648174 |
D014810 | Vitamin E | alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | 19735175 |
D014810 | Vitamin E | Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] | 19735175 |
D014810 | Vitamin E | Vitamin E deficiency results in increased expression of CCL2 protein | 19735175 |
C111237 | vorinostat | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CCL2 mRNA] | 22711276 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCL2 mRNA" | 27188386 |
C111237 | vorinostat | vorinostat results in increased expression of CCL2 mRNA | 26272509 |
C009684 | withaferin A | withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] | 20438634 |
C009687 | wortmannin | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] | 22225513 |
C581157 | XL147 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA | 27935865 |
D015215 | Zidovudine | Zidovudine results in increased expression of CCL2 protein | 17668557 |
C063449 | zileuton | zileuton inhibits the reaction [CCL2 protein results in increased abundance of Leukotriene B4] | 12388339 |
C063449 | zileuton | zileuton inhibits the reaction [Ovalbumin results in increased expression of CCL2 mRNA] | 12794006 |
D015032 | Zinc | IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of CCL2 protein] | 18215484 |
D015032 | Zinc | MT1A gene polymorphism affects the reaction [Zinc results in decreased expression of CCL2 protein] | 18215484 |
D015032 | Zinc | Zinc results in decreased expression of CCL2 protein | 18215484|2042773 |
D015032 | Zinc | TNF protein promotes the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA] | 23503329 |
D015032 | Zinc | [Zinc co-treated with Nickel co-treated with Cobalt] affects the reaction [Dietary Fats affects the expression of CCL2 mRNA] | 23503329 |
D015032 | Zinc | [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CCL2 mRNA | 23503329 |
C042103 | zinc nitrate | MYD88 mutant form inhibits the reaction [zinc nitrate results in increased expression of CCL2 mRNA] | 23352990 |
C042103 | zinc nitrate | zinc nitrate results in increased expression of CCL2 mRNA | 23352990 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased secretion of CCL2 protein | 24746987 |
D015034 | Zinc Oxide | MYD88 mutant form inhibits the reaction [Zinc Oxide analog results in increased expression of CCL2 mRNA] | 23352990 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased expression of CCL2 mRNA | 23352990 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased expression of CCL2 protein | 20851137 |
C017803 | zinc protoporphyrin | zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of CCL2 protein] | 20357190 |
C017803 | zinc protoporphyrin | zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of CCL2 mRNA] | 23892052 |
C031238 | zinc sulfide | [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA | 21481475 |
C031238 | zinc sulfide | [cadmium selenide co-treated with zinc sulfide] results in decreased expression of CCL2 mRNA | 22342292 |
C088658 | zoledronic acid | zoledronic acid promotes the reaction [Gossypol results in decreased expression of CCL2 mRNA] | 19825521 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of CCL2 mRNA | 24714768 |
C451427 | zoxamide | zoxamide results in decreased expression of CCL2 | 21788198 |
D015054 | Zymosan | Zymosan affects the secretion of CCL2 protein | 15196211 |
D015054 | Zymosan | Zymosan results in increased secretion of CCL2 protein | 15196211 |
D015054 | Zymosan | CCL2 gene affects the susceptibility to Zymosan | 19641140 |
D015054 | Zymosan | CCR2 protein affects the reaction [Zymosan results in increased expression of CCL2 protein] | 12845637 |
D015054 | Zymosan | fluridone inhibits the reaction [Zymosan results in increased expression of CCL2 protein] | 24211328 |
D015054 | Zymosan | Zymosan results in increased expression of CCL2 mRNA | 14507659|9973430 |
D015054 | Zymosan | Zymosan results in increased expression of CCL2 protein | 12845637|1757215 |
D015054 | Zymosan | Zymosan results in increased secretion of CCL2 protein | 19641140|9973430 |